{"parse":{"title":"DNA vaccination","pageid":45570,"revid":851112829,"text":{"*":"<div class=\"mw-parser-output\"><div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:252px;\"><a href=\"/wiki/File:Making_of_a_DNA_vaccine.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/da/Making_of_a_DNA_vaccine.jpg/250px-Making_of_a_DNA_vaccine.jpg\" width=\"250\" height=\"401\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/da/Making_of_a_DNA_vaccine.jpg/375px-Making_of_a_DNA_vaccine.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/da/Making_of_a_DNA_vaccine.jpg/500px-Making_of_a_DNA_vaccine.jpg 2x\" data-file-width=\"725\" data-file-height=\"1164\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Making_of_a_DNA_vaccine.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>The making of a DNA vaccine.</div></div></div>\n<p><b>DNA vaccination</b> is a technique for protecting against disease by injection with <a href=\"/wiki/Genetically_engineered\" class=\"mw-redirect\" title=\"Genetically engineered\">genetically engineered</a> <a href=\"/wiki/DNA\" title=\"DNA\">DNA</a> so cells directly produce an <a href=\"/wiki/Antigen\" title=\"Antigen\">antigen</a>, producing a protective <a href=\"/wiki/Immunological_response\" class=\"mw-redirect\" title=\"Immunological response\">immunological response</a>. DNA vaccines have potential advantages over conventional vaccines, including the ability to induce a wider range of immune response types.\n</p><p>Several DNA vaccines are available for <a href=\"/wiki/Veterinary_medicine\" title=\"Veterinary medicine\">veterinary</a> use. Currently no DNA vaccines have been approved for human use. Research is investigating the approach for <a href=\"/wiki/Virus\" title=\"Virus\">viral</a>, <a href=\"/wiki/Bacterial\" class=\"mw-redirect\" title=\"Bacterial\">bacterial</a> and <a href=\"/wiki/Parasitic\" class=\"mw-redirect\" title=\"Parasitic\">parasitic</a> diseases in humans, as well as for several cancers.\n</p>\n<div class=\"toclimit-3\"><div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#History\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">History</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-2\"><a href=\"#Whole_organism\"><span class=\"tocnumber\">1.1</span> <span class=\"toctext\">Whole organism</span></a></li>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Subunit\"><span class=\"tocnumber\">1.2</span> <span class=\"toctext\">Subunit</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#DNA\"><span class=\"tocnumber\">1.3</span> <span class=\"toctext\">DNA</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Applications\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Applications</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#Advantages_and_disadvantages\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Advantages and disadvantages</span></a></li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#Plasmid_vectors\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Plasmid vectors</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Vector_design\"><span class=\"tocnumber\">4.1</span> <span class=\"toctext\">Vector design</span></a></li>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Mechanism_of_plasmids\"><span class=\"tocnumber\">4.2</span> <span class=\"toctext\">Mechanism of plasmids</span></a></li>\n<li class=\"toclevel-2 tocsection-10\"><a href=\"#Vaccine_insert_design\"><span class=\"tocnumber\">4.3</span> <span class=\"toctext\">Vaccine insert design</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#Delivery\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Delivery</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-12\"><a href=\"#Saline_injection\"><span class=\"tocnumber\">5.1</span> <span class=\"toctext\">Saline injection</span></a></li>\n<li class=\"toclevel-2 tocsection-13\"><a href=\"#Gene_gun\"><span class=\"tocnumber\">5.2</span> <span class=\"toctext\">Gene gun</span></a></li>\n<li class=\"toclevel-2 tocsection-14\"><a href=\"#Dosage\"><span class=\"tocnumber\">5.3</span> <span class=\"toctext\">Dosage</span></a></li>\n<li class=\"toclevel-2 tocsection-15\"><a href=\"#Alternatives\"><span class=\"tocnumber\">5.4</span> <span class=\"toctext\">Alternatives</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-16\"><a href=\"#Immune_response\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Immune response</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-17\"><a href=\"#Helper_T_cell_responses\"><span class=\"tocnumber\">6.1</span> <span class=\"toctext\">Helper T cell responses</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-18\"><a href=\"#Other_types_of_T-cell_help\"><span class=\"tocnumber\">6.1.1</span> <span class=\"toctext\">Other types of T-cell help</span></a></li>\n<li class=\"toclevel-3 tocsection-19\"><a href=\"#Basis_for_different_types_of_T-cell_help\"><span class=\"tocnumber\">6.1.2</span> <span class=\"toctext\">Basis for different types of T-cell help</span></a></li>\n<li class=\"toclevel-3 tocsection-20\"><a href=\"#Practical_uses_of_polarised_T-cell_help\"><span class=\"tocnumber\">6.1.3</span> <span class=\"toctext\">Practical uses of polarised T-cell help</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-2 tocsection-21\"><a href=\"#Cytotoxic_T-cell_responses\"><span class=\"tocnumber\">6.2</span> <span class=\"toctext\">Cytotoxic T-cell responses</span></a></li>\n<li class=\"toclevel-2 tocsection-22\"><a href=\"#Humoral_(antibody)_response\"><span class=\"tocnumber\">6.3</span> <span class=\"toctext\">Humoral (antibody) response</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-23\"><a href=\"#Kinetics_of_antibody_response\"><span class=\"tocnumber\">6.3.1</span> <span class=\"toctext\">Kinetics of antibody response</span></a></li>\n</ul>\n</li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-24\"><a href=\"#Mechanistic_basis_for_DNA-raised_immune_responses\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">Mechanistic basis for DNA-raised immune responses</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-25\"><a href=\"#DNA_uptake_mechanism\"><span class=\"tocnumber\">7.1</span> <span class=\"toctext\">DNA uptake mechanism</span></a></li>\n<li class=\"toclevel-2 tocsection-26\"><a href=\"#Antigen_presentation_by_bone_marrow-derived_cells\"><span class=\"tocnumber\">7.2</span> <span class=\"toctext\">Antigen presentation by bone marrow-derived cells</span></a></li>\n<li class=\"toclevel-2 tocsection-27\"><a href=\"#Target_site_role\"><span class=\"tocnumber\">7.3</span> <span class=\"toctext\">Target site role</span></a></li>\n<li class=\"toclevel-2 tocsection-28\"><a href=\"#Maintenance_of_immune_response\"><span class=\"tocnumber\">7.4</span> <span class=\"toctext\">Maintenance of immune response</span></a></li>\n<li class=\"toclevel-2 tocsection-29\"><a href=\"#Interferons\"><span class=\"tocnumber\">7.5</span> <span class=\"toctext\">Interferons</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-30\"><a href=\"#Immune_response_modulation\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">Immune response modulation</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-31\"><a href=\"#Cytokine_modulation\"><span class=\"tocnumber\">8.1</span> <span class=\"toctext\">Cytokine modulation</span></a></li>\n<li class=\"toclevel-2 tocsection-32\"><a href=\"#Immunostimulatory_CpG_motifs\"><span class=\"tocnumber\">8.2</span> <span class=\"toctext\">Immunostimulatory CpG motifs</span></a></li>\n<li class=\"toclevel-2 tocsection-33\"><a href=\"#Alternative_boosts\"><span class=\"tocnumber\">8.3</span> <span class=\"toctext\">Alternative boosts</span></a></li>\n<li class=\"toclevel-2 tocsection-34\"><a href=\"#Enhancing_immune_responses\"><span class=\"tocnumber\">8.4</span> <span class=\"toctext\">Enhancing immune responses</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-35\"><a href=\"#DNA_2\"><span class=\"tocnumber\">8.4.1</span> <span class=\"toctext\">DNA</span></a></li>\n<li class=\"toclevel-3 tocsection-36\"><a href=\"#Alphavirus_vectors\"><span class=\"tocnumber\">8.4.2</span> <span class=\"toctext\">Alphavirus vectors</span></a></li>\n</ul>\n</li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-37\"><a href=\"#See_also\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-38\"><a href=\"#References\"><span class=\"tocnumber\">10</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-39\"><a href=\"#External_links\"><span class=\"tocnumber\">11</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n</div>\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=1\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p><a href=\"/wiki/Vaccine\" title=\"Vaccine\">Vaccines</a> have eliminated naturally occurring <a href=\"/wiki/Smallpox\" title=\"Smallpox\">smallpox</a>, and nearly eliminated <a href=\"/wiki/Polio\" class=\"mw-redirect\" title=\"Polio\">polio</a>, while other diseases, such as <a href=\"/wiki/Typhus\" title=\"Typhus\">typhus</a>, <a href=\"/wiki/Rotavirus\" title=\"Rotavirus\">rotavirus</a>, <a href=\"/wiki/Hepatitis\" title=\"Hepatitis\">hepatitis</a> A and B and others are well controlled. Conventional vaccines cover a small number of diseases, but are not effective at controlling many other infections.\n</p>\n<h3><span class=\"mw-headline\" id=\"Whole_organism\">Whole organism</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=2\" title=\"Edit section: Whole organism\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>First generation vaccines are whole-organism vaccines \u2013 either live and <a href=\"/wiki/Attenuated_virus\" class=\"mw-redirect\" title=\"Attenuated virus\">weakened</a>, or killed forms.<sup id=\"cite_ref-Alarcon1999_1-0\" class=\"reference\"><a href=\"#cite_note-Alarcon1999-1\">&#91;1&#93;</a></sup> Live, attenuated vaccines, such as smallpox and polio vaccines, are able to induce <a href=\"/wiki/Cytotoxic_T_cell\" title=\"Cytotoxic T cell\">killer T-cell</a> (T<sub>C</sub> or CTL) responses, <a href=\"/wiki/Helper_T_cell\" class=\"mw-redirect\" title=\"Helper T cell\">helper T-cell</a> (T<sub>H</sub>) responses and <a href=\"/wiki/Antibody\" title=\"Antibody\">antibody</a> <a href=\"/wiki/Immune_system\" title=\"Immune system\">immunity</a>. However, attenuated forms of a <a href=\"/wiki/Pathogen\" title=\"Pathogen\">pathogen</a> can convert to a dangerous form and may cause disease in <a href=\"/wiki/Immunocompromised\" class=\"mw-redirect\" title=\"Immunocompromised\">immunocompromised</a> vaccine recipients (such as those with <a href=\"/wiki/AIDS\" class=\"mw-redirect\" title=\"AIDS\">AIDS</a>). While killed vaccines do not have this risk, they cannot generate specific killer T cell responses and may not work at all for some diseases.<sup id=\"cite_ref-Alarcon1999_1-1\" class=\"reference\"><a href=\"#cite_note-Alarcon1999-1\">&#91;1&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Subunit\">Subunit</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=3\" title=\"Edit section: Subunit\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Second generation vaccines were developed to reduce the risks from live vaccines. These are subunit vaccines, consisting of specific <a href=\"/wiki/Protein\" title=\"Protein\">protein</a> <a href=\"/wiki/Antigen\" title=\"Antigen\">antigens</a> (such as <a href=\"/wiki/Tetanus\" title=\"Tetanus\">tetanus</a> or <a href=\"/wiki/Diphtheria\" title=\"Diphtheria\">diphtheria</a> <a href=\"/wiki/Toxoid\" title=\"Toxoid\">toxoid</a>) or <a href=\"/wiki/Recombinant_DNA\" title=\"Recombinant DNA\">recombinant</a> protein components (such as the hepatitis B surface antigen). They can generate T<sub>H</sub> and antibody responses, but not killer T cell responses.\n</p>\n<h3><span class=\"mw-headline\" id=\"DNA\">DNA</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=4\" title=\"Edit section: DNA\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>DNA vaccines are third generation vaccines. They contain DNA that codes for specific proteins (antigens) from a pathogen. The DNA is injected into the body and taken up by cells, whose normal metabolic processes synthesize proteins based on the genetic code in the plasmid that they have taken up. Because these proteins contain regions of amino acid sequences that are characteristic of bacteria or viruses, they are recognized as foreign and when they are processed by the host cells and displayed on their surface, the immune system is alerted, which then triggers immune responses.<sup id=\"cite_ref-Alarcon1999_1-2\" class=\"reference\"><a href=\"#cite_note-Alarcon1999-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Robinson2000_2-0\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup>\n</p><p>Alternatively, the DNA may be encapsulated in protein to facilitate cell entry. If this <a href=\"/wiki/Capsid\" title=\"Capsid\">capsid</a> protein is included in the DNA, the resulting vaccine can combine the potency of a live vaccine without reversion risks. In 1983, <a href=\"/wiki/Enzo_Paoletti\" title=\"Enzo Paoletti\">Enzo Paoletti</a> and Dennis Panicali at the New York Department of Health devised a strategy to produce <a href=\"/wiki/Recombinant_DNA\" title=\"Recombinant DNA\">recombinant DNA</a> vaccines by using genetic engineering to transform ordinary <a href=\"/wiki/Smallpox_vaccine\" title=\"Smallpox vaccine\">smallpox vaccine</a> into vaccines that may be able to prevent other diseases.<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup> They altered the DNA of <a href=\"/wiki/Cowpox\" title=\"Cowpox\">cowpox</a> virus by inserting a gene from other viruses (namely <a href=\"/wiki/Herpes_simplex_virus\" title=\"Herpes simplex virus\">Herpes simplex virus</a>, <a href=\"/wiki/Hepatitis_B\" title=\"Hepatitis B\">hepatitis B</a> and <a href=\"/wiki/Influenza\" title=\"Influenza\">influenza</a>).<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup><sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup>\n</p><p>In 2016 a DNA vaccine for the <a href=\"/wiki/Zika_virus\" title=\"Zika virus\">Zika virus</a> began testing at the <a href=\"/wiki/National_Institutes_of_Health\" title=\"National Institutes of Health\">National Institutes of Health</a>. The study was planned to involve up to 120 subjects between 18 and 35. Separately, Inovio Pharmaceuticals and GeneOne Life Science began tests of a different DNA vaccine against Zika in Miami. The NIH vaccine is injected into the upper arm under high pressure. Manufacturing the vaccines in volume remains unsolved.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Applications\">Applications</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=5\" title=\"Edit section: Applications\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>No DNA vaccines have been approved for human use in the United States. Few experimental trials have evoked a response strong enough to protect against disease and the technique's usefulness remains to be proven in humans. A <a href=\"/wiki/Veterinary\" class=\"mw-redirect\" title=\"Veterinary\">veterinary</a> DNA vaccine to protect <a href=\"/wiki/Horse\" title=\"Horse\">horses</a> from <a href=\"/wiki/West_Nile_virus\" title=\"West Nile virus\">West Nile virus</a> has been approved.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup><sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Advantages_and_disadvantages\">Advantages and disadvantages</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=6\" title=\"Edit section: Advantages and disadvantages\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table class=\"wikitable\">\n<caption>Table 1. Advantages And Disadvantages Of Nucleic Acid-Based Immunization\n</caption>\n<tbody><tr>\n<th>Advantages</th>\n<th>Disadvantages\n</th></tr>\n<tr>\n<td>\n<ul><li>No risk for infection<sup id=\"cite_ref-Robinson2000_2-1\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup></li>\n<li>Antigen presentation by both <a href=\"/wiki/Major_histocompatibility_complex\" title=\"Major histocompatibility complex\">MHC</a> <a href=\"/wiki/MHC_class_I\" title=\"MHC class I\">class I</a> and <a href=\"/wiki/MHC_class_II\" title=\"MHC class II\">class II</a> molecules<sup id=\"cite_ref-Robinson2000_2-2\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup></li>\n<li>Polarise T-cell response toward type 1 or type 2<sup id=\"cite_ref-Robinson2000_2-3\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup></li>\n<li>Immune response focused on antigen of interest</li>\n<li>Ease of development and production<sup id=\"cite_ref-Robinson2000_2-4\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup></li>\n<li>Stability for storage and shipping</li>\n<li>Cost-effectiveness</li>\n<li>Obviates need for peptide synthesis, expression and purification of recombinant proteins and use of toxic adjuvants<sup id=\"cite_ref-Sedegah1994_9-0\" class=\"reference\"><a href=\"#cite_note-Sedegah1994-9\">&#91;9&#93;</a></sup></li>\n<li>Long-term persistence of immunogen<sup id=\"cite_ref-Alarcon1999_1-3\" class=\"reference\"><a href=\"#cite_note-Alarcon1999-1\">&#91;1&#93;</a></sup></li>\n<li><i>In vivo</i> expression ensures protein more closely resembles normal eukaryotic structure, with accompanying post-translational modifications<sup id=\"cite_ref-Alarcon1999_1-4\" class=\"reference\"><a href=\"#cite_note-Alarcon1999-1\">&#91;1&#93;</a></sup></li></ul>\n</td>\n<td>\n<ul><li>Limited to protein immunogens (not useful for non-protein based antigens such as bacterial polysaccharides)</li>\n<li>Risk of affecting genes controlling cell growth</li>\n<li>Possibility of inducing antibody production against DNA</li>\n<li>Possibility of tolerance to the antigen (protein) produced</li>\n<li>Potential for atypical processing of bacterial and parasite proteins<sup id=\"cite_ref-Robinson2000_2-5\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup></li></ul>\n</td></tr></tbody></table>\n<h2><span class=\"mw-headline\" id=\"Plasmid_vectors\">Plasmid vectors</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=7\" title=\"Edit section: Plasmid vectors\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Vector_design\">Vector design</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=8\" title=\"Edit section: Vector design\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>DNA vaccines elicit the best immune response when highly active expression vectors are used. These are <a href=\"/wiki/Plasmids\" class=\"mw-redirect\" title=\"Plasmids\">plasmids</a> that usually consist of a strong viral promoter to drive the in vivo <a href=\"/wiki/Transcription_(genetics)\" class=\"mw-redirect\" title=\"Transcription (genetics)\">transcription</a> and <a href=\"/wiki/Translation_(biology)\" title=\"Translation (biology)\">translation</a> of the gene (or <a href=\"/wiki/Complementary_DNA\" title=\"Complementary DNA\">complementary DNA</a>) of interest.<sup id=\"cite_ref-Mor1995_10-0\" class=\"reference\"><a href=\"#cite_note-Mor1995-10\">&#91;10&#93;</a></sup> <a href=\"/wiki/Interferon_alfa-2b\" title=\"Interferon alfa-2b\">Intron A</a> may sometimes be included to improve <a href=\"/wiki/MRNA\" class=\"mw-redirect\" title=\"MRNA\">mRNA</a> stability and hence increase protein expression.<sup id=\"cite_ref-Leitner1997_11-0\" class=\"reference\"><a href=\"#cite_note-Leitner1997-11\">&#91;11&#93;</a></sup> Plasmids also include a strong <a href=\"/wiki/Polyadenylation\" title=\"Polyadenylation\">polyadenylation</a>/transcriptional termination signal, such as bovine <a href=\"/wiki/Growth_hormone\" title=\"Growth hormone\">growth hormone</a> or rabbit <a href=\"/wiki/Beta-globulin\" class=\"mw-redirect\" title=\"Beta-globulin\">beta-globulin</a> polyadenylation sequences.<sup id=\"cite_ref-Alarcon1999_1-5\" class=\"reference\"><a href=\"#cite_note-Alarcon1999-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Robinson2000_2-6\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-B\u00f6hm1996_12-0\" class=\"reference\"><a href=\"#cite_note-B\u00f6hm1996-12\">&#91;12&#93;</a></sup> <a href=\"/wiki/Cistron\" title=\"Cistron\">Polycistronic</a> vectors (ones located at multiple genome sites) are sometimes constructed to express more than one immunogen, or to express an immunogen and an immunostimulatory protein.<sup id=\"cite_ref-Lewis1999_13-0\" class=\"reference\"><a href=\"#cite_note-Lewis1999-13\">&#91;13&#93;</a></sup>\n</p><p>Because the plasmid is the \u201cvehicle\u201d from which the immunogen is expressed, optimising vector design for maximal protein expression is essential.<sup id=\"cite_ref-Lewis1999_13-1\" class=\"reference\"><a href=\"#cite_note-Lewis1999-13\">&#91;13&#93;</a></sup> One way of enhancing protein expression is by optimising the <a href=\"/wiki/Codon\" class=\"mw-redirect\" title=\"Codon\">codon</a> usage of pathogenic mRNAs for <a href=\"/wiki/Eukaryotic\" class=\"mw-redirect\" title=\"Eukaryotic\">eukaryotic</a> cells. Pathogens often have different <a href=\"/wiki/GC-content\" title=\"GC-content\">AT-contents</a> than the target species, so altering the <a href=\"/wiki/Gene_sequence\" class=\"mw-redirect\" title=\"Gene sequence\">gene sequence</a> of the immunogen to reflect the <a href=\"/wiki/Genetic_code\" title=\"Genetic code\">codons</a> more commonly used in the target species may improve its expression.<sup id=\"cite_ref-Andre1998_14-0\" class=\"reference\"><a href=\"#cite_note-Andre1998-14\">&#91;14&#93;</a></sup>\n</p><p>Another consideration is the choice of <a href=\"/wiki/Promoter_(biology)\" class=\"mw-redirect\" title=\"Promoter (biology)\">promoter</a>. The <a href=\"/wiki/SV40\" title=\"SV40\">SV40</a> promoter was conventionally used until research showed that vectors driven by the <a href=\"/wiki/Rous_Sarcoma_Virus\" class=\"mw-redirect\" title=\"Rous Sarcoma Virus\">Rous Sarcoma Virus</a> (RSV) promoter had much higher expression rates.<sup id=\"cite_ref-Alarcon1999_1-6\" class=\"reference\"><a href=\"#cite_note-Alarcon1999-1\">&#91;1&#93;</a></sup> More recently, expression rates have been further increased by the use of the <a href=\"/wiki/Cytomegalovirus\" title=\"Cytomegalovirus\">cytomegalovirus</a> (CMV) immediate early promoter. Inclusion of the <a href=\"/wiki/Simian_retrovirus\" title=\"Simian retrovirus\">Mason-Pfizer monkey virus</a> (MPV)-CTE with/without rev increased envelope expression. Furthermore, the CTE+rev construct was significantly more immunogenic than CTE-alone vector.<sup id=\"cite_ref-Muthumani1998_15-0\" class=\"reference\"><a href=\"#cite_note-Muthumani1998-15\">&#91;15&#93;</a></sup> Additional modifications to improve expression rates include the insertion of enhancer sequences, synthetic <a href=\"/wiki/Introns\" class=\"mw-redirect\" title=\"Introns\">introns</a>, <a href=\"/wiki/Adenovirus\" class=\"mw-redirect\" title=\"Adenovirus\">adenovirus</a> tripartite leader (TPL) sequences and modifications to the polyadenylation and transcriptional termination sequences.<sup id=\"cite_ref-Alarcon1999_1-7\" class=\"reference\"><a href=\"#cite_note-Alarcon1999-1\">&#91;1&#93;</a></sup> An example of DNA vaccine plasmid is pVAC, which uses SV40 <a href=\"/wiki/Promoter_(biology)\" class=\"mw-redirect\" title=\"Promoter (biology)\">promoter</a>.\n</p><p>Structural instability phenomena are of particular concern for plasmid manufacture, DNA vaccination and gene therapy.<sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup> Accessory regions pertaining to the plasmid backbone may engage in a wide range of structural instability phenomena. Well-known catalysts of genetic instability include direct, inverted and tandem repeats, which are conspicuous in many commercially available cloning and expression vectors. Therefore, the reduction or complete elimination of extraneous noncoding backbone sequences would pointedly reduce the propensity for such events to take place and consequently the overall plasmid's recombinogenic potential.<sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Mechanism_of_plasmids\">Mechanism of plasmids</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=9\" title=\"Edit section: Mechanism of plasmids\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Once the plasmid inserts itself into the transfected cell nucleus, it codes for a peptide string of a foreign antigen. On its surface the cell displays the foreign antigen with both histocompatibility complex (MHC) classes I and class II molecules. The antigen-presenting cell then travels to the lymph nodes and presents the antigen peptide and costimulatory molecule signaled by T-cell, initiating the immune response.<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Vaccine_insert_design\">Vaccine insert design</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=10\" title=\"Edit section: Vaccine insert design\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Immunogens can be targeted to various cellular compartments to improve antibody or cytotoxic T-cell responses. Secreted or <a href=\"/wiki/Plasma_membrane\" class=\"mw-redirect\" title=\"Plasma membrane\">plasma membrane</a>-bound antigens are more effective at inducing antibody responses than <a href=\"/wiki/Cytosolic\" class=\"mw-redirect\" title=\"Cytosolic\">cytosolic</a> antigens, while <a href=\"/wiki/Cytotoxic_T-cell\" class=\"mw-redirect\" title=\"Cytotoxic T-cell\">cytotoxic T-cell</a> responses can be improved by targeting antigens for cytoplasmic degradation and subsequent entry into the <a href=\"/wiki/Major_histocompatibility_complex\" title=\"Major histocompatibility complex\">major histocompatibility complex</a> (MHC) class I pathway.<sup id=\"cite_ref-Robinson2000_2-7\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup> This is usually accomplished by the addition of <a href=\"/wiki/N-terminal\" class=\"mw-redirect\" title=\"N-terminal\">N-terminal</a> <a href=\"/wiki/Ubiquitin\" title=\"Ubiquitin\">ubiquitin</a> signals.<sup id=\"cite_ref-Rodriguez1997_19-0\" class=\"reference\"><a href=\"#cite_note-Rodriguez1997-19\">&#91;19&#93;</a></sup><sup id=\"cite_ref-Tobery1997_20-0\" class=\"reference\"><a href=\"#cite_note-Tobery1997-20\">&#91;20&#93;</a></sup><sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup>\n</p><p>The <a href=\"/wiki/Protein_conformation\" class=\"mw-redirect\" title=\"Protein conformation\">conformation</a> of the protein can also affect antibody responses. \u201cOrdered\u201d structures (such as viral particles) are more effective than unordered structures.<sup id=\"cite_ref-Wunderlich2000_22-0\" class=\"reference\"><a href=\"#cite_note-Wunderlich2000-22\">&#91;22&#93;</a></sup> Strings of minigenes (or MHC class I <a href=\"/wiki/Epitopes\" class=\"mw-redirect\" title=\"Epitopes\">epitopes</a>) from different pathogens raise cytotoxic T-cell responses to some pathogens, especially if a TH epitope is also included.<sup id=\"cite_ref-Robinson2000_2-8\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Delivery\">Delivery</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=11\" title=\"Edit section: Delivery\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Gene_therapy.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/3d/Gene_therapy.jpg/220px-Gene_therapy.jpg\" width=\"220\" height=\"165\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/3d/Gene_therapy.jpg/330px-Gene_therapy.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/3d/Gene_therapy.jpg/440px-Gene_therapy.jpg 2x\" data-file-width=\"495\" data-file-height=\"371\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Gene_therapy.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>DNA vaccine and Gene therapy techniques are similar.</div></div></div>\n<p>DNA vaccines have been introduced into animal tissues by multiple methods.\n</p>\n<h3><span class=\"mw-headline\" id=\"Saline_injection\">Saline injection</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=12\" title=\"Edit section: Saline injection\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The two most popular approaches are injection of DNA in <a href=\"/wiki/Saline_(medicine)\" title=\"Saline (medicine)\">saline</a>, using a standard hypodermic needle and <a href=\"/wiki/Gene_gun\" title=\"Gene gun\">gene gun</a> delivery.<sup id=\"cite_ref-Weiner1999_23-0\" class=\"reference\"><a href=\"#cite_note-Weiner1999-23\">&#91;23&#93;</a></sup> Injection in saline is normally conducted intramuscularly (IM) in <a href=\"/wiki/Skeletal_muscle\" title=\"Skeletal muscle\">skeletal muscle</a>, or <a href=\"/wiki/Dermis\" title=\"Dermis\">intradermally</a> (ID), delivering DNA to extracellular spaces. This can be assisted by <a href=\"/wiki/Electroporation\" title=\"Electroporation\">electroporation</a>;<sup id=\"cite_ref-Widera2000_24-0\" class=\"reference\"><a href=\"#cite_note-Widera2000-24\">&#91;24&#93;</a></sup> by temporarily damaging muscle fibres with myotoxins such as <a href=\"/wiki/Bupivacaine\" title=\"Bupivacaine\">bupivacaine</a>; or by using hypertonic solutions of saline or <a href=\"/wiki/Sucrose\" title=\"Sucrose\">sucrose</a>.<sup id=\"cite_ref-Alarcon1999_1-8\" class=\"reference\"><a href=\"#cite_note-Alarcon1999-1\">&#91;1&#93;</a></sup> Immune responses to this method can be affected by factors including needle type,<sup id=\"cite_ref-Sedegah1994_9-1\" class=\"reference\"><a href=\"#cite_note-Sedegah1994-9\">&#91;9&#93;</a></sup> needle alignment, speed of injection, volume of injection, muscle type, and age, sex and physiological condition of the recipient.<sup id=\"cite_ref-Alarcon1999_1-9\" class=\"reference\"><a href=\"#cite_note-Alarcon1999-1\">&#91;1&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Gene_gun\">Gene gun</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=13\" title=\"Edit section: Gene gun\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Gene_gun\" title=\"Gene gun\">Gene gun</a> delivery ballistically accelerates plasmid DNA (pDNA) that has been absorbed onto <a href=\"/wiki/Gold\" title=\"Gold\">gold</a> or <a href=\"/wiki/Tungsten\" title=\"Tungsten\">tungsten</a> microparticles into the target cells, using compressed <a href=\"/wiki/Helium\" title=\"Helium\">helium</a> as an accelerant.<sup id=\"cite_ref-Alarcon1999_1-10\" class=\"reference\"><a href=\"#cite_note-Alarcon1999-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Lewis1999_13-2\" class=\"reference\"><a href=\"#cite_note-Lewis1999-13\">&#91;13&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Dosage\">Dosage</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=14\" title=\"Edit section: Dosage\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The delivery method determines the dose required to raise an effective immune response. Saline injections require variable amounts of DNA, from 10&#160;\u03bcg-1&#160;mg, whereas gene gun deliveries require 100 to 1000 times.<sup id=\"cite_ref-Fynan1993_25-0\" class=\"reference\"><a href=\"#cite_note-Fynan1993-25\">&#91;25&#93;</a></sup> Generally, 0.2&#160;\u03bcg \u2013 20&#160;\u03bcg are required, although quantities as low as 16&#160;ng have been reported.<sup id=\"cite_ref-Alarcon1999_1-11\" class=\"reference\"><a href=\"#cite_note-Alarcon1999-1\">&#91;1&#93;</a></sup> These quantities vary by species. Mice for example, require approximately 10 times less DNA than <a href=\"/wiki/Primates\" class=\"mw-redirect\" title=\"Primates\">primates</a>.<sup id=\"cite_ref-Robinson2000_2-9\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup> Saline injections require more DNA because the DNA is delivered to the extracellular spaces of the target tissue (normally muscle), where it has to overcome physical barriers (such as the <a href=\"/wiki/Basal_lamina\" title=\"Basal lamina\">basal lamina</a> and large amounts of <a href=\"/wiki/Connective_tissue\" title=\"Connective tissue\">connective tissue</a>, to mention a few) before it is taken up by the cells, while gene gun deliveries bombard DNA directly into the cells, resulting in less \u201cwastage\u201d.<sup id=\"cite_ref-Alarcon1999_1-12\" class=\"reference\"><a href=\"#cite_note-Alarcon1999-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Robinson2000_2-10\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Alternatives\">Alternatives</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=15\" title=\"Edit section: Alternatives\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Alternatives included <a href=\"/wiki/Aerosol\" title=\"Aerosol\">aerosol</a> instillation of naked DNA on <a href=\"/wiki/Mucosal\" class=\"mw-redirect\" title=\"Mucosal\">mucosal</a> surfaces, such as the <a href=\"/wiki/Human_nose\" title=\"Human nose\">nasal</a> and <a href=\"/wiki/Human_lung\" class=\"mw-redirect\" title=\"Human lung\">lung</a> <a href=\"/wiki/Mucosa\" class=\"mw-redirect\" title=\"Mucosa\">mucosa</a>,<sup id=\"cite_ref-Lewis1999_13-3\" class=\"reference\"><a href=\"#cite_note-Lewis1999-13\">&#91;13&#93;</a></sup> and topical administration of pDNA to the eye<sup id=\"cite_ref-Daheshia1997_26-0\" class=\"reference\"><a href=\"#cite_note-Daheshia1997-26\">&#91;26&#93;</a></sup> and vaginal mucosa.<sup id=\"cite_ref-Lewis1999_13-4\" class=\"reference\"><a href=\"#cite_note-Lewis1999-13\">&#91;13&#93;</a></sup> Mucosal surface delivery has also been achieved using cationic <a href=\"/wiki/Liposome\" title=\"Liposome\">liposome</a>-DNA preparations,<sup id=\"cite_ref-Robinson2000_2-11\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup> <a href=\"/wiki/Biodegradable\" class=\"mw-redirect\" title=\"Biodegradable\">biodegradable</a> microspheres,<sup id=\"cite_ref-Chen1998_27-0\" class=\"reference\"><a href=\"#cite_note-Chen1998-27\">&#91;27&#93;</a></sup><sup id=\"cite_ref-Lewis1999_13-5\" class=\"reference\"><a href=\"#cite_note-Lewis1999-13\">&#91;13&#93;</a></sup> attenuated <i><a href=\"/wiki/Salmonella\" title=\"Salmonella\">Salmonalla</a></i>,<sup id=\"cite_ref-28\" class=\"reference\"><a href=\"#cite_note-28\">&#91;28&#93;</a></sup> <i><a href=\"/wiki/Shigella\" title=\"Shigella\">Shigella</a></i> or <i><a href=\"/wiki/Listeria\" title=\"Listeria\">Listeria</a></i> vectors for oral administration to the intestinal mucosa<sup id=\"cite_ref-Sizemore1995_29-0\" class=\"reference\"><a href=\"#cite_note-Sizemore1995-29\">&#91;29&#93;</a></sup> and recombinant adenovirus vectors.<sup id=\"cite_ref-Lewis1999_13-6\" class=\"reference\"><a href=\"#cite_note-Lewis1999-13\">&#91;13&#93;</a></sup> Another alternative vector is a hybrid vehicle composed of bacteria cell and synthetic <a href=\"/wiki/Polymers\" class=\"mw-redirect\" title=\"Polymers\">polymers</a>. An <i><a href=\"/wiki/E._coli\" class=\"mw-redirect\" title=\"E. coli\">E. coli</a></i> inner core and poly(beta-amino ester) outer coat function synergistically to increase efficiency by addressing barriers associated with <a href=\"/wiki/Antigen-presenting_cell\" title=\"Antigen-presenting cell\">antigen-presenting cell</a> gene delivery which include cellular uptake and internalization, <a href=\"/wiki/Phagocytosis\" title=\"Phagocytosis\">phagosomal</a> escape and intracellular cargo concentration. Tested in mice, the hybrid vector was found to induce immune response.<sup id=\"cite_ref-30\" class=\"reference\"><a href=\"#cite_note-30\">&#91;30&#93;</a></sup><sup id=\"cite_ref-31\" class=\"reference\"><a href=\"#cite_note-31\">&#91;31&#93;</a></sup>\n</p><p>Another approach to DNA vaccination is <a href=\"/wiki/Expression_library\" class=\"mw-redirect\" title=\"Expression library\">expression library</a> immunization (ELI). Using this technique, potentially all the genes from a pathogen can be delivered at one time, which may be useful for pathogens that are difficult to attenuate or culture.<sup id=\"cite_ref-Alarcon1999_1-13\" class=\"reference\"><a href=\"#cite_note-Alarcon1999-1\">&#91;1&#93;</a></sup> ELI can be used to identify which genes induce a protective response. This has been tested with <i><a href=\"/wiki/Mycoplasma\" title=\"Mycoplasma\">Mycoplasma</a> pulmonis</i>, a <a href=\"/wiki/Murine\" class=\"mw-redirect\" title=\"Murine\">murine</a> lung pathogen with a relatively small <a href=\"/wiki/Genome\" title=\"Genome\">genome</a>. Even partial expression libraries can induce protection from subsequent challenge.<sup id=\"cite_ref-Barry1995_32-0\" class=\"reference\"><a href=\"#cite_note-Barry1995-32\">&#91;32&#93;</a></sup>\n</p>\n<table class=\"wikitable\">\n<caption>Table 2. Summary of plasmid DNA delivery methods\n</caption>\n<tbody><tr>\n<th colspan=\"2\">Method of delivery</th>\n<th>Formulation of DNA</th>\n<th>Target tissue</th>\n<th>Amount of DNA\n</th></tr>\n<tr>\n<th rowspan=\"3\">Parenteral\n</th>\n<td>Injection (hypodermic needle)\n</td>\n<td>Aqueous solution in saline\n</td>\n<td>IM (skeletal); ID; (IV, subcutaneous and intraperitoneal with variable success)\n</td>\n<td>Large amounts (approximately 100-200&#160;\u03bcg)\n</td></tr>\n<tr>\n<td>Gene gun\n</td>\n<td>DNA-coated gold beads\n</td>\n<td>ED (abdominal skin); vaginal mucosa; surgically exposed muscle and other organs\n</td>\n<td>Small amounts (as little as 16&#160;ng)\n</td></tr>\n<tr>\n<td>Pneumatic (jet) injection\n</td>\n<td>Aqueous solution\n</td>\n<td>ED\n</td>\n<td>Very high (as much as 300&#160;\u03bcg)\n</td></tr>\n<tr>\n<td colspan=\"2\">Topical application\n</td>\n<td>Aqueous solution\n</td>\n<td>Ocular; intravaginal\n</td>\n<td>Small amounts (up to 100&#160;\u03bcg)\n</td></tr>\n<tr>\n<td colspan=\"2\">Cytofectin-mediated\n</td>\n<td><a href=\"/wiki/Liposomes\" class=\"mw-redirect\" title=\"Liposomes\">Liposomes</a> (cationic); microspheres; recombinant adenovirus vectors; attenuated <a href=\"/wiki/Shigella\" title=\"Shigella\">Shigella</a> vector; aerosolised cationic <a href=\"/wiki/Lipid\" title=\"Lipid\">lipid</a> formulations\n</td>\n<td>IM; IV (to transfect tissues systemically); intraperitoneal; oral immunization to the intestinal mucosa; nasal/lung mucosal membranes\n</td>\n<td>variable\n</td></tr></tbody></table>\n<table class=\"wikitable\">\n<caption>Table 3. Advantages and disadvantages of commonly used DNA vaccine delivery methods\n</caption>\n<tbody><tr>\n<th width=\"20%\">Method of delivery\n</th>\n<th width=\"40%\">Advantage\n</th>\n<th width=\"40%\">Disadvantage\n</th></tr>\n<tr>\n<td>Intramuscular or Intradermal injection\n</td>\n<td>\n<ul><li>No special delivery mechanism</li>\n<li>Permanent or semi-permanent expression</li>\n<li>pDNA spreads rapidly throughout the body</li></ul>\n</td>\n<td>\n<ul><li>Inefficient site for uptake due to morphology of muscle tissue</li>\n<li>Relatively large amounts of DNA used</li>\n<li>Th1 response may not be the response required</li></ul>\n</td></tr>\n<tr>\n<td>Gene gun\n</td>\n<td>\n<ul><li>DNA bombarded directly into cells</li>\n<li>Small amounts DNA</li></ul>\n</td>\n<td>\n<ul><li>Th2 response may not be the response required</li>\n<li>Requires inert particles as carrier</li></ul>\n</td></tr>\n<tr>\n<td>Jet injection\n</td>\n<td>\n<ul><li>No particles required</li>\n<li>DNA can be delivered to cells mm to cm below skin surface</li></ul>\n</td>\n<td>\n<ul><li>Significant shearing of DNA after high-pressure expulsion</li>\n<li>10-fold lower expression, and lower immune response</li>\n<li>Requires large amounts of DNA (up to 300&#160;\u03bcg)</li></ul>\n</td></tr>\n<tr>\n<td>Liposome-mediated delivery\n</td>\n<td>\n<ul><li>High levels of immune response can be generated</li>\n<li>Can increase transfection of intravenously delivered pDNA</li>\n<li>Intravenously delivered liposome-DNA complexes can potentially transfect all tissues</li>\n<li>Intranasally delivered liposome-DNA complexes can result in expression in distal mucosa as well as nasal muscosa and the generation of IgA antibodies</li></ul>\n</td>\n<td>\n<ul><li>Toxicity</li>\n<li>Ineffectiveness in serum</li>\n<li>Risk of disease or immune reactions</li></ul>\n</td></tr></tbody></table>\n<h2><span class=\"mw-headline\" id=\"Immune_response\">Immune response</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=16\" title=\"Edit section: Immune response\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Helper_T_cell_responses\">Helper T cell responses</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=17\" title=\"Edit section: Helper T cell responses\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Antigen_presentation.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/4d/Antigen_presentation.svg/220px-Antigen_presentation.svg.png\" width=\"220\" height=\"155\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/4/4d/Antigen_presentation.svg/330px-Antigen_presentation.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4d/Antigen_presentation.svg/440px-Antigen_presentation.svg.png 2x\" data-file-width=\"842\" data-file-height=\"595\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Antigen_presentation.svg\" class=\"internal\" title=\"Enlarge\"></a></div>Antigen presentation stimulates T cells to become either \"cytotoxic\" CD8+ cells or \"helper\" CD4+ cells. Cytotoxic cells directly attack other cells carrying certain foreign or abnormal molecules on their surfaces. Helper T cells, or Th cells, coordinate immune responses by communicating with other cells. In most cases, T cells only recognize an antigen if it is carried on the surface of a cell by one of the body\u2019s own MHC, or major histocompatibility complex, molecules.</div></div></div>\n<p>DNA immunization can raise multiple T<sub>H</sub> responses, including lymphoproliferation and the generation of a variety of <a href=\"/wiki/Cytokine\" title=\"Cytokine\">cytokine</a> profiles. A major advantage of DNA vaccines is the ease with which they can be manipulated to bias the type of T-cell help towards a TH1 or TH2 response.<sup id=\"cite_ref-Feltquate1997_33-0\" class=\"reference\"><a href=\"#cite_note-Feltquate1997-33\">&#91;33&#93;</a></sup> Each type has distinctive patterns of <a href=\"/wiki/Lymphokine\" title=\"Lymphokine\">lymphokine</a> and chemokine expression, specific types of <a href=\"/wiki/Immunoglobulins\" class=\"mw-redirect\" title=\"Immunoglobulins\">immunoglobulins</a>, patterns of lymphocyte trafficking and types of <a href=\"/wiki/Innate_immune_response\" class=\"mw-redirect\" title=\"Innate immune response\">innate immune responses</a>.\n</p>\n<h4><span class=\"mw-headline\" id=\"Other_types_of_T-cell_help\">Other types of T-cell help</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=18\" title=\"Edit section: Other types of T-cell help\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>The type of T-cell help raised is influenced by the delivery method and the type of immunogen expressed, as well as the targeting of different lymphoid compartments.<sup id=\"cite_ref-Alarcon1999_1-14\" class=\"reference\"><a href=\"#cite_note-Alarcon1999-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-References1996_34-0\" class=\"reference\"><a href=\"#cite_note-References1996-34\">&#91;34&#93;</a></sup> Generally, saline needle injections (either IM or ID) tend to induce TH1 responses, while gene gun delivery raises TH2 responses.<sup id=\"cite_ref-Feltquate1997_33-1\" class=\"reference\"><a href=\"#cite_note-Feltquate1997-33\">&#91;33&#93;</a></sup><sup id=\"cite_ref-References1996_34-1\" class=\"reference\"><a href=\"#cite_note-References1996-34\">&#91;34&#93;</a></sup> This is true for intracellular and plasma membrane-bound antigens, but not for secreted antigens, which seem to generate TH2 responses, regardless of the method of delivery.<sup id=\"cite_ref-S\u00e4llberg1997_35-0\" class=\"reference\"><a href=\"#cite_note-S\u00e4llberg1997-35\">&#91;35&#93;</a></sup>\n</p><p>Generally the type of T-cell help raised is stable over time, and does not change when challenged or after subsequent immunizations that would normally have raised the opposite type of response in a na\u00efve specimen.<sup id=\"cite_ref-Feltquate1997_33-2\" class=\"reference\"><a href=\"#cite_note-Feltquate1997-33\">&#91;33&#93;</a></sup><sup id=\"cite_ref-References1996_34-2\" class=\"reference\"><a href=\"#cite_note-References1996-34\">&#91;34&#93;</a></sup> However, Mor <i>et al.</i>. (1995)<sup id=\"cite_ref-Mor1995_10-1\" class=\"reference\"><a href=\"#cite_note-Mor1995-10\">&#91;10&#93;</a></sup> immunized and boosted mice with pDNA encoding the circumsporozoite protein of the mouse <a href=\"/wiki/Malaria\" title=\"Malaria\">malarial</a> parasite <i><a href=\"/wiki/Plasmodium_yoelii\" title=\"Plasmodium yoelii\">Plasmodium yoelii</a></i> (PyCSP) and found that the initial TH2 response changed, after boosting, to a TH1 response.\n</p>\n<h4><span class=\"mw-headline\" id=\"Basis_for_different_types_of_T-cell_help\">Basis for different types of T-cell help</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=19\" title=\"Edit section: Basis for different types of T-cell help\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>How these different methods operate, the forms of antigen expressed, and the different profiles of T-cell help is not understood. It was thought that the relatively large amounts of DNA used in IM injection were responsible for the induction of TH1 responses. However, evidence shows no dose-related differences in TH type.<sup id=\"cite_ref-Feltquate1997_33-3\" class=\"reference\"><a href=\"#cite_note-Feltquate1997-33\">&#91;33&#93;</a></sup> The type of T-cell help raised is determined by the differentiated state of <a href=\"/wiki/Antigen_presenting_cells\" class=\"mw-redirect\" title=\"Antigen presenting cells\">antigen presenting cells</a>. <a href=\"/wiki/Dendritic_cells\" class=\"mw-redirect\" title=\"Dendritic cells\">Dendritic cells</a> can differentiate to secrete <a href=\"/wiki/Interleukin\" title=\"Interleukin\">IL-12</a> (which supports TH1 cell development) or <a href=\"/wiki/Interleukin-4_receptor\" title=\"Interleukin-4 receptor\">IL-4</a> (which supports TH2 responses).<sup id=\"cite_ref-Banchereau1998_36-0\" class=\"reference\"><a href=\"#cite_note-Banchereau1998-36\">&#91;36&#93;</a></sup> pDNA injected by needle is <a href=\"/wiki/Endocytosis\" title=\"Endocytosis\">endocytosed</a> into the dendritic cell, which is then stimulated to differentiate for TH1 <a href=\"/wiki/Cytokine\" title=\"Cytokine\">cytokine</a> production,<sup id=\"cite_ref-Jakob1998_37-0\" class=\"reference\"><a href=\"#cite_note-Jakob1998-37\">&#91;37&#93;</a></sup> while the gene gun bombards the DNA directly into the cell, thus bypassing TH1 stimulation.\n</p>\n<h4><span class=\"mw-headline\" id=\"Practical_uses_of_polarised_T-cell_help\">Practical uses of polarised T-cell help</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=20\" title=\"Edit section: Practical uses of polarised T-cell help\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>Polarisation in T-cell help is useful in influencing <a href=\"/wiki/Allergic\" class=\"mw-redirect\" title=\"Allergic\">allergic</a> responses and <a href=\"/wiki/Autoimmune_diseases\" class=\"mw-redirect\" title=\"Autoimmune diseases\">autoimmune diseases</a>. In autoimmune diseases, the goal is to shift the self-destructive TH1 response (with its associated cytotoxic T cell activity) to a non-destructive TH2 response. This has been successfully applied in predisease priming for the desired type of response in preclinical models<sup id=\"cite_ref-Robinson2000_2-12\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup> and is somewhat successful in shifting the response for an established disease.<sup id=\"cite_ref-Raz1996_38-0\" class=\"reference\"><a href=\"#cite_note-Raz1996-38\">&#91;38&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Cytotoxic_T-cell_responses\">Cytotoxic T-cell responses</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=21\" title=\"Edit section: Cytotoxic T-cell responses\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>One of the advantages of DNA vaccines is that they are able to induce <a href=\"/wiki/Cytotoxic_T_cell\" title=\"Cytotoxic T cell\">cytotoxic T lymphocytes</a> (CTL) without the inherent risk associated with live vaccines. CTL responses can be raised against immunodominant and immunorecessive CTL epitopes,<sup id=\"cite_ref-Fu1997_39-0\" class=\"reference\"><a href=\"#cite_note-Fu1997-39\">&#91;39&#93;</a></sup> as well as subdominant CTL epitopes,<sup id=\"cite_ref-Chen1998_27-1\" class=\"reference\"><a href=\"#cite_note-Chen1998-27\">&#91;27&#93;</a></sup> in a manner that appears to mimic natural <a href=\"/wiki/Infection\" title=\"Infection\">infection</a>. This may prove to be a useful tool in assessing CTL epitopes and their role in providing immunity.\n</p><p>Cytotoxic T-cells recognise small <a href=\"/wiki/Peptides\" class=\"mw-redirect\" title=\"Peptides\">peptides</a> (8-10 <a href=\"/wiki/Amino_acids\" class=\"mw-redirect\" title=\"Amino acids\">amino acids</a>) complexed to <a href=\"/wiki/MHC_class_I\" title=\"MHC class I\">MHC class I</a> molecules.<sup id=\"cite_ref-40\" class=\"reference\"><a href=\"#cite_note-40\">&#91;40&#93;</a></sup> These peptides are derived from endogenous cytosolic proteins that are degraded and delivered to the nascent MHC class I molecule within the <a href=\"/wiki/Endoplasmic_reticulum\" title=\"Endoplasmic reticulum\">endoplasmic reticulum</a> (ER).<sup id=\"cite_ref-Restifo1995_41-0\" class=\"reference\"><a href=\"#cite_note-Restifo1995-41\">&#91;41&#93;</a></sup> Targeting gene products directly to the ER (by the addition of an <a href=\"/wiki/Amino-terminal\" class=\"mw-redirect\" title=\"Amino-terminal\">amino-terminal</a> insertion <a href=\"/wiki/Protein_sequence\" class=\"mw-redirect\" title=\"Protein sequence\">sequence</a>) should thus enhance CTL responses. This was successfully demonstrated using recombinant <a href=\"/wiki/Vaccinia\" title=\"Vaccinia\">vaccinia</a> viruses expressing <a href=\"/wiki/Influenza\" title=\"Influenza\">influenza</a> proteins,<sup id=\"cite_ref-Restifo1995_41-1\" class=\"reference\"><a href=\"#cite_note-Restifo1995-41\">&#91;41&#93;</a></sup> but the principle should also be applicable to DNA vaccines. Targeting antigens for intracellular degradation (and thus entry into the MHC class I pathway) by the addition of <a href=\"/wiki/Ubiquitin\" title=\"Ubiquitin\">ubiquitin</a> signal sequences, or mutation of other signal sequences, was shown to be effective at increasing CTL responses.<sup id=\"cite_ref-Tobery1997_20-1\" class=\"reference\"><a href=\"#cite_note-Tobery1997-20\">&#91;20&#93;</a></sup>\n</p><p>CTL responses can be enhanced by co-inoculation with co-stimulatory molecules such as <a href=\"/wiki/CD80\" title=\"CD80\">B7-1</a> or <a href=\"/wiki/CD86\" title=\"CD86\">B7-2</a> for DNA vaccines against influenza nucleoprotein,<sup id=\"cite_ref-Fu1997_39-1\" class=\"reference\"><a href=\"#cite_note-Fu1997-39\">&#91;39&#93;</a></sup><sup id=\"cite_ref-Iwasaki1997_42-0\" class=\"reference\"><a href=\"#cite_note-Iwasaki1997-42\">&#91;42&#93;</a></sup> or <a href=\"/wiki/GM-CSF\" class=\"mw-redirect\" title=\"GM-CSF\">GM-CSF</a> for DNA vaccines against the murine malaria model <i><a href=\"/wiki/Plasmodium_yoelii\" title=\"Plasmodium yoelii\">P. yoelii</a></i>.<sup id=\"cite_ref-Weiss1998_43-0\" class=\"reference\"><a href=\"#cite_note-Weiss1998-43\">&#91;43&#93;</a></sup> Co-inoculation with plasmids encoding co-stimulatory molecules IL-12 and TCA3 were shown to increase CTL activity against HIV-1 and influenza nucleoprotein antigens.<sup id=\"cite_ref-Iwasaki1997_42-1\" class=\"reference\"><a href=\"#cite_note-Iwasaki1997-42\">&#91;42&#93;</a></sup><sup id=\"cite_ref-Tsuji1997_44-0\" class=\"reference\"><a href=\"#cite_note-Tsuji1997-44\">&#91;44&#93;</a></sup>\n</p>\n<h3><span id=\"Humoral_.28antibody.29_response\"></span><span class=\"mw-headline\" id=\"Humoral_(antibody)_response\">Humoral (antibody) response</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=22\" title=\"Edit section: Humoral (antibody) response\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Antibody.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2d/Antibody.svg/220px-Antibody.svg.png\" width=\"220\" height=\"311\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2d/Antibody.svg/330px-Antibody.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2d/Antibody.svg/440px-Antibody.svg.png 2x\" data-file-width=\"255\" data-file-height=\"360\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Antibody.svg\" class=\"internal\" title=\"Enlarge\"></a></div>Schematic diagram of an antibody and antigens</div></div></div>\n<p>Antibody responses elicited by DNA vaccinations are influenced by multiple variables, including antigen type; antigen location (i.e. intracellular vs. secreted); number, frequency and immunization dose; site and method of antigen delivery.\n</p>\n<h4><span class=\"mw-headline\" id=\"Kinetics_of_antibody_response\">Kinetics of antibody response</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=23\" title=\"Edit section: Kinetics of antibody response\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>Humoral responses after a single DNA injection can be much longer-lived than after a single injection with a recombinant protein. Antibody responses against <a href=\"/wiki/Hepatitis_B\" title=\"Hepatitis B\">hepatitis B</a> virus (HBV) envelope protein (HBsAg) have been sustained for up to 74 weeks without boost, while lifelong maintenance of protective response to influenza <a href=\"/wiki/Haemagglutinin\" class=\"mw-redirect\" title=\"Haemagglutinin\">haemagglutinin</a> was demonstrated in mice after gene gun delivery.<sup id=\"cite_ref-Justewicz1996_45-0\" class=\"reference\"><a href=\"#cite_note-Justewicz1996-45\">&#91;45&#93;</a></sup> Antibody-secreting cells migrate to the <a href=\"/wiki/Bone_marrow\" title=\"Bone marrow\">bone marrow</a> and <a href=\"/wiki/Spleen\" title=\"Spleen\">spleen</a> for long-term antibody production, and generally localise there after one year.<sup id=\"cite_ref-Justewicz1996_45-1\" class=\"reference\"><a href=\"#cite_note-Justewicz1996-45\">&#91;45&#93;</a></sup>\n</p><p>Comparisons of antibody responses generated by natural (viral) infection, immunization with recombinant protein and immunization with pDNA are summarised in Table 4. DNA-raised antibody responses rise much more slowly than when natural infection or recombinant protein immunization occurs. As many as 12 weeks may be required to reach peak titres in mice, although boosting can decrease the interval. This response is probably due to the low levels of antigen expressed over several weeks, which supports both primary and secondary phases of antibody response. DNA vaccine expressing HBV small and middle envelope protein was injected into adults with chronic hepatitis. The vaccine resulted in specific interferon gamma cell production. Also specific T-cells for middle envelop proteins antigens were developed. The immune response of the patients was not robust enough to control HBV infection<sup id=\"cite_ref-46\" class=\"reference\"><a href=\"#cite_note-46\">&#91;46&#93;</a></sup>\n</p>\n<table class=\"wikitable\">\n<caption>Table 4. Comparison of T-dependent antibody responses raise by DNA immunisations, protein inoculations and viral infections\n</caption>\n<tbody><tr>\n<th rowspan=\"2\">&#160;\n</th>\n<th colspan=\"3\">Method of Immunization\n</th></tr>\n<tr>\n<th>DNA vaccine\n</th>\n<th>Recombinant protein\n</th>\n<th>Natural infection\n</th></tr>\n<tr>\n<th>Amount of inducing antigen\n</th>\n<td>ng\n</td>\n<td>\u03bcg\n</td>\n<td>? (ng-\u03bcg)\n</td></tr>\n<tr>\n<th>Duration of antigen presentation\n</th>\n<td>several weeks\n</td>\n<td>&lt; 1 week\n</td>\n<td>several weeks\n</td></tr>\n<tr>\n<th>Kinetics of antibody response\n</th>\n<td>slow rise\n</td>\n<td>rapid rise\n</td>\n<td>rapid rise\n</td></tr>\n<tr>\n<th>Number of inoculations to obtain high avidity IgG and migration of ASC to bone marrow\n</th>\n<td>one\n</td>\n<td>two\n</td>\n<td>one\n</td></tr>\n<tr>\n<th>Ab isotype (murine models)\n</th>\n<td>C\u2019-dependent or C\u2019-independent\n</td>\n<td>C\u2019-dependent\n</td>\n<td>C\u2019-independent\n</td></tr></tbody></table>\n<p>Additionally, the titres of specific antibodies raised by DNA vaccination are lower than those obtained after vaccination with a recombinant protein. However, DNA immunization-induced antibodies show greater affinity to native epitopes than recombinant protein-induced antibodies. In other words, DNA immunization induces a qualitatively superior response. Antibodies can be induced after one vaccination with DNA, whereas recombinant protein vaccinations generally require a boost. DNA immunization can be used to bias the TH profile of the immune response and thus the antibody isotype, which is not possible with either natural infection or recombinant protein immunization. Antibody responses generated by DNA are useful as a preparative tool. For example, polyclonal and monoclonal antibodies can be generated for use as reagents.\n</p>\n<h2><span class=\"mw-headline\" id=\"Mechanistic_basis_for_DNA-raised_immune_responses\">Mechanistic basis for DNA-raised immune responses</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=24\" title=\"Edit section: Mechanistic basis for DNA-raised immune responses\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"DNA_uptake_mechanism\">DNA uptake mechanism</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=25\" title=\"Edit section: DNA uptake mechanism\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>When DNA uptake and subsequent expression was first demonstrated <i>in vivo</i> in <a href=\"/wiki/Muscle\" title=\"Muscle\">muscle</a> cells,<sup id=\"cite_ref-Wolff1992_47-0\" class=\"reference\"><a href=\"#cite_note-Wolff1992-47\">&#91;47&#93;</a></sup> these cells were thought to be unique because of their extensive network of T-tubules. Using <a href=\"/wiki/Electron_microscopy\" class=\"mw-redirect\" title=\"Electron microscopy\">electron microscopy</a>, it was proposed that DNA uptake was facilitated by <a href=\"/wiki/Caveolae\" title=\"Caveolae\">caveolae</a> (or, non-clathrin coated pits).<sup id=\"cite_ref-Anderson1992_48-0\" class=\"reference\"><a href=\"#cite_note-Anderson1992-48\">&#91;48&#93;</a></sup> However, subsequent research revealed that other cells (such as <a href=\"/wiki/Keratinocytes\" class=\"mw-redirect\" title=\"Keratinocytes\">keratinocytes</a>, <a href=\"/wiki/Fibroblasts\" class=\"mw-redirect\" title=\"Fibroblasts\">fibroblasts</a> and <a href=\"/wiki/Epithelial\" class=\"mw-redirect\" title=\"Epithelial\">epithelial</a> <a href=\"/wiki/Langerhans_cells\" class=\"mw-redirect\" title=\"Langerhans cells\">Langerhans cells</a>) could also internalize DNA.<sup id=\"cite_ref-Raz1996_38-1\" class=\"reference\"><a href=\"#cite_note-Raz1996-38\">&#91;38&#93;</a></sup><sup id=\"cite_ref-Casares1997_49-0\" class=\"reference\"><a href=\"#cite_note-Casares1997-49\">&#91;49&#93;</a></sup> The mechanism of DNA uptake is not known.\n</p><p>Two theories dominate \u2013 that <i>in vivo</i> uptake of DNA occurs non-specifically, in a method similar to <a href=\"/wiki/Phagocytosis\" title=\"Phagocytosis\">phago</a>- or <a href=\"/wiki/Pinocytosis\" title=\"Pinocytosis\">pinocytosis</a>,<sup id=\"cite_ref-Lewis1999_13-7\" class=\"reference\"><a href=\"#cite_note-Lewis1999-13\">&#91;13&#93;</a></sup> or through specific receptors.<sup id=\"cite_ref-Bennett1985_50-0\" class=\"reference\"><a href=\"#cite_note-Bennett1985-50\">&#91;50&#93;</a></sup> These might include a 30kDa surface <a href=\"/wiki/Immune_receptor\" title=\"Immune receptor\">receptor</a>, or <a href=\"/wiki/Macrophage\" title=\"Macrophage\">macrophage</a> scavenger receptors. The 30kDa surface receptor binds specifically to 4500-bp DNA fragments (which are then internalised) and is found on professional APCs and T-cells. Macrophage scavenger receptors bind to a variety of macromolecules, including poly<a href=\"/wiki/Ribonucleotides\" class=\"mw-redirect\" title=\"Ribonucleotides\">ribonucleotides</a> and are thus candidates for DNA uptake.<sup id=\"cite_ref-Bennett1985_50-1\" class=\"reference\"><a href=\"#cite_note-Bennett1985-50\">&#91;50&#93;</a></sup><sup id=\"cite_ref-Bennet1988_51-0\" class=\"reference\"><a href=\"#cite_note-Bennet1988-51\">&#91;51&#93;</a></sup> Receptor-mediated DNA uptake could be facilitated by the presence of <a href=\"/wiki/Guanine\" title=\"Guanine\">polyguanylate sequences</a>. Gene gun delivery systems, cationic liposome packaging, and other delivery methods bypass this entry method, but understanding it may be useful in reducing costs (e.g. by reducing the requirement for cytofectins), which could be important in animal husbandry.\n</p>\n<h3><span class=\"mw-headline\" id=\"Antigen_presentation_by_bone_marrow-derived_cells\">Antigen presentation by bone marrow-derived cells</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=26\" title=\"Edit section: Antigen presentation by bone marrow-derived cells\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:222px;\"><a href=\"/wiki/File:Dendritic_cell.JPG\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/3b/Dendritic_cell.JPG/220px-Dendritic_cell.JPG\" width=\"220\" height=\"183\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/3/3b/Dendritic_cell.JPG/330px-Dendritic_cell.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/3b/Dendritic_cell.JPG/440px-Dendritic_cell.JPG 2x\" data-file-width=\"580\" data-file-height=\"483\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Dendritic_cell.JPG\" class=\"internal\" title=\"Enlarge\"></a></div>A dendritic cell.</div></div></div>\n<p>Studies using <a href=\"/wiki/Chimera_(genetics)\" title=\"Chimera (genetics)\">chimeric</a> mice have shown that antigen is presented by bone-marrow derived cells, which include dendritic cells, macrophages and specialised <a href=\"/wiki/B-cells\" class=\"mw-redirect\" title=\"B-cells\">B-cells</a> called professional <a href=\"/wiki/Antigen_presenting_cells\" class=\"mw-redirect\" title=\"Antigen presenting cells\">antigen presenting cells</a> (APC).<sup id=\"cite_ref-Iwasaki1997_42-2\" class=\"reference\"><a href=\"#cite_note-Iwasaki1997-42\">&#91;42&#93;</a></sup><sup id=\"cite_ref-Corr1996_52-0\" class=\"reference\"><a href=\"#cite_note-Corr1996-52\">&#91;52&#93;</a></sup> After gene gun inoculation to the skin, transfected <a href=\"/wiki/Langerhans_cell\" title=\"Langerhans cell\">Langerhans cells</a> migrate to the draining <a href=\"/wiki/Lymph_node\" title=\"Lymph node\">lymph node</a> to present antigens.<sup id=\"cite_ref-Robinson2000_2-13\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup> After IM and ID injections, dendritic cells present antigen in the draining lymph node<sup id=\"cite_ref-Casares1997_49-1\" class=\"reference\"><a href=\"#cite_note-Casares1997-49\">&#91;49&#93;</a></sup> and transfected macrophages have been found in the peripheral blood.<sup id=\"cite_ref-Chattergoon1998_53-0\" class=\"reference\"><a href=\"#cite_note-Chattergoon1998-53\">&#91;53&#93;</a></sup>\n</p><p>Besides direct transfection of dendritic cells or macrophages, cross priming occurs following IM, ID and gene gun DNA deliveries. Cross-priming occurs when a bone marrow-derived cell presents peptides from proteins synthesised in another cell in the context of MHC class 1. This can prime cytotoxic T-cell responses and seems to be important for a full primary immune response.<sup id=\"cite_ref-Robinson2000_2-14\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Torres1997_54-0\" class=\"reference\"><a href=\"#cite_note-Torres1997-54\">&#91;54&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Target_site_role\">Target site role</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=27\" title=\"Edit section: Target site role\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>IM and ID DNA delivery initiate immune responses differently. In the skin, keratinocytes, fibroblasts and Langerhans cells take up and express antigens and are responsible for inducing a primary antibody response. Transfected Langerhans cells migrate out of the skin (within 12 hours) to the draining lymph node where they prime secondary B- and T-cell responses. In skeletal muscle striated muscle cells are most frequently transfected, but seem to be unimportant in immune response. Instead, IM inoculated DNA \u201cwashes\u201d into the draining lymph node within minutes, where distal dendritic cells are transfected and then initiate an immune response. Transfected myocytes seem to act as a \u201creservoir\u201d of antigen for trafficking professional APCs.<sup id=\"cite_ref-Lewis1999_13-8\" class=\"reference\"><a href=\"#cite_note-Lewis1999-13\">&#91;13&#93;</a></sup><sup id=\"cite_ref-Wolff1992_47-1\" class=\"reference\"><a href=\"#cite_note-Wolff1992-47\">&#91;47&#93;</a></sup><sup id=\"cite_ref-Torres1997_54-1\" class=\"reference\"><a href=\"#cite_note-Torres1997-54\">&#91;54&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Maintenance_of_immune_response\">Maintenance of immune response</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=28\" title=\"Edit section: Maintenance of immune response\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>DNA vaccination generates an effective immune memory via the display of antigen-antibody complexes on <a href=\"/wiki/Follicular_dendritic_cells\" title=\"Follicular dendritic cells\">follicular dendritic cells</a> (FDC), which are potent B-cell stimulators. T-cells can be stimulated by similar, germinal centre dendritic cells. FDC are able to generate an immune memory because antibodies production \u201coverlaps\u201d long-term expression of antigen, allowing antigen-antibody immunocomplexes to form and be displayed by FDC.<sup id=\"cite_ref-Robinson2000_2-15\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Interferons\">Interferons</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=29\" title=\"Edit section: Interferons\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Both helper and cytotoxic T-cells can control viral infections by secreting interferons. Cytotoxic T cells usually kill virally infected cells. However, they can also be stimulated to secrete antiviral cytokines such as <a href=\"/wiki/Interferon_gamma\" title=\"Interferon gamma\">IFN-\u03b3</a> and <a href=\"/wiki/Tumor_necrosis_factor_alpha\" title=\"Tumor necrosis factor alpha\">TNF-\u03b1</a>, which do not kill the cell, but limit viral infection by down-regulating the expression of viral components.<sup id=\"cite_ref-Franco1997_55-0\" class=\"reference\"><a href=\"#cite_note-Franco1997-55\">&#91;55&#93;</a></sup> DNA vaccinations can be used to curb viral infections by non-destructive IFN-mediated control. This was demonstrated for hepatitis B.<sup id=\"cite_ref-Mancini1996_56-0\" class=\"reference\"><a href=\"#cite_note-Mancini1996-56\">&#91;56&#93;</a></sup> IFN-\u03b3 is critically important in controlling malaria infections<sup id=\"cite_ref-Doolan1999_57-0\" class=\"reference\"><a href=\"#cite_note-Doolan1999-57\">&#91;57&#93;</a></sup> and is a consideration for anti-malarial DNA vaccines.\n</p>\n<h2><span class=\"mw-headline\" id=\"Immune_response_modulation\">Immune response modulation</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=30\" title=\"Edit section: Immune response modulation\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Cytokine_modulation\">Cytokine modulation</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=31\" title=\"Edit section: Cytokine modulation\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>An effective vaccine must induce an appropriate immune response for a given pathogen. DNA vaccines can polarise T-cell help towards TH1 or TH2 profiles and generate CTL and/or antibody when required. This can be accomplished by modifications to the form of antigen expressed (i.e. intracellular vs. secreted), the method and route of delivery or the dose.<sup id=\"cite_ref-Feltquate1997_33-4\" class=\"reference\"><a href=\"#cite_note-Feltquate1997-33\">&#91;33&#93;</a></sup><sup id=\"cite_ref-References1996_34-3\" class=\"reference\"><a href=\"#cite_note-References1996-34\">&#91;34&#93;</a></sup><sup id=\"cite_ref-Cardoso1996_58-0\" class=\"reference\"><a href=\"#cite_note-Cardoso1996-58\">&#91;58&#93;</a></sup><sup id=\"cite_ref-Sato1996_59-0\" class=\"reference\"><a href=\"#cite_note-Sato1996-59\">&#91;59&#93;</a></sup><sup id=\"cite_ref-Weiss2000_60-0\" class=\"reference\"><a href=\"#cite_note-Weiss2000-60\">&#91;60&#93;</a></sup> It can also be accomplished by the co-administration of plasmid DNA encoding immune regulatory molecules, i.e. cytokines, <a href=\"/wiki/Lymphokine\" title=\"Lymphokine\">lymphokines</a> or co-stimulatory molecules. These \u201cgenetic <a href=\"/wiki/Adjuvants\" class=\"mw-redirect\" title=\"Adjuvants\">adjuvants</a>\u201d can be administered as a:\n</p>\n<ul><li>mixture of 2 plasmids, one encoding the immunogen and the other encoding the cytokine</li>\n<li>single bi- or polycistronic vector, separated by spacer regions</li>\n<li>plasmid-encoded <a href=\"/wiki/Fusion_protein\" title=\"Fusion protein\">chimera</a>, or fusion protein</li></ul>\n<p>In general, co-administration of pro-inflammatory agents (such as various <a href=\"/wiki/Interleukins\" class=\"mw-redirect\" title=\"Interleukins\">interleukins</a>, <a href=\"/wiki/Tumor_necrosis_factor\" class=\"mw-redirect\" title=\"Tumor necrosis factor\">tumor necrosis factor</a>, and GM-CSF) plus TH2-inducing cytokines increase antibody responses, whereas pro-inflammatory agents and TH1-inducing cytokines decrease humoral responses and increase cytotoxic responses (more important in viral protection). Co-stimulatory molecules such as <a href=\"/wiki/CD80\" title=\"CD80\">B7-1</a>, <a href=\"/wiki/CD86\" title=\"CD86\">B7-2</a> and <a href=\"/wiki/CD154\" title=\"CD154\">CD40L</a> are sometimes used.\n</p><p>This concept was applied in topical administration of pDNA encoding <a href=\"/wiki/Interleukin_10\" title=\"Interleukin 10\">IL-10</a>.<sup id=\"cite_ref-Daheshia1997_26-1\" class=\"reference\"><a href=\"#cite_note-Daheshia1997-26\">&#91;26&#93;</a></sup> Plasmid encoding B7-1 (a ligand on APCs) successfully enhanced the immune response in tumour models. Mixing plasmids encoding GM-CSF and the circumsporozoite protein of <i>P. yoelii</i> (PyCSP) enhanced protection against subsequent challenge (whereas plasmid-encoded PyCSP alone did not). It was proposed that GM-CSF caused dendritic cells to present antigen more efficiently and enhance IL-2 production and TH cell activation, thus driving the increased immune response.<sup id=\"cite_ref-Weiss1998_43-1\" class=\"reference\"><a href=\"#cite_note-Weiss1998-43\">&#91;43&#93;</a></sup> This can be further enhanced by first priming with a pPyCSP and pGM-CSF mixture, followed by boosting with a recombinant <a href=\"/wiki/Poxviridae\" title=\"Poxviridae\">poxvirus</a> expressing PyCSP.<sup id=\"cite_ref-Sedegah2000_61-0\" class=\"reference\"><a href=\"#cite_note-Sedegah2000-61\">&#91;61&#93;</a></sup> However, co-injection of plasmids encoding GM-CSF (or IFN-\u03b3, or IL-2) and a fusion protein of <i><a href=\"/wiki/Plasmodium_chabaudi\" title=\"Plasmodium chabaudi\">P. chabaudi</a></i> <a href=\"/wiki/Apicomplexan_life_cycle\" title=\"Apicomplexan life cycle\">merozoite surface protein</a> 1 (C-terminus)-hepatitis B virus surface protein (PcMSP1-HBs) abolished protection against challenge, compared to protection acquired by delivery of pPcMSP1-HBs alone.<sup id=\"cite_ref-Wunderlich2000_22-1\" class=\"reference\"><a href=\"#cite_note-Wunderlich2000-22\">&#91;22&#93;</a></sup>\n</p><p>The advantages of genetic adjuvants are their low cost and simple administration, as well as avoidance of unstable <a href=\"/wiki/Recombinant_cytokine\" class=\"mw-redirect\" title=\"Recombinant cytokine\">recombinant cytokines</a> and potentially toxic, \u201cconventional\u201d adjuvants (such as <a href=\"/wiki/Alum\" title=\"Alum\">alum</a>, <a href=\"/wiki/Calcium_phosphate\" title=\"Calcium phosphate\">calcium phosphate</a>, monophosphoryl lipid A, <a href=\"/wiki/Cholera\" title=\"Cholera\">cholera</a> toxin, cationic and mannan-coated liposomes, <a href=\"/wiki/QS21\" title=\"QS21\">QS21</a>, <a href=\"/wiki/Carboxymethyl_cellulose\" title=\"Carboxymethyl cellulose\">carboxymethyl cellulose</a> and <a href=\"/wiki/Ubenimex\" title=\"Ubenimex\">ubenimix</a>).<sup id=\"cite_ref-Robinson2000_2-16\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Lewis1999_13-9\" class=\"reference\"><a href=\"#cite_note-Lewis1999-13\">&#91;13&#93;</a></sup> However, the potential toxicity of prolonged cytokine expression is not  established. In many commercially important animal species, cytokine genes have not been identified and isolated. In addition, various plasmid-encoded cytokines modulate the immune system differently according to the delivery time. For example, some cytokine plasmid DNAs are best delivered after immunogen pDNA, because pre- or co-delivery can decrease specific responses and increase non-specific responses.<sup id=\"cite_ref-Barouch1998_62-0\" class=\"reference\"><a href=\"#cite_note-Barouch1998-62\">&#91;62&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Immunostimulatory_CpG_motifs\">Immunostimulatory CpG motifs</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=32\" title=\"Edit section: Immunostimulatory CpG motifs\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Plasmid DNA itself appears to have an adjuvant effect on the immune system.<sup id=\"cite_ref-Alarcon1999_1-15\" class=\"reference\"><a href=\"#cite_note-Alarcon1999-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Robinson2000_2-17\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup> Bacterially derived DNA can trigger innate immune defence mechanisms, the activation of dendritic cells and the production of TH1 cytokines.<sup id=\"cite_ref-Jakob1998_37-1\" class=\"reference\"><a href=\"#cite_note-Jakob1998-37\">&#91;37&#93;</a></sup><sup id=\"cite_ref-Krieg1995_63-0\" class=\"reference\"><a href=\"#cite_note-Krieg1995-63\">&#91;63&#93;</a></sup> This is due to recognition of certain CpG dinucleotide sequences that are immunostimulatory.<sup id=\"cite_ref-Sato1996_59-1\" class=\"reference\"><a href=\"#cite_note-Sato1996-59\">&#91;59&#93;</a></sup><sup id=\"cite_ref-Klinman1997_64-0\" class=\"reference\"><a href=\"#cite_note-Klinman1997-64\">&#91;64&#93;</a></sup> CpG stimulatory (CpG-S) sequences occur twenty times more frequently in bacterially-derived DNA than in eukaryotes. This is because eukaryotes exhibit \u201cCpG suppression\u201d \u2013 i.e. CpG dinucleotide pairs occur much less frequently than expected. Additionally, CpG-S sequences are hypomethylated. This occurs frequently in bacterial DNA, while CpG motifs occurring in eukaryotes are methylated at the cytosine nucleotide. In contrast, nucleotide sequences that inhibit the activation of an immune response (termed CpG neutralising, or CpG-N) are over represented in eukaryotic genomes.<sup id=\"cite_ref-Krieg1998_65-0\" class=\"reference\"><a href=\"#cite_note-Krieg1998-65\">&#91;65&#93;</a></sup> The optimal immunostimulatory sequence is an unmethylated CpG dinucleotide flanked by two 5\u2019 <a href=\"/wiki/Purine\" title=\"Purine\">purines</a> and two 3\u2019 <a href=\"/wiki/Pyrimidine\" title=\"Pyrimidine\">pyrimidines</a>.<sup id=\"cite_ref-Sato1996_59-2\" class=\"reference\"><a href=\"#cite_note-Sato1996-59\">&#91;59&#93;</a></sup><sup id=\"cite_ref-Krieg1995_63-1\" class=\"reference\"><a href=\"#cite_note-Krieg1995-63\">&#91;63&#93;</a></sup> Additionally, flanking regions outside this immunostimulatory <a href=\"/wiki/Oligomer\" title=\"Oligomer\">hexamer</a> must be <a href=\"/wiki/Guanine\" title=\"Guanine\">guanine</a>-rich to ensure binding and uptake into target cells.\n</p><p>The innate system works with the adaptive immune system to mount a response against the DNA encoded protein. CpG-S sequences induce polyclonal B-cell activation and the upregulation of cytokine expression and secretion.<sup id=\"cite_ref-Klinsman1996_66-0\" class=\"reference\"><a href=\"#cite_note-Klinsman1996-66\">&#91;66&#93;</a></sup> Stimulated macrophages secrete IL-12, <a href=\"/wiki/IL18BP\" title=\"IL18BP\">IL-18</a>, TNF-\u03b1, IFN-\u03b1, IFN-\u03b2 and IFN-\u03b3, while stimulated B-cells secrete IL-6 and some IL-12.<sup id=\"cite_ref-Lewis1999_13-10\" class=\"reference\"><a href=\"#cite_note-Lewis1999-13\">&#91;13&#93;</a></sup><sup id=\"cite_ref-Klinsman1996_66-1\" class=\"reference\"><a href=\"#cite_note-Klinsman1996-66\">&#91;66&#93;</a></sup><sup id=\"cite_ref-Yi1996_67-0\" class=\"reference\"><a href=\"#cite_note-Yi1996-67\">&#91;67&#93;</a></sup>\n</p><p>Manipulation of CpG-S and CpG-N sequences in the plasmid backbone of DNA vaccines can ensure the success of the immune response to the encoded antigen and drive the immune response toward a TH1 phenotype. This is useful if a pathogen requires a TH response for protection. CpG-S sequences have also been used as external adjuvants for both DNA and recombinant protein vaccination with variable success rates. Other organisms with hypomethylated CpG motifs have demonstrated the stimulation of polyclonal B-cell expansion.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (August 2015)\">citation needed</span></a></i>&#93;</sup> The mechanism behind this may be more complicated than simple methylation \u2013 hypomethylated murine DNA has not been found to mount an immune response.\n</p><p>Most of the evidence for immunostimulatory CpG sequences comes from murine studies. Extrapolation of this data to other species requires caution \u2013 individual species may require different flanking sequences, as binding specificities of scavenger receptors vary across species. Additionally, species such as ruminants may be insensitive to immunostimulatory sequences due to their large gastrointestinal load.\n</p>\n<h3><span class=\"mw-headline\" id=\"Alternative_boosts\">Alternative boosts</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=33\" title=\"Edit section: Alternative boosts\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>DNA-primed immune responses can be boosted by the administration of recombinant protein or recombinant poxviruses. \"Prime-boost\" strategies with recombinant protein have successfully increased both neutralising antibody titre, and antibody avidity and persistence, for weak immunogens, such as HIV-1 envelope protein.<sup id=\"cite_ref-Robinson2000_2-18\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Letvin1997_68-0\" class=\"reference\"><a href=\"#cite_note-Letvin1997-68\">&#91;68&#93;</a></sup> Recombinant virus boosts have been shown to be very efficient at boosting DNA-primed CTL responses. Priming with DNA focuses the immune response on the required immunogen, while boosting with the recombinant virus provides a larger amount of expressed antigen, leading to a large increase in specific CTL responses.\n</p><p>Prime-boost strategies have been successful in inducing protection against malarial challenge in a number of studies. Primed mice with plasmid DNA encoding <i>Plasmodium yoelii</i> circumsporozoite surface protein (PyCSP), then boosted with a recombinant vaccinia virus expressing the same protein had significantly higher levels of antibody, CTL activity and IFN-\u03b3, and hence higher levels of protection, than mice immunized and boosted with plasmid DNA alone.<sup id=\"cite_ref-Sedegah1998_69-0\" class=\"reference\"><a href=\"#cite_note-Sedegah1998-69\">&#91;69&#93;</a></sup> This can be further enhanced by priming with a mixture of plasmids encoding PyCSP and murine GM-CSF, before boosting with recombinant vaccinia virus.<sup id=\"cite_ref-Sedegah2000_61-1\" class=\"reference\"><a href=\"#cite_note-Sedegah2000-61\">&#91;61&#93;</a></sup> An effective prime-boost strategy for the <a href=\"/wiki/Simian\" title=\"Simian\">simian</a> malarial model <i>P. knowlesi</i> has also been demonstrated.<sup id=\"cite_ref-Rogers2001_70-0\" class=\"reference\"><a href=\"#cite_note-Rogers2001-70\">&#91;70&#93;</a></sup> <a href=\"/wiki/Rhesus_monkeys\" class=\"mw-redirect\" title=\"Rhesus monkeys\">Rhesus monkeys</a> were primed with a multicomponent, multistage DNA vaccine encoding two liver-stage antigens \u2013 the circumsporozoite surface protein (PkCSP) and sporozoite surface protein 2 (PkSSP2) \u2013 and two blood stage antigens \u2013 the apical merozoite surface protein 1 (PkAMA1) and merozoite surface protein 1 (PkMSP1p42). They were then boosted with a recombinant canarypox virus encoding all four antigens (ALVAC-4). Immunized monkeys developed antibodies against sporozoites and infected erythrocytes, and IFN-\u03b3-secreting T-cell responses against peptides from PkCSP. Partial protection against sporozoite challenge was achieved, and mean parasitemia was significantly reduced, compared to control monkeys. These models, while not ideal for extrapolation to <i>P. falciparum</i> in humans, will be important in pre-clinical trials.\n</p>\n<h3><span class=\"mw-headline\" id=\"Enhancing_immune_responses\">Enhancing immune responses</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=34\" title=\"Edit section: Enhancing immune responses\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<h4><span class=\"mw-headline\" id=\"DNA_2\">DNA</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=35\" title=\"Edit section: DNA\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>The efficiency of DNA immunization can be improved by stabilising DNA against degradation, and increasing the efficiency of delivery of DNA into <a href=\"/wiki/Antigen-presenting_cell\" title=\"Antigen-presenting cell\">antigen-presenting cells</a>.<sup id=\"cite_ref-Robinson2000_2-19\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup> This has been demonstrated by coating biodegradable cationic microparticles (such as poly(lactide-co-glycolide) formulated with <a href=\"/wiki/Cetrimonium_bromide\" title=\"Cetrimonium bromide\">cetyltrimethylammonium bromide</a>) with DNA. Such DNA-coated microparticles can be as effective at raising CTL as recombinant viruses, especially when mixed with alum. Particles 300&#160;nm in diameter appear to be most efficient for uptake by antigen presenting cells.<sup id=\"cite_ref-Robinson2000_2-20\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Alphavirus_vectors\">Alphavirus vectors</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=36\" title=\"Edit section: Alphavirus vectors\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>Recombinant alphavirus-based vectors have been used to improve DNA vaccination efficiency.<sup id=\"cite_ref-Robinson2000_2-21\" class=\"reference\"><a href=\"#cite_note-Robinson2000-2\">&#91;2&#93;</a></sup> The gene encoding the antigen of interest is inserted into the alphavirus replicon, replacing structural genes but leaving non-structural replicase genes intact. The <a href=\"/wiki/Sindbis_virus\" title=\"Sindbis virus\">Sindbis virus</a> and <a href=\"/wiki/Semliki_Forest_virus\" title=\"Semliki Forest virus\">Semliki Forest virus</a> have been used to build recombinant <a href=\"/wiki/Alphavirus\" title=\"Alphavirus\">alphavirus</a> <a href=\"/wiki/Replicon_(genetics)\" title=\"Replicon (genetics)\">replicons</a>. Unlike conventional DNA vaccinations alphavirus vectors kill transfected cells and are only transiently expressed. Alphavirus replicase genes are expressed in addition to the vaccine insert. It is not clear how alphavirus replicons raise an immune response, but it may be due to the high levels of protein expressed by this vector, replicon-induced cytokine responses, or replicon-induced apoptosis leading to enhanced antigen uptake by dendritic cells.\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=37\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Vector_DNA\" class=\"mw-redirect\" title=\"Vector DNA\">Vector DNA</a></li>\n<li><a href=\"/wiki/HIV_vaccine\" title=\"HIV vaccine\">HIV vaccine</a></li>\n<li><a href=\"/wiki/Gene_therapy\" title=\"Gene therapy\">Gene therapy</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=38\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-Alarcon1999-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Alarcon1999_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Alarcon1999_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Alarcon1999_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Alarcon1999_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Alarcon1999_1-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Alarcon1999_1-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-Alarcon1999_1-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-Alarcon1999_1-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-Alarcon1999_1-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-Alarcon1999_1-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-Alarcon1999_1-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-Alarcon1999_1-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-Alarcon1999_1-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-Alarcon1999_1-13\"><sup><i><b>n</b></i></sup></a> <a href=\"#cite_ref-Alarcon1999_1-14\"><sup><i><b>o</b></i></sup></a> <a href=\"#cite_ref-Alarcon1999_1-15\"><sup><i><b>p</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Alarcon JB, Waine GW, McManus DP; Waine; McManus (1999). \"DNA vaccines: technology and application as anti-parasite and anti-microbial agents\". <i>Adv. Parasitol</i>. Advances in Parasitology. <b>42</b>: 343\u2013410. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0065-308X%2808%2960152-9\">10.1016/S0065-308X(08)60152-9</a>. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/9780120317424\" title=\"Special:BookSources/9780120317424\">9780120317424</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10050276\">10050276</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Adv.+Parasitol.&amp;rft.atitle=DNA+vaccines%3A+technology+and+application+as+anti-parasite+and+anti-microbial+agents&amp;rft.volume=42&amp;rft.pages=343-410&amp;rft.date=1999&amp;rft_id=info%3Apmid%2F10050276&amp;rft_id=info%3Adoi%2F10.1016%2FS0065-308X%2808%2960152-9&amp;rft.isbn=9780120317424&amp;rft.au=Alarcon+JB%2C+Waine+GW%2C+McManus+DP&amp;rft.au=Waine&amp;rft.au=McManus&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span class=\"citation-comment\" style=\"display:none; color:#33aa33; margin-left:0.3em\">CS1 maint: Multiple names: authors list (<a href=\"/wiki/Category:CS1_maint:_Multiple_names:_authors_list\" title=\"Category:CS1 maint: Multiple names: authors list\">link</a>) </span></span>\n</li>\n<li id=\"cite_note-Robinson2000-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Robinson2000_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Robinson2000_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Robinson2000_2-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Robinson2000_2-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Robinson2000_2-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Robinson2000_2-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-Robinson2000_2-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-Robinson2000_2-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-Robinson2000_2-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-Robinson2000_2-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-Robinson2000_2-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-Robinson2000_2-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-Robinson2000_2-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-Robinson2000_2-13\"><sup><i><b>n</b></i></sup></a> <a href=\"#cite_ref-Robinson2000_2-14\"><sup><i><b>o</b></i></sup></a> <a href=\"#cite_ref-Robinson2000_2-15\"><sup><i><b>p</b></i></sup></a> <a href=\"#cite_ref-Robinson2000_2-16\"><sup><i><b>q</b></i></sup></a> <a href=\"#cite_ref-Robinson2000_2-17\"><sup><i><b>r</b></i></sup></a> <a href=\"#cite_ref-Robinson2000_2-18\"><sup><i><b>s</b></i></sup></a> <a href=\"#cite_ref-Robinson2000_2-19\"><sup><i><b>t</b></i></sup></a> <a href=\"#cite_ref-Robinson2000_2-20\"><sup><i><b>u</b></i></sup></a> <a href=\"#cite_ref-Robinson2000_2-21\"><sup><i><b>v</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Robinson HL, Pertmer TM; Pertmer (2000). \"DNA vaccines for viral infections: basic studies and applications\". <i>Adv. Virus Res</i>. Advances in Virus Research. <b>55</b>: 1\u201374. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0065-3527%2800%2955001-5\">10.1016/S0065-3527(00)55001-5</a>. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/9780120398553\" title=\"Special:BookSources/9780120398553\">9780120398553</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11050940\">11050940</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Adv.+Virus+Res.&amp;rft.atitle=DNA+vaccines+for+viral+infections%3A+basic+studies+and+applications&amp;rft.volume=55&amp;rft.pages=1-74&amp;rft.date=2000&amp;rft_id=info%3Apmid%2F11050940&amp;rft_id=info%3Adoi%2F10.1016%2FS0065-3527%2800%2955001-5&amp;rft.isbn=9780120398553&amp;rft.au=Robinson+HL%2C+Pertmer+TM&amp;rft.au=Pertmer&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Panicali Dennis, Davis Stephen W., Weinberg Randall L., Paoletti Enzo (1983). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC384256\">\"Construction of Live Vaccines by Using Genetically Engineered Poxviruses: Biological Activity of Recombinant Vaccinia Virus Expressing Influenza Virus Hemagglutinin\"</a>. <i>Proc. Natl. Acad. Sci. USA</i>. <b>80</b>: 5364\u20135368. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.80.17.5364\">10.1073/pnas.80.17.5364</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC384256\">384256</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+USA&amp;rft.atitle=Construction+of+Live+Vaccines+by+Using+Genetically+Engineered+Poxviruses%3A+Biological+Activity+of+Recombinant+Vaccinia+Virus+Expressing+Influenza+Virus+Hemagglutinin&amp;rft.volume=80&amp;rft.pages=5364-5368&amp;rft.date=1983&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC384256&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.80.17.5364&amp;rft.au=Panicali+Dennis%2C+Davis+Stephen+W.%2C+Weinberg+Randall+L.%2C+Paoletti+Enzo&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC384256&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span class=\"citation-comment\" style=\"display:none; color:#33aa33; margin-left:0.3em\">CS1 maint: Multiple names: authors list (<a href=\"/wiki/Category:CS1_maint:_Multiple_names:_authors_list\" title=\"Category:CS1 maint: Multiple names: authors list\">link</a>) </span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Paoletti Enzo, Lipinskas Bernard R., Samsonoff Carol, Mercer Susan, Panicali Dennis (1984). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC344637\">\"Construction of Live Vaccines Using Genetically Engineered Poxviruses: Biological Activity of Vaccinia Virus Recombinants Expressing the Hepatitis B Virus Surface Antigen and the Herpes Simplex Virus Glycoprotein D\"</a>. <i>Proc. Natl. Acad. Sci. USA</i>. <b>81</b>: 193\u2013197. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.81.1.193\">10.1073/pnas.81.1.193</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC344637\">344637</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+USA&amp;rft.atitle=Construction+of+Live+Vaccines+Using+Genetically+Engineered+Poxviruses%3A+Biological+Activity+of+Vaccinia+Virus+Recombinants+Expressing+the+Hepatitis+B+Virus+Surface+Antigen+and+the+Herpes+Simplex+Virus+Glycoprotein+D&amp;rft.volume=81&amp;rft.pages=193-197&amp;rft.date=1984&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC344637&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.81.1.193&amp;rft.au=Paoletti+Enzo%2C+Lipinskas+Bernard+R.%2C+Samsonoff+Carol%2C+Mercer+Susan%2C+Panicali+Dennis&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC344637&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span class=\"citation-comment\" style=\"display:none; color:#33aa33; margin-left:0.3em\">CS1 maint: Multiple names: authors list (<a href=\"/wiki/Category:CS1_maint:_Multiple_names:_authors_list\" title=\"Category:CS1 maint: Multiple names: authors list\">link</a>) </span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\">US Patent 4722848 - Method for immunizing animals with synthetically modified vaccinia virus</span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Regalado, Antonio. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.technologyreview.com/s/602073/us-government-starts-test-of-zika-vaccine-in-humans/?set=602081\">\"The U.S. government has begun testing its first Zika vaccine in humans\"</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2016-08-06</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+U.S.+government+has+begun+testing+its+first+Zika+vaccine+in+humans&amp;rft.aulast=Regalado&amp;rft.aufirst=Antonio&amp;rft_id=https%3A%2F%2Fwww.technologyreview.com%2Fs%2F602073%2Fus-government-starts-test-of-zika-vaccine-in-humans%2F%3Fset%3D602081&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.highbeam.com/doc/1G1-134116417.html\">\"Fort Dodge Animal Health Announces Approval of West Nile Virus DNA Vaccine for Horses\"</a>. <i>PR Newswire</i>. 2005-07-18<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PR+Newswire&amp;rft.atitle=Fort+Dodge+Animal+Health+Announces+Approval+of+West+Nile+Virus+DNA+Vaccine+for+Horses&amp;rft.date=2005-07-18&amp;rft_id=http%3A%2F%2Fwww.highbeam.com%2Fdoc%2F1G1-134116417.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20070820194311/http://www.cdc.gov/od/oc/media/pressrel/r050718.htm\">\"CDC and Fort Dodge Animal Health Achieve First Licensed DNA Vaccine\"</a>. <i>CDC</i>. 2005-07-18. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"https://www.cdc.gov/od/oc/media/pressrel/r050718.htm\">the original</a> on 2007-08-20<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CDC&amp;rft.atitle=CDC+and+Fort+Dodge+Animal+Health+Achieve+First+Licensed+DNA+Vaccine&amp;rft.date=2005-07-18&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fod%2Foc%2Fmedia%2Fpressrel%2Fr050718.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Sedegah1994-9\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Sedegah1994_9-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Sedegah1994_9-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sedegah, M.; Hedstrom, R.; Hobart, P.; Hoffman, S.L. (1994). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC44918\">\"Protection against Malaria by Immunization with Plasmid DNA Encoding Circumsporozoite Protein\"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>91</b> (21): 9866\u20139870. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.91.21.9866\">10.1073/pnas.91.21.9866</a>. <a href=\"/wiki/JSTOR\" title=\"JSTOR\">JSTOR</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.jstor.org/stable/2365723\">2365723</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC44918\">44918</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7937907\">7937907</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;rft.atitle=Protection+against+Malaria+by+Immunization+with+Plasmid+DNA+Encoding+Circumsporozoite+Protein&amp;rft.volume=91&amp;rft.issue=21&amp;rft.pages=9866-9870&amp;rft.date=1994&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC44918&amp;rft_id=info%3Apmid%2F7937907&amp;rft_id=%2F%2Fwww.jstor.org%2Fstable%2F2365723&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.91.21.9866&amp;rft.au=Sedegah%2C+M.&amp;rft.au=Hedstrom%2C+R.&amp;rft.au=Hobart%2C+P.&amp;rft.au=Hoffman%2C+S.L.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC44918&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Mor1995-10\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Mor1995_10-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Mor1995_10-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Mor, G.; Klinman, DM; Shapiro, S; Hagiwara, E; Sedegah, M; Norman, JA; Hoffman, SL; Steinberg, AD (August 15, 1995). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jimmunol.org/cgi/content/abstract/155/4/2039\">\"Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA\"</a>. <i>The Journal of Immunology</i>. <b>155</b> (4): 2039\u20132046. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7636255\">7636255</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Immunology&amp;rft.atitle=Complexity+of+the+cytokine+and+antibody+response+elicited+by+immunizing+mice+with+Plasmodium+yoelii+circumsporozoite+protein+plasmid+DNA&amp;rft.volume=155&amp;rft.issue=4&amp;rft.pages=2039-2046&amp;rft.date=1995-08-15&amp;rft_id=info%3Apmid%2F7636255&amp;rft.au=Mor%2C+G.&amp;rft.au=Klinman%2C+DM&amp;rft.au=Shapiro%2C+S&amp;rft.au=Hagiwara%2C+E&amp;rft.au=Sedegah%2C+M&amp;rft.au=Norman%2C+JA&amp;rft.au=Hoffman%2C+SL&amp;rft.au=Steinberg%2C+AD&amp;rft_id=http%3A%2F%2Fwww.jimmunol.org%2Fcgi%2Fcontent%2Fabstract%2F155%2F4%2F2039&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Leitner1997-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Leitner1997_11-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Leitner, W.W.; Seguin, MC; Ballou, WR; Seitz, JP; Schultz, AM; Sheehy, MJ; Lyon, JA (December 15, 1997). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jimmunol.org/cgi/content/abstract/159/12/6112\">\"Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites\"</a>. <i>The Journal of Immunology</i>. <b>159</b> (12): 6112\u20136119. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9550412\">9550412</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Immunology&amp;rft.atitle=Immune+responses+induced+by+intramuscular+or+gene+gun+injection+of+protective+deoxyribonucleic+acid+vaccines+that+express+the+circumsporozoite+protein+from+Plasmodium+berghei+malaria+parasites&amp;rft.volume=159&amp;rft.issue=12&amp;rft.pages=6112-6119&amp;rft.date=1997-12-15&amp;rft_id=info%3Apmid%2F9550412&amp;rft.au=Leitner%2C+W.W.&amp;rft.au=Seguin%2C+MC&amp;rft.au=Ballou%2C+WR&amp;rft.au=Seitz%2C+JP&amp;rft.au=Schultz%2C+AM&amp;rft.au=Sheehy%2C+MJ&amp;rft.au=Lyon%2C+JA&amp;rft_id=http%3A%2F%2Fwww.jimmunol.org%2Fcgi%2Fcontent%2Fabstract%2F159%2F12%2F6112&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-B\u00f6hm1996-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-B\u00f6hm1996_12-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">B\u00f6hm, W.; Kuhr\u00f6ber, A.; Paier, T.; Mertens, T.; Reimann, J.; Schirmbeck, R. (1996). <a rel=\"nofollow\" class=\"external text\" href=\"http://linkinghub.elsevier.com/retrieve/pii/002217599600035X\">\"DNA vector constructs that prime hepatitis B surface antigen-specific cytotoxic T lymphocyte and antibody responses in mice after intramuscular injection\"</a>. <i>Journal of Immunological Methods</i>. <b>193</b> (1): 29\u201340. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/0022-1759%2896%2900035-X\">10.1016/0022-1759(96)00035-X</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8690928\">8690928</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Immunological+Methods&amp;rft.atitle=DNA+vector+constructs+that+prime+hepatitis+B+surface+antigen-specific+cytotoxic+T+lymphocyte+and+antibody+responses+in+mice+after+intramuscular+injection&amp;rft.volume=193&amp;rft.issue=1&amp;rft.pages=29-40&amp;rft.date=1996&amp;rft_id=info%3Adoi%2F10.1016%2F0022-1759%2896%2900035-X&amp;rft_id=info%3Apmid%2F8690928&amp;rft.au=B%C3%B6hm%2C+W.&amp;rft.au=Kuhr%C3%B6ber%2C+A.&amp;rft.au=Paier%2C+T.&amp;rft.au=Mertens%2C+T.&amp;rft.au=Reimann%2C+J.&amp;rft.au=Schirmbeck%2C+R.&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2F002217599600035X&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Lewis1999-13\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Lewis1999_13-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Lewis1999_13-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Lewis1999_13-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Lewis1999_13-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Lewis1999_13-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Lewis1999_13-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-Lewis1999_13-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-Lewis1999_13-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-Lewis1999_13-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-Lewis1999_13-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-Lewis1999_13-10\"><sup><i><b>k</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lewis, P.J.; Babiuk, L.A. (1999). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=lrMc3G9nIpkC&amp;pg=PA129&amp;dq=lewis\">\"DNA Vaccines: A Review\"</a>. <i>Advances in Virus Research</i>. Academic Press. <b>54</b>: 129\u201388. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0065-3527%2808%2960367-X\">10.1016/S0065-3527(08)60367-X</a>. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-12-039854-6\" title=\"Special:BookSources/978-0-12-039854-6\">978-0-12-039854-6</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10547676\">10547676</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Advances+in+Virus+Research&amp;rft.atitle=DNA+Vaccines%3A+A+Review&amp;rft.volume=54&amp;rft.pages=129-88&amp;rft.date=1999&amp;rft_id=info%3Apmid%2F10547676&amp;rft_id=info%3Adoi%2F10.1016%2FS0065-3527%2808%2960367-X&amp;rft.isbn=978-0-12-039854-6&amp;rft.au=Lewis%2C+P.J.&amp;rft.au=Babiuk%2C+L.A.&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DlrMc3G9nIpkC%26pg%3DPA129%26dq%3Dlewis&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Andre1998-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Andre1998_14-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Andre, S.; Seed, B.; Eberle, J.; Schraut, W.; Bultmann, A.; Haas, J. (February 1, 1998). <a rel=\"nofollow\" class=\"external text\" href=\"http://jvi.asm.org/cgi/content/abstract/72/2/1497\">\"Increased Immune Response Elicited by DNA Vaccination with a Synthetic gp120 Sequence with Optimized Codon Usage\"</a>. <i>Journal of Virology</i>. <b>72</b> (2): 1497\u2013503. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC124631\">124631</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9445053\">9445053</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Virology&amp;rft.atitle=Increased+Immune+Response+Elicited+by+DNA+Vaccination+with+a+Synthetic+gp120+Sequence+with+Optimized+Codon+Usage&amp;rft.volume=72&amp;rft.issue=2&amp;rft.pages=1497-503&amp;rft.date=1998-02-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC124631&amp;rft_id=info%3Apmid%2F9445053&amp;rft.au=Andre%2C+S.&amp;rft.au=Seed%2C+B.&amp;rft.au=Eberle%2C+J.&amp;rft.au=Schraut%2C+W.&amp;rft.au=Bultmann%2C+A.&amp;rft.au=Haas%2C+J.&amp;rft_id=http%3A%2F%2Fjvi.asm.org%2Fcgi%2Fcontent%2Fabstract%2F72%2F2%2F1497&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Muthumani1998-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Muthumani1998_15-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Muthumani, K.; Zhang, D.; Dayes, NS.; Hwang, DS.; Calarota, SA.; Choo, AY.; Boyer, JD.; Weiner, DB. (2003). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.sciencedirect.com/science?_ob=ArticleURL&amp;_udi=B6WXR-49KGT6R-6&amp;_user=489256&amp;_rdoc=1&amp;_fmt=&amp;_orig=search&amp;_sort=d&amp;view=c&amp;_acct=C000022721&amp;_version=1&amp;_urlVersion=0&amp;_userid=489256&amp;md5=5ac81624c72867e12d2a89d0aa3cfc6b\">\"Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo\"</a>. <i>Virology</i>. <b>314</b> (1): 134\u201346. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0042-6822%2803%2900459-8\">10.1016/S0042-6822(03)00459-8</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14517067\">14517067</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-03-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Virology&amp;rft.atitle=Novel+engineered+HIV-1+East+African+Clade-A+gp160+plasmid+construct+induces+strong+humoral+and+cell-mediated+immune+responses+in+vivo&amp;rft.volume=314&amp;rft.issue=1&amp;rft.pages=134-46&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1016%2FS0042-6822%2803%2900459-8&amp;rft_id=info%3Apmid%2F14517067&amp;rft.au=Muthumani%2C+K.&amp;rft.au=Zhang%2C+D.&amp;rft.au=Dayes%2C+NS.&amp;rft.au=Hwang%2C+DS.&amp;rft.au=Calarota%2C+SA.&amp;rft.au=Choo%2C+AY.&amp;rft.au=Boyer%2C+JD.&amp;rft.au=Weiner%2C+DB.&amp;rft_id=http%3A%2F%2Fwww.sciencedirect.com%2Fscience%3F_ob%3DArticleURL%26_udi%3DB6WXR-49KGT6R-6%26_user%3D489256%26_rdoc%3D1%26_fmt%3D%26_orig%3Dsearch%26_sort%3Dd%26view%3Dc%26_acct%3DC000022721%26_version%3D1%26_urlVersion%3D0%26_userid%3D489256%26md5%3D5ac81624c72867e12d2a89d0aa3cfc6b&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Oliveira, PH; Prather, KLJ; Prazeres, DMF; Monteiro, GA (2009). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.sciencedirect.com/science/article/pii/S0167779909001164\">\"Structural instability of plasmid biopharmaceuticals: challenges and implications\"</a>. <i>Trends in Biotechnology</i>. <b>27</b> (9): 503\u2013511. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.tibtech.2009.06.004\">10.1016/j.tibtech.2009.06.004</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Trends+in+Biotechnology&amp;rft.atitle=Structural+instability+of+plasmid+biopharmaceuticals%3A+challenges+and+implications&amp;rft.volume=27&amp;rft.issue=9&amp;rft.pages=503-511&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.1016%2Fj.tibtech.2009.06.004&amp;rft.aulast=Oliveira&amp;rft.aufirst=PH&amp;rft.au=Prather%2C+KLJ&amp;rft.au=Prazeres%2C+DMF&amp;rft.au=Monteiro%2C+GA&amp;rft_id=http%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS0167779909001164&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Oliveira, PH; Mairhofer, J (2013). \"Marker-free plasmids for biotechnological applications - implications and perspectives\". <i>Trends in Biotechnology</i>. <b>31</b> (9): 539\u201347. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.tibtech.2013.06.001\">10.1016/j.tibtech.2013.06.001</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23830144\">23830144</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Trends+in+Biotechnology&amp;rft.atitle=Marker-free+plasmids+for+biotechnological+applications+-+implications+and+perspectives&amp;rft.volume=31&amp;rft.issue=9&amp;rft.pages=539-47&amp;rft.date=2013&amp;rft_id=info%3Adoi%2F10.1016%2Fj.tibtech.2013.06.001&amp;rft_id=info%3Apmid%2F23830144&amp;rft.aulast=Oliveira&amp;rft.aufirst=PH&amp;rft.au=Mairhofer%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kutzler, Michele A.; David B. Weiner (2008). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4317294\">\"DNA Vaccines: Ready for Prime Time?\"</a>. <i>Nature Reviews Genetics</i>. <b>9</b>: 776\u2013788. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nrg2432\">10.1038/nrg2432</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4317294\">4317294</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18781156\">18781156</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Genetics&amp;rft.atitle=DNA+Vaccines%3A+Ready+for+Prime+Time%3F&amp;rft.volume=9&amp;rft.pages=776-788&amp;rft.date=2008&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4317294&amp;rft_id=info%3Apmid%2F18781156&amp;rft_id=info%3Adoi%2F10.1038%2Fnrg2432&amp;rft.aulast=Kutzler&amp;rft.aufirst=Michele+A.&amp;rft.au=David+B.+Weiner&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4317294&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Rodriguez1997-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Rodriguez1997_19-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rodriguez, F.; Zhang, J.; Whitton, J.L. (1997). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC192313\">\"DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction\"</a>. <i>Journal of Virology</i>. <b>71</b> (11): 8497\u2013503. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC192313\">192313</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9343207\">9343207</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Virology&amp;rft.atitle=DNA+immunization%3A+ubiquitination+of+a+viral+protein+enhances+cytotoxic+T-lymphocyte+induction+and+antiviral+protection+but+abrogates+antibody+induction.&amp;rft.volume=71&amp;rft.issue=11&amp;rft.pages=8497-503&amp;rft.date=1997&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC192313&amp;rft_id=info%3Apmid%2F9343207&amp;rft.au=Rodriguez%2C+F.&amp;rft.au=Zhang%2C+J.&amp;rft.au=Whitton%2C+J.L.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC192313&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Tobery1997-20\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Tobery1997_20-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Tobery1997_20-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Tobery, T.W.; Siliciano, R.F. (1997). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2196169\">\"Targeting of HIV-1 Antigens for Rapid Intracellular Degradation Enhances Cytotoxic T Lymphocyte (CTL) Recognition and the Induction of De Novo CTL Responses In Vivo After Immunization\"</a>. <i>Journal of Experimental Medicine</i>. <b>185</b> (5): 909\u2013920. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1084/jem.185.5.909\">10.1084/jem.185.5.909</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2196169\">2196169</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9120397\">9120397</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Experimental+Medicine&amp;rft.atitle=Targeting+of+HIV-1+Antigens+for+Rapid+Intracellular+Degradation+Enhances+Cytotoxic+T+Lymphocyte+%28CTL%29+Recognition+and+the+Induction+of+De+Novo+CTL+Responses+In+Vivo+After+Immunization&amp;rft.volume=185&amp;rft.issue=5&amp;rft.pages=909-920&amp;rft.date=1997&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2196169&amp;rft_id=info%3Apmid%2F9120397&amp;rft_id=info%3Adoi%2F10.1084%2Fjem.185.5.909&amp;rft.au=Tobery%2C+T.W.&amp;rft.au=Siliciano%2C+R.F.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2196169&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Huebener N (Jul 2008). \"A rationally designed tyrosine hydroxylase DNA vaccine induces specific antineuroblastoma immunity\". <i>Mol Cancer Ther</i>. <b>7</b> (7): 2241\u201351. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1158/1535-7163.MCT-08-0109\">10.1158/1535-7163.MCT-08-0109</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mol+Cancer+Ther.&amp;rft.atitle=A+rationally+designed+tyrosine+hydroxylase+DNA+vaccine+induces+specific+antineuroblastoma+immunity&amp;rft.volume=7&amp;rft.issue=7&amp;rft.pages=2241-51&amp;rft.date=2008-07&amp;rft_id=info%3Adoi%2F10.1158%2F1535-7163.MCT-08-0109&amp;rft.au=Huebener+N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Wunderlich2000-22\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Wunderlich2000_22-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Wunderlich2000_22-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wunderlich, G.; Moura, I.C.; Del Portillo, H.A. (2000). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC101545\">\"Genetic Immunization of BALB/c mice with a Plasmid Bearing the Gene Coding for a Hybrid Merozoite Surface Protein 1-Hepatitis B Virus Surface Protein Fusion Protects Mice against Lethal Plasmodium chabaudi chabaudi PC1 Infection\"</a>. <i>Infection and Immunity</i>. <b>68</b> (10): 5839\u201345. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1128/IAI.68.10.5839-5845.2000\">10.1128/IAI.68.10.5839-5845.2000</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC101545\">101545</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10992493\">10992493</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Infection+and+Immunity&amp;rft.atitle=Genetic+Immunization+of+BALB%2Fc+mice+with+a+Plasmid+Bearing+the+Gene+Coding+for+a+Hybrid+Merozoite+Surface+Protein+1-Hepatitis+B+Virus+Surface+Protein+Fusion+Protects+Mice+against+Lethal+Plasmodium+chabaudi+chabaudi+PC1+Infection&amp;rft.volume=68&amp;rft.issue=10&amp;rft.pages=5839-45&amp;rft.date=2000&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC101545&amp;rft_id=info%3Apmid%2F10992493&amp;rft_id=info%3Adoi%2F10.1128%2FIAI.68.10.5839-5845.2000&amp;rft.au=Wunderlich%2C+G.&amp;rft.au=Moura%2C+I.C.&amp;rft.au=Del+Portillo%2C+H.A.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC101545&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Weiner1999-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Weiner1999_23-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Weiner, D.B.; Kennedy, R.C. (1999). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.sciamdigital.com/gsp_qpdf.cfm?ISSUEID_CHAR=8FF32714-CA1C-4025-BE8D-0FE4B5C348B&amp;ARTICLEID_CHAR=14F98F90-1708-4B77-A8D4-44F867A153F\">\"Genetic vaccines\"</a>. <i>Scientific American</i>. <b>281</b> (1): 34\u201341<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Scientific+American&amp;rft.atitle=Genetic+vaccines&amp;rft.volume=281&amp;rft.issue=1&amp;rft.pages=34-41&amp;rft.date=1999&amp;rft.au=Weiner%2C+D.B.&amp;rft.au=Kennedy%2C+R.C.&amp;rft_id=http%3A%2F%2Fwww.sciamdigital.com%2Fgsp_qpdf.cfm%3FISSUEID_CHAR%3D8FF32714-CA1C-4025-BE8D-0FE4B5C348B%26ARTICLEID_CHAR%3D14F98F90-1708-4B77-A8D4-44F867A153F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Widera2000-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Widera2000_24-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Widera, G.; Austin, M.; Rabussay, D.; Goldbeck, C.; Barnett, S.W.; Chen, M.; Leung, L.; Otten, G.R.; Thudium, K.; Selby, M.J.;  et al. (May 1, 2000). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jimmunol.org/cgi/content/abstract/164/9/4635\">\"Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo\"</a>. <i>The Journal of Immunology</i>. <b>164</b> (9): 4635\u20134640. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.4049/jimmunol.164.9.4635\">10.4049/jimmunol.164.9.4635</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10779767\">10779767</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Immunology&amp;rft.atitle=Increased+DNA+Vaccine+Delivery+and+Immunogenicity+by+Electroporation+In+Vivo&amp;rft.volume=164&amp;rft.issue=9&amp;rft.pages=4635-4640&amp;rft.date=2000-05-01&amp;rft_id=info%3Adoi%2F10.4049%2Fjimmunol.164.9.4635&amp;rft_id=info%3Apmid%2F10779767&amp;rft.au=Widera%2C+G.&amp;rft.au=Austin%2C+M.&amp;rft.au=Rabussay%2C+D.&amp;rft.au=Goldbeck%2C+C.&amp;rft.au=Barnett%2C+S.W.&amp;rft.au=Chen%2C+M.&amp;rft.au=Leung%2C+L.&amp;rft.au=Otten%2C+G.R.&amp;rft.au=Thudium%2C+K.&amp;rft.au=Selby%2C+M.J.&amp;rft_id=http%3A%2F%2Fwww.jimmunol.org%2Fcgi%2Fcontent%2Fabstract%2F164%2F9%2F4635&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Fynan1993-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Fynan1993_25-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fynan, E.F.; Webster, R.G.; Fuller, D.H.; Haynes, J.R.; Santoro, J.C.; Robinson, H.L. (1993). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC48007\">\"DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>90</b> (24): 11478\u201382. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.90.24.11478\">10.1073/pnas.90.24.11478</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC48007\">48007</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8265577\">8265577</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=DNA+vaccines%3A+protective+immunizations+by+parenteral%2C+mucosal%2C+and+gene-gun+inoculations&amp;rft.volume=90&amp;rft.issue=24&amp;rft.pages=11478-82&amp;rft.date=1993&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC48007&amp;rft_id=info%3Apmid%2F8265577&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.90.24.11478&amp;rft.au=Fynan%2C+E.F.&amp;rft.au=Webster%2C+R.G.&amp;rft.au=Fuller%2C+D.H.&amp;rft.au=Haynes%2C+J.R.&amp;rft.au=Santoro%2C+J.C.&amp;rft.au=Robinson%2C+H.L.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC48007&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Daheshia1997-26\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Daheshia1997_26-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Daheshia1997_26-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Daheshia, M.; Kuklin, N; Kanangat, S; Manickan, E; Rouse, BT (August 15, 1997). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jimmunol.org/cgi/content/abstract/159/4/1945\">\"Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10\"</a>. <i>The Journal of Immunology</i>. <b>159</b> (4): 1945\u20131952. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9257860\">9257860</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Immunology&amp;rft.atitle=Suppression+of+ongoing+ocular+inflammatory+disease+by+topical+administration+of+plasmid+DNA+encoding+IL-10&amp;rft.volume=159&amp;rft.issue=4&amp;rft.pages=1945-1952&amp;rft.date=1997-08-15&amp;rft_id=info%3Apmid%2F9257860&amp;rft.au=Daheshia%2C+M.&amp;rft.au=Kuklin%2C+N&amp;rft.au=Kanangat%2C+S&amp;rft.au=Manickan%2C+E&amp;rft.au=Rouse%2C+BT&amp;rft_id=http%3A%2F%2Fwww.jimmunol.org%2Fcgi%2Fcontent%2Fabstract%2F159%2F4%2F1945&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Chen1998-27\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Chen1998_27-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Chen1998_27-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Chen, Y.; Webster, R.G.; Woodland, D.L. (March 1, 1998). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jimmunol.org/cgi/content/abstract/160/5/2425\">\"Induction of CD<sup>8+</sup> T Cell Responses to Dominant and Subdominant Epitopes and Protective Immunity to Sendai Virus Infection by DNA Vaccination 1\"</a>. <i>The Journal of Immunology</i>. <b>160</b> (5): 2425\u20132432. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9498786\">9498786</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Immunology&amp;rft.atitle=Induction+of+CD%3Csup%3E8%2B%3C%2Fsup%3E+T+Cell+Responses+to+Dominant+and+Subdominant+Epitopes+and+Protective+Immunity+to+Sendai+Virus+Infection+by+DNA+Vaccination+1&amp;rft.volume=160&amp;rft.issue=5&amp;rft.pages=2425-2432&amp;rft.date=1998-03-01&amp;rft_id=info%3Apmid%2F9498786&amp;rft.au=Chen%2C+Y.&amp;rft.au=Webster%2C+R.G.&amp;rft.au=Woodland%2C+D.L.&amp;rft_id=http%3A%2F%2Fwww.jimmunol.org%2Fcgi%2Fcontent%2Fabstract%2F160%2F5%2F2425&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-28\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lode HN, Huebener N, Zeng Y, Fest S, Weixler S, Gaedicke G (Dec 2004). \"DNA minigene vaccination for adjuvant neuroblastoma therapy\". <i>Ann N Y Acad Sci</i>. <b>1028</b>: 113\u201321. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1196/annals.1322.012\">10.1196/annals.1322.012</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Ann+N+Y+Acad+Sci&amp;rft.atitle=DNA+minigene+vaccination+for+adjuvant+neuroblastoma+therapy&amp;rft.volume=1028&amp;rft.pages=113-21&amp;rft.date=2004-12&amp;rft_id=info%3Adoi%2F10.1196%2Fannals.1322.012&amp;rft.au=Lode+HN%2C+Huebener+N%2C+Zeng+Y%2C+Fest+S%2C+Weixler+S%2C+Gaedicke+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span class=\"citation-comment\" style=\"display:none; color:#33aa33; margin-left:0.3em\">CS1 maint: Multiple names: authors list (<a href=\"/wiki/Category:CS1_maint:_Multiple_names:_authors_list\" title=\"Category:CS1 maint: Multiple names: authors list\">link</a>) </span></span>\n</li>\n<li id=\"cite_note-Sizemore1995-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Sizemore1995_29-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sizemore DR, Branstrom AA, Sadoff JC (October 1995). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.sciencemag.org/cgi/pmidlookup?view=long&amp;pmid=7569980\">\"Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization\"</a>. <i>Science</i>. <b>270</b> (5234): 299\u2013302. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.270.5234.299\">10.1126/science.270.5234.299</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7569980\">7569980</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Attenuated+Shigella+as+a+DNA+delivery+vehicle+for+DNA-mediated+immunization&amp;rft.volume=270&amp;rft.issue=5234&amp;rft.pages=299-302&amp;rft.date=1995-10&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.270.5234.299&amp;rft_id=info%3Apmid%2F7569980&amp;rft.aulast=Sizemore&amp;rft.aufirst=DR&amp;rft.au=Branstrom%2C+AA&amp;rft.au=Sadoff%2C+JC&amp;rft_id=http%3A%2F%2Fwww.sciencemag.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D7569980&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-30\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Nealon, Cory (25 November 2014). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.buffalo.edu/news/releases/2014/11/035.html\">\"A hybrid vehicle that delivers DNA\"</a>. The State University of New York at Buffalo<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">16 December</span> 2014</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=A+hybrid+vehicle+that+delivers+DNA&amp;rft.pub=The+State+University+of+New+York+at+Buffalo&amp;rft.date=2014-11-25&amp;rft.au=Nealon%2C+Cory&amp;rft_id=http%3A%2F%2Fwww.buffalo.edu%2Fnews%2Freleases%2F2014%2F11%2F035.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-31\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Pfeifer, Blaine;  et al. (2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4151754\">\"Hybrid biosynthetic gene therapy vector development and dual engineering capacity\"</a>. <i>PNAS</i>. National Academy of Sciences. <b>111</b> (34): 12360\u201312365. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.1411355111\">10.1073/pnas.1411355111</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4151754\">4151754</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25114239\">25114239</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PNAS&amp;rft.atitle=Hybrid+biosynthetic+gene+therapy+vector+development+and+dual+engineering+capacity&amp;rft.volume=111&amp;rft.issue=34&amp;rft.pages=12360-12365&amp;rft.date=2014&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4151754&amp;rft_id=info%3Apmid%2F25114239&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.1411355111&amp;rft.aulast=Pfeifer&amp;rft.aufirst=Blaine&amp;rft.au=Jones%2C+Charles&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4151754&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Barry1995-32\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Barry1995_32-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Barry, M.A.; Lai, W.C.; Johnston, S.A.;  et al. (1995). \"Protection against mycoplasma infection using expression-library immunization\". <i>Nature</i>. <b>377</b> (6550): 632\u2013635. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/377632a0\">10.1038/377632a0</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7566175\">7566175</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Protection+against+mycoplasma+infection+using+expression-library+immunization&amp;rft.volume=377&amp;rft.issue=6550&amp;rft.pages=632-635&amp;rft.date=1995&amp;rft_id=info%3Adoi%2F10.1038%2F377632a0&amp;rft_id=info%3Apmid%2F7566175&amp;rft.au=Barry%2C+M.A.&amp;rft.au=Lai%2C+W.C.&amp;rft.au=Johnston%2C+S.A.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Feltquate1997-33\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Feltquate1997_33-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Feltquate1997_33-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Feltquate1997_33-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Feltquate1997_33-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Feltquate1997_33-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Feltquate, D.M.; Heaney, S; Webster, RG; Robinson, HL (March 1, 1997). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jimmunol.org/cgi/content/abstract/158/5/2278\">\"Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization\"</a>. <i>The Journal of Immunology</i>. <b>158</b> (5): 2278\u20132284. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9036975\">9036975</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Immunology&amp;rft.atitle=Different+T+helper+cell+types+and+antibody+isotypes+generated+by+saline+and+gene+gun+DNA+immunization&amp;rft.volume=158&amp;rft.issue=5&amp;rft.pages=2278-2284&amp;rft.date=1997-03-01&amp;rft_id=info%3Apmid%2F9036975&amp;rft.au=Feltquate%2C+D.M.&amp;rft.au=Heaney%2C+S&amp;rft.au=Webster%2C+RG&amp;rft.au=Robinson%2C+HL&amp;rft_id=http%3A%2F%2Fwww.jimmunol.org%2Fcgi%2Fcontent%2Fabstract%2F158%2F5%2F2278&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-References1996-34\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-References1996_34-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-References1996_34-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-References1996_34-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-References1996_34-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">References, S.; Boyle, C.; Morin, M.; Webster, R.; Robinson, H. (1996). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC191015\">\"Role of different lymphoid tissues in the initiation and maintenance of DNA-raised antibody responses to the influenza virus H1 glycoprotein\"</a>. <i>J Virol</i>. <b>70</b> (12): 9074\u20138. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC191015\">191015</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8971047\">8971047</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Virol&amp;rft.atitle=Role+of+different+lymphoid+tissues+in+the+initiation+and+maintenance+of+DNA-raised+antibody+responses+to+the+influenza+virus+H1+glycoprotein.&amp;rft.volume=70&amp;rft.issue=12&amp;rft.pages=9074-8&amp;rft.date=1996&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC191015&amp;rft_id=info%3Apmid%2F8971047&amp;rft.au=References%2C+S.&amp;rft.au=Boyle%2C+C.&amp;rft.au=Morin%2C+M.&amp;rft.au=Webster%2C+R.&amp;rft.au=Robinson%2C+H.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC191015&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-S\u00e4llberg1997-35\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-S\u00e4llberg1997_35-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">S\u00e4llberg, M.; Townsend, K.; Chen, M.;  et al. (1997). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC191766\">\"Characterization of humoral and CD4+ cellular responses after genetic immunization with retroviral vectors expressing different forms of the hepatitis B virus core and e antigens\"</a>. <i>Journal of Virology</i>. <b>71</b> (7): 5295\u2013303. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC191766\">191766</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9188598\">9188598</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Virology&amp;rft.atitle=Characterization+of+humoral+and+CD4%2B+cellular+responses+after+genetic+immunization+with+retroviral+vectors+expressing+different+forms+of+the+hepatitis+B+virus+core+and+e+antigens.&amp;rft.volume=71&amp;rft.issue=7&amp;rft.pages=5295-303&amp;rft.date=1997&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC191766&amp;rft_id=info%3Apmid%2F9188598&amp;rft.au=S%C3%A4llberg%2C+M.&amp;rft.au=Townsend%2C+K.&amp;rft.au=Chen%2C+M.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC191766&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Banchereau1998-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Banchereau1998_36-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Banchereau, J.; Steinman, R.M. (1998). \"Dendritic cells and the control of immunity\". <i>Nature</i>. <b>392</b> (6673): 245\u2013252. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/32588\">10.1038/32588</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9521319\">9521319</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Dendritic+cells+and+the+control+of+immunity&amp;rft.volume=392&amp;rft.issue=6673&amp;rft.pages=245-252&amp;rft.date=1998&amp;rft_id=info%3Adoi%2F10.1038%2F32588&amp;rft_id=info%3Apmid%2F9521319&amp;rft.au=Banchereau%2C+J.&amp;rft.au=Steinman%2C+R.M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Jakob1998-37\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Jakob1998_37-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Jakob1998_37-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Jakob, T.; Walker, P.S.; Krieg, A.M.; Udey, M.C.; Vogel, J.C. (September 15, 1998). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jimmunol.org/cgi/content/abstract/161/6/3042\">\"Activation of Cutaneous Dendritic Cells by CpG-Containing Oligodeoxynucleotides: A Role for Dendritic Cells in the Augmentation of Th1 Responses by Immunostimulatory DNA 1\"</a>. <i>The Journal of Immunology</i>. <b>161</b> (6): 3042\u20133049. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9743369\">9743369</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Immunology&amp;rft.atitle=Activation+of+Cutaneous+Dendritic+Cells+by+CpG-Containing+Oligodeoxynucleotides%3A+A+Role+for+Dendritic+Cells+in+the+Augmentation+of+Th1+Responses+by+Immunostimulatory+DNA+1&amp;rft.volume=161&amp;rft.issue=6&amp;rft.pages=3042-3049&amp;rft.date=1998-09-15&amp;rft_id=info%3Apmid%2F9743369&amp;rft.au=Jakob%2C+T.&amp;rft.au=Walker%2C+P.S.&amp;rft.au=Krieg%2C+A.M.&amp;rft.au=Udey%2C+M.C.&amp;rft.au=Vogel%2C+J.C.&amp;rft_id=http%3A%2F%2Fwww.jimmunol.org%2Fcgi%2Fcontent%2Fabstract%2F161%2F6%2F3042&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Raz1996-38\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Raz1996_38-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Raz1996_38-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Raz, E.; Tighe, H.; Sato, Y.; Corr, M.; Dudler, J.A.; Roman, M.; Swain, S.L.; Spiegelberg, H.L.; Carson, D.A. (1996). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC39421\">\"Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>93</b> (10): 5141\u20135. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.93.10.5141\">10.1073/pnas.93.10.5141</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC39421\">39421</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8643542\">8643542</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=Preferential+induction+of+a+Th1+immune+response+and+inhibition+of+specific+IgE+antibody+formation+by+plasmid+DNA+immunization&amp;rft.volume=93&amp;rft.issue=10&amp;rft.pages=5141-5&amp;rft.date=1996&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC39421&amp;rft_id=info%3Apmid%2F8643542&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.93.10.5141&amp;rft.au=Raz%2C+E.&amp;rft.au=Tighe%2C+H.&amp;rft.au=Sato%2C+Y.&amp;rft.au=Corr%2C+M.&amp;rft.au=Dudler%2C+J.A.&amp;rft.au=Roman%2C+M.&amp;rft.au=Swain%2C+S.L.&amp;rft.au=Spiegelberg%2C+H.L.&amp;rft.au=Carson%2C+D.A.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC39421&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Fu1997-39\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Fu1997_39-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Fu1997_39-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fu TM, Friedman A, Ulmer JB, Liu MA, Donnelly JJ (April 1, 1997). <a rel=\"nofollow\" class=\"external text\" href=\"http://jvi.asm.org/cgi/pmidlookup?view=long&amp;pmid=9060624\">\"Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization\"</a>. <i>J. Virol</i>. <b>71</b> (4): 2715\u201321. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC191393\">191393</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9060624\">9060624</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Virol.&amp;rft.atitle=Protective+cellular+immunity%3A+cytotoxic+T-lymphocyte+responses+against+dominant+and+recessive+epitopes+of+influenza+virus+nucleoprotein+induced+by+DNA+immunization&amp;rft.volume=71&amp;rft.issue=4&amp;rft.pages=2715-21&amp;rft.date=1997-04-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC191393&amp;rft_id=info%3Apmid%2F9060624&amp;rft.aulast=Fu&amp;rft.aufirst=TM&amp;rft.au=Friedman%2C+A&amp;rft.au=Ulmer%2C+JB&amp;rft.au=Liu%2C+MA&amp;rft.au=Donnelly%2C+JJ&amp;rft_id=http%3A%2F%2Fjvi.asm.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D9060624&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-40\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-40\">^</a></b></span> <span class=\"reference-text\">Restifo et al., 1995</span>\n</li>\n<li id=\"cite_note-Restifo1995-41\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Restifo1995_41-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Restifo1995_41-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Restifo, N.P.; Bac\u00edk, I; Irvine, KR; Yewdell, JW; McCabe, BJ; Anderson, RW; Eisenlohr, LC; Rosenberg, SA; Bennink, JR (May 1, 1995). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jimmunol.org/cgi/content/abstract/154/9/4414\">\"Antigen processing in vivo and the elicitation of primary CTL responses\"</a>. <i>The Journal of Immunology</i>. <b>154</b> (9): 4414\u201322. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1952186\">1952186</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7722298\">7722298</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Immunology&amp;rft.atitle=Antigen+processing+in+vivo+and+the+elicitation+of+primary+CTL+responses&amp;rft.volume=154&amp;rft.issue=9&amp;rft.pages=4414-22&amp;rft.date=1995-05-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1952186&amp;rft_id=info%3Apmid%2F7722298&amp;rft.au=Restifo%2C+N.P.&amp;rft.au=Bac%C3%ADk%2C+I&amp;rft.au=Irvine%2C+KR&amp;rft.au=Yewdell%2C+JW&amp;rft.au=McCabe%2C+BJ&amp;rft.au=Anderson%2C+RW&amp;rft.au=Eisenlohr%2C+LC&amp;rft.au=Rosenberg%2C+SA&amp;rft.au=Bennink%2C+JR&amp;rft_id=http%3A%2F%2Fwww.jimmunol.org%2Fcgi%2Fcontent%2Fabstract%2F154%2F9%2F4414&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Iwasaki1997-42\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Iwasaki1997_42-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Iwasaki1997_42-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Iwasaki1997_42-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Iwasaki, A.; Stiernholm, BJ; Chan, AK; Berinstein, NL; Barber, BH (May 15, 1997). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jimmunol.org/cgi/content/abstract/158/10/4591\">\"Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines\"</a>. <i>The Journal of Immunology</i>. <b>158</b> (10): 4591\u20134601. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9144471\">9144471</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Immunology&amp;rft.atitle=Enhanced+CTL+responses+mediated+by+plasmid+DNA+immunogens+encoding+costimulatory+molecules+and+cytokines&amp;rft.volume=158&amp;rft.issue=10&amp;rft.pages=4591-4601&amp;rft.date=1997-05-15&amp;rft_id=info%3Apmid%2F9144471&amp;rft.au=Iwasaki%2C+A.&amp;rft.au=Stiernholm%2C+BJ&amp;rft.au=Chan%2C+AK&amp;rft.au=Berinstein%2C+NL&amp;rft.au=Barber%2C+BH&amp;rft_id=http%3A%2F%2Fwww.jimmunol.org%2Fcgi%2Fcontent%2Fabstract%2F158%2F10%2F4591&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Weiss1998-43\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Weiss1998_43-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Weiss1998_43-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Weiss, W.R.; Ishii, K.J.; Hedstrom, R.C.; Sedegah, M.; Ichino, M.; Barnhart, K.; Klinman, D.M.; Hoffman, S.L. (September 1, 1998). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jimmunol.org/cgi/content/abstract/161/5/2325\">\"A Plasmid Encoding Murine Granulocyte-Macrophage Colony-Stimulating Factor Increases Protection Conferred by a Malaria DNA Vaccine 1\"</a>. <i>The Journal of Immunology</i>. <b>161</b> (5): 2325\u20132332. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9725227\">9725227</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Immunology&amp;rft.atitle=A+Plasmid+Encoding+Murine+Granulocyte-Macrophage+Colony-Stimulating+Factor+Increases+Protection+Conferred+by+a+Malaria+DNA+Vaccine+1&amp;rft.volume=161&amp;rft.issue=5&amp;rft.pages=2325-2332&amp;rft.date=1998-09-01&amp;rft_id=info%3Apmid%2F9725227&amp;rft.au=Weiss%2C+W.R.&amp;rft.au=Ishii%2C+K.J.&amp;rft.au=Hedstrom%2C+R.C.&amp;rft.au=Sedegah%2C+M.&amp;rft.au=Ichino%2C+M.&amp;rft.au=Barnhart%2C+K.&amp;rft.au=Klinman%2C+D.M.&amp;rft.au=Hoffman%2C+S.L.&amp;rft_id=http%3A%2F%2Fwww.jimmunol.org%2Fcgi%2Fcontent%2Fabstract%2F161%2F5%2F2325&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Tsuji1997-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Tsuji1997_44-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Tsuji, T.; Hamajima, K; Fukushima, J; Xin, KQ; Ishii, N; Aoki, I; Ishigatsubo, Y; Tani, K;  et al. (April 15, 1997). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jimmunol.org/cgi/content/abstract/158/8/4008\">\"Enhancement of cell-mediated immunity against HIV-1 induced by coinnoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12\"</a>. <i>The Journal of Immunology</i>. <b>158</b> (8): 4008\u20134013. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9103472\">9103472</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Immunology&amp;rft.atitle=Enhancement+of+cell-mediated+immunity+against+HIV-1+induced+by+coinnoculation+of+plasmid-encoded+HIV-1+antigen+with+plasmid+expressing+IL-12&amp;rft.volume=158&amp;rft.issue=8&amp;rft.pages=4008-4013&amp;rft.date=1997-04-15&amp;rft_id=info%3Apmid%2F9103472&amp;rft.au=Tsuji%2C+T.&amp;rft.au=Hamajima%2C+K&amp;rft.au=Fukushima%2C+J&amp;rft.au=Xin%2C+KQ&amp;rft.au=Ishii%2C+N&amp;rft.au=Aoki%2C+I&amp;rft.au=Ishigatsubo%2C+Y&amp;rft.au=Tani%2C+K&amp;rft.au=Kawamoto%2C+S&amp;rft_id=http%3A%2F%2Fwww.jimmunol.org%2Fcgi%2Fcontent%2Fabstract%2F158%2F8%2F4008&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Justewicz1996-45\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Justewicz1996_45-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Justewicz1996_45-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Justewicz, D.M.; Webster, R.G. (1996). <a rel=\"nofollow\" class=\"external text\" href=\"http://linkinghub.elsevier.com/retrieve/pii/S0042682296905012\">\"Long-Term Maintenance of B Cell Immunity to Influenza Virus Hemagglutinin in Mice Following DNA-Based Immunization\"</a>. <i>Virology</i>. <b>224</b> (1): 10\u201317. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1006/viro.1996.0501\">10.1006/viro.1996.0501</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8862394\">8862394</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Virology&amp;rft.atitle=Long-Term+Maintenance+of+B+Cell+Immunity+to+Influenza+Virus+Hemagglutinin+in+Mice+Following+DNA-Based+Immunization&amp;rft.volume=224&amp;rft.issue=1&amp;rft.pages=10-17&amp;rft.date=1996&amp;rft_id=info%3Adoi%2F10.1006%2Fviro.1996.0501&amp;rft_id=info%3Apmid%2F8862394&amp;rft.au=Justewicz%2C+D.M.&amp;rft.au=Webster%2C+R.G.&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0042682296905012&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-46\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-46\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Mancini - Bourgine, Maryline; H\u00e9l\u00e9ne Fontaine; Christian Br\u00e9chot; Stanislas Pol; Marie-Louise Michel (2006). \"Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers\". <i>Vaccine</i>. <b>24</b>: 4482\u20134489. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.vaccine.2005.08.013\">10.1016/j.vaccine.2005.08.013</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16310901\">16310901</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Vaccine&amp;rft.atitle=Immunogenicity+of+a+hepatitis+B+DNA+vaccine+administered+to+chronic+HBV+carriers&amp;rft.volume=24&amp;rft.pages=4482-4489&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1016%2Fj.vaccine.2005.08.013&amp;rft_id=info%3Apmid%2F16310901&amp;rft.aulast=Mancini+-+Bourgine&amp;rft.aufirst=Maryline&amp;rft.au=H%C3%A9l%C3%A9ne+Fontaine&amp;rft.au=Christian+Br%C3%A9chot&amp;rft.au=Stanislas+Pol&amp;rft.au=Marie-Louise+Michel&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Wolff1992-47\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Wolff1992_47-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Wolff1992_47-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wolff JA, Dowty ME, Jiao S,  et al. (December 1, 1992). <a rel=\"nofollow\" class=\"external text\" href=\"http://jcs.biologists.org/cgi/pmidlookup?view=long&amp;pmid=1487500\">\"Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules and caveolae of mammalian skeletal muscle\"</a>. <i>J. Cell Sci</i>. 103. ( Pt 4) (4): 1249\u201359. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/1487500\">1487500</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Cell+Sci.&amp;rft.atitle=Expression+of+naked+plasmids+by+cultured+myotubes+and+entry+of+plasmids+into+T+tubules+and+caveolae+of+mammalian+skeletal+muscle&amp;rft.volume=%28+Pt+4%29&amp;rft.issue=4&amp;rft.pages=1249-59&amp;rft.date=1992-12-01&amp;rft_id=info%3Apmid%2F1487500&amp;rft.aulast=Wolff&amp;rft.aufirst=JA&amp;rft.au=Dowty%2C+ME&amp;rft.au=Jiao%2C+S&amp;rft_id=http%3A%2F%2Fjcs.biologists.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D1487500&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Anderson1992-48\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Anderson1992_48-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Anderson RG, Kamen BA, Rothberg KG, Lacey SW (January 1992). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.sciencemag.org/cgi/pmidlookup?view=long&amp;pmid=1310359\">\"Potocytosis: sequestration and transport of small molecules by caveolae\"</a>. <i>Science</i>. <b>255</b> (5043): 410\u20131. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.1310359\">10.1126/science.1310359</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/1310359\">1310359</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Potocytosis%3A+sequestration+and+transport+of+small+molecules+by+caveolae&amp;rft.volume=255&amp;rft.issue=5043&amp;rft.pages=410-1&amp;rft.date=1992-01&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.1310359&amp;rft_id=info%3Apmid%2F1310359&amp;rft.aulast=Anderson&amp;rft.aufirst=RG&amp;rft.au=Kamen%2C+BA&amp;rft.au=Rothberg%2C+KG&amp;rft.au=Lacey%2C+SW&amp;rft_id=http%3A%2F%2Fwww.sciencemag.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D1310359&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Casares1997-49\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Casares1997_49-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Casares1997_49-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Casares S, Inaba K, Brumeanu TD, Steinman RM, Bona CA (November 1997). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jem.org/cgi/pmidlookup?view=long&amp;pmid=9348305\">\"Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope\"</a>. <i>J. Exp. Med</i>. <b>186</b> (9): 1481\u20136. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1084/jem.186.9.1481\">10.1084/jem.186.9.1481</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2199124\">2199124</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9348305\">9348305</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Exp.+Med.&amp;rft.atitle=Antigen+presentation+by+dendritic+cells+after+immunization+with+DNA+encoding+a+major+histocompatibility+complex+class+II-restricted+viral+epitope&amp;rft.volume=186&amp;rft.issue=9&amp;rft.pages=1481-6&amp;rft.date=1997-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2199124&amp;rft_id=info%3Apmid%2F9348305&amp;rft_id=info%3Adoi%2F10.1084%2Fjem.186.9.1481&amp;rft.aulast=Casares&amp;rft.aufirst=S&amp;rft.au=Inaba%2C+K&amp;rft.au=Brumeanu%2C+TD&amp;rft.au=Steinman%2C+RM&amp;rft.au=Bona%2C+CA&amp;rft_id=http%3A%2F%2Fwww.jem.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D9348305&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Bennett1985-50\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Bennett1985_50-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Bennett1985_50-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bennett, R.M.; Gabor, G.T.; Merritt, M.M. (1985). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC424340\">\"DNA binding to human leukocytes. Evidence for a receptor-mediated association, internalization, and degradation of DNA\"</a>. <i>J Clin Invest</i>. <b>76</b> (6): 2182\u201390. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1172/JCI112226\">10.1172/JCI112226</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC424340\">424340</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/3001145\">3001145</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Clin+Invest&amp;rft.atitle=DNA+binding+to+human+leukocytes.+Evidence+for+a+receptor-mediated+association%2C+internalization%2C+and+degradation+of+DNA&amp;rft.volume=76&amp;rft.issue=6&amp;rft.pages=2182-90&amp;rft.date=1985&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC424340&amp;rft_id=info%3Apmid%2F3001145&amp;rft_id=info%3Adoi%2F10.1172%2FJCI112226&amp;rft.au=Bennett%2C+R.M.&amp;rft.au=Gabor%2C+G.T.&amp;rft.au=Merritt%2C+M.M.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC424340&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Bennet1988-51\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Bennet1988_51-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bennet, R.M.; Hefeneider, SH; Bakke, A; Merritt, M; Smith, CA; Mourich, D; Heinrich, MC (May 1, 1988). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jimmunol.org/cgi/content/abstract/140/9/2937\">\"The production and characterization of murine monoclonal antibodies to a DNA receptor on human leukocytes\"</a>. <i>The Journal of Immunology</i>. <b>140</b> (9): 2937\u201342. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/2452195\">2452195</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Immunology&amp;rft.atitle=The+production+and+characterization+of+murine+monoclonal+antibodies+to+a+DNA+receptor+on+human+leukocytes&amp;rft.volume=140&amp;rft.issue=9&amp;rft.pages=2937-42&amp;rft.date=1988-05-01&amp;rft_id=info%3Apmid%2F2452195&amp;rft.au=Bennet%2C+R.M.&amp;rft.au=Hefeneider%2C+SH&amp;rft.au=Bakke%2C+A&amp;rft.au=Merritt%2C+M&amp;rft.au=Smith%2C+CA&amp;rft.au=Mourich%2C+D&amp;rft.au=Heinrich%2C+MC&amp;rft_id=http%3A%2F%2Fwww.jimmunol.org%2Fcgi%2Fcontent%2Fabstract%2F140%2F9%2F2937&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Corr1996-52\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Corr1996_52-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Corr, M.; Lee, DJ; Carson, DA; Tighe, H (1996). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2192808\">\"Gene vaccination with naked plasmid DNA: mechanism of CTL priming\"</a>. <i>Journal of Experimental Medicine</i>. <b>184</b> (4): 1555\u20131560. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1084/jem.184.4.1555\">10.1084/jem.184.4.1555</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2192808\">2192808</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8879229\">8879229</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Experimental+Medicine&amp;rft.atitle=Gene+vaccination+with+naked+plasmid+DNA%3A+mechanism+of+CTL+priming&amp;rft.volume=184&amp;rft.issue=4&amp;rft.pages=1555-1560&amp;rft.date=1996&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2192808&amp;rft_id=info%3Apmid%2F8879229&amp;rft_id=info%3Adoi%2F10.1084%2Fjem.184.4.1555&amp;rft.au=Corr%2C+M.&amp;rft.au=Lee%2C+DJ&amp;rft.au=Carson%2C+DA&amp;rft.au=Tighe%2C+H&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2192808&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Chattergoon1998-53\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Chattergoon1998_53-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Chattergoon, M.A.; Robinson, T.M.; Boyer, J.D.; Weiner, D.B. (June 15, 1998). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jimmunol.org/cgi/content/abstract/160/12/5707\">\"Specific Immune Induction Following DNA-Based Immunization Through In Vivo Transfection and Activation of Macrophages/Antigen-Presenting Cells 1\"</a>. <i>The Journal of Immunology</i>. <b>160</b> (12): 5707\u20135718. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9637479\">9637479</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Immunology&amp;rft.atitle=Specific+Immune+Induction+Following+DNA-Based+Immunization+Through+In+Vivo+Transfection+and+Activation+of+Macrophages%2FAntigen-Presenting+Cells+1&amp;rft.volume=160&amp;rft.issue=12&amp;rft.pages=5707-5718&amp;rft.date=1998-06-15&amp;rft_id=info%3Apmid%2F9637479&amp;rft.au=Chattergoon%2C+M.A.&amp;rft.au=Robinson%2C+T.M.&amp;rft.au=Boyer%2C+J.D.&amp;rft.au=Weiner%2C+D.B.&amp;rft_id=http%3A%2F%2Fwww.jimmunol.org%2Fcgi%2Fcontent%2Fabstract%2F160%2F12%2F5707&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Torres1997-54\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Torres1997_54-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Torres1997_54-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Torres CA, Iwasaki A, Barber BH, Robinson HL (May 1997). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jimmunol.org/cgi/pmidlookup?view=long&amp;pmid=9144463\">\"Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations\"</a>. <i>Journal of Immunology</i>. <b>158</b> (10): 4529\u201332. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9144463\">9144463</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Immunology&amp;rft.atitle=Differential+dependence+on+target+site+tissue+for+gene+gun+and+intramuscular+DNA+immunizations&amp;rft.volume=158&amp;rft.issue=10&amp;rft.pages=4529-32&amp;rft.date=1997-05&amp;rft_id=info%3Apmid%2F9144463&amp;rft.aulast=Torres&amp;rft.aufirst=CA&amp;rft.au=Iwasaki%2C+A&amp;rft.au=Barber%2C+BH&amp;rft.au=Robinson%2C+HL&amp;rft_id=http%3A%2F%2Fwww.jimmunol.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D9144463&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Franco1997-55\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Franco1997_55-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Franco, A.; Guidotti, LG; Hobbs, MV; Pasquetto, V; Chisari, FV (August 15, 1997). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jimmunol.org/cgi/content/abstract/159/4/2001\">\"Pathogenetic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice\"</a>. <i>The Journal of Immunology</i>. <b>159</b> (4): 2001\u20132008. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9257867\">9257867</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Immunology&amp;rft.atitle=Pathogenetic+effector+function+of+CD4-positive+T+helper+1+cells+in+hepatitis+B+virus+transgenic+mice&amp;rft.volume=159&amp;rft.issue=4&amp;rft.pages=2001-2008&amp;rft.date=1997-08-15&amp;rft_id=info%3Apmid%2F9257867&amp;rft.au=Franco%2C+A.&amp;rft.au=Guidotti%2C+LG&amp;rft.au=Hobbs%2C+MV&amp;rft.au=Pasquetto%2C+V&amp;rft.au=Chisari%2C+FV&amp;rft_id=http%3A%2F%2Fwww.jimmunol.org%2Fcgi%2Fcontent%2Fabstract%2F159%2F4%2F2001&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Mancini1996-56\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Mancini1996_56-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Mancini, M.; Hadchouel, M.; Davis, H.L.; Whalen, R.G.; Tiollais, P.; Michel, M.L. (1996). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC38020\">\"DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>93</b> (22): 12496\u2013501. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.93.22.12496\">10.1073/pnas.93.22.12496</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC38020\">38020</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8901610\">8901610</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=DNA-mediated+immunization+in+a+transgenic+mouse+model+of+the+hepatitis+B+surface+antigen+chronic+carrier+state.&amp;rft.volume=93&amp;rft.issue=22&amp;rft.pages=12496-501&amp;rft.date=1996&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC38020&amp;rft_id=info%3Apmid%2F8901610&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.93.22.12496&amp;rft.au=Mancini%2C+M.&amp;rft.au=Hadchouel%2C+M.&amp;rft.au=Davis%2C+H.L.&amp;rft.au=Whalen%2C+R.G.&amp;rft.au=Tiollais%2C+P.&amp;rft.au=Michel%2C+M.L.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC38020&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Doolan1999-57\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Doolan1999_57-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Doolan, D.L.; Hoffman, S.L. (July 15, 1999). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jimmunol.org/cgi/content/abstract/163/2/884\">\"IL-12 and NK Cells Are Required for Antigen-Specific Adaptive Immunity Against Malaria Initiated by CD8+ T Cells in the <i>Plasmodium yoelii</i> Model 1\"</a>. <i>The Journal of Immunology</i>. <b>163</b> (2): 884\u201392. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10395683\">10395683</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Immunology&amp;rft.atitle=IL-12+and+NK+Cells+Are+Required+for+Antigen-Specific+Adaptive+Immunity+Against+Malaria+Initiated+by+CD8%2B+T+Cells+in+the+Plasmodium+yoelii+Model+1&amp;rft.volume=163&amp;rft.issue=2&amp;rft.pages=884-92&amp;rft.date=1999-07-15&amp;rft_id=info%3Apmid%2F10395683&amp;rft.au=Doolan%2C+D.L.&amp;rft.au=Hoffman%2C+S.L.&amp;rft_id=http%3A%2F%2Fwww.jimmunol.org%2Fcgi%2Fcontent%2Fabstract%2F163%2F2%2F884&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Cardoso1996-58\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Cardoso1996_58-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cardoso AI, Blixenkrone-Moller M, Fayolle J, Liu M, Buckland R, Wild TF (November 1996). <a rel=\"nofollow\" class=\"external text\" href=\"http://linkinghub.elsevier.com/retrieve/pii/S0042682296906030\">\"Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity\"</a>. <i>Virology</i>. <b>225</b> (2): 293\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1006/viro.1996.0603\">10.1006/viro.1996.0603</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8918915\">8918915</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Virology&amp;rft.atitle=Immunization+with+plasmid+DNA+encoding+for+the+measles+virus+hemagglutinin+and+nucleoprotein+leads+to+humoral+and+cell-mediated+immunity&amp;rft.volume=225&amp;rft.issue=2&amp;rft.pages=293-9&amp;rft.date=1996-11&amp;rft_id=info%3Adoi%2F10.1006%2Fviro.1996.0603&amp;rft_id=info%3Apmid%2F8918915&amp;rft.aulast=Cardoso&amp;rft.aufirst=AI&amp;rft.au=Blixenkrone-Moller%2C+M&amp;rft.au=Fayolle%2C+J&amp;rft.au=Liu%2C+M&amp;rft.au=Buckland%2C+R&amp;rft.au=Wild%2C+TF&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0042682296906030&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Sato1996-59\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Sato1996_59-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Sato1996_59-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Sato1996_59-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sato, Y.; Roman, M.; Tighe, H.; Lee, D.; Corr, M.; Nguyen, M.D.; Silverman, G.J.; Lotz, M.; Carson, D.A.; Raz, E. (1996). \"Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization\". <i>Science</i>. <b>273</b> (5273): 352\u20134. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.273.5273.352\">10.1126/science.273.5273.352</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8662521\">8662521</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Immunostimulatory+DNA+Sequences+Necessary+for+Effective+Intradermal+Gene+Immunization&amp;rft.volume=273&amp;rft.issue=5273&amp;rft.pages=352-4&amp;rft.date=1996&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.273.5273.352&amp;rft_id=info%3Apmid%2F8662521&amp;rft.au=Sato%2C+Y.&amp;rft.au=Roman%2C+M.&amp;rft.au=Tighe%2C+H.&amp;rft.au=Lee%2C+D.&amp;rft.au=Corr%2C+M.&amp;rft.au=Nguyen%2C+M.D.&amp;rft.au=Silverman%2C+G.J.&amp;rft.au=Lotz%2C+M.&amp;rft.au=Carson%2C+D.A.&amp;rft.au=Raz%2C+E.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Weiss2000-60\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Weiss2000_60-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Weiss, R.; Leitner, W.W.; Scheiblhofer, S.; Chen, D.; Bernhaupt, A.; Mostbock, S.; Thalhamer, J.; Lyon, J.A. (2000). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC101554\">\"Genetic Vaccination against Malaria Infection by Intradermal and Epidermal Injections of a Plasmid Containing the Gene Encoding the Plasmodium berghei Circumsporozoite Protein\"</a>. <i>Infection and Immunity</i>. <b>68</b> (10): 5914\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1128/IAI.68.10.5914-5919.2000\">10.1128/IAI.68.10.5914-5919.2000</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC101554\">101554</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10992502\">10992502</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Infection+and+Immunity&amp;rft.atitle=Genetic+Vaccination+against+Malaria+Infection+by+Intradermal+and+Epidermal+Injections+of+a+Plasmid+Containing+the+Gene+Encoding+the+Plasmodium+berghei+Circumsporozoite+Protein&amp;rft.volume=68&amp;rft.issue=10&amp;rft.pages=5914-9&amp;rft.date=2000&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC101554&amp;rft_id=info%3Apmid%2F10992502&amp;rft_id=info%3Adoi%2F10.1128%2FIAI.68.10.5914-5919.2000&amp;rft.au=Weiss%2C+R.&amp;rft.au=Leitner%2C+W.W.&amp;rft.au=Scheiblhofer%2C+S.&amp;rft.au=Chen%2C+D.&amp;rft.au=Bernhaupt%2C+A.&amp;rft.au=Mostbock%2C+S.&amp;rft.au=Thalhamer%2C+J.&amp;rft.au=Lyon%2C+J.A.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC101554&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Sedegah2000-61\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Sedegah2000_61-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Sedegah2000_61-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sedegah, M.; Weiss, W.; Sacci, J.B.; Charoenvit, Y.; Hedstrom, R.; Gowda, K.; Majam, V.F.; Tine, J.; Kumar, S.; Hobart, P.;  et al. (June 1, 2000). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jimmunol.org/cgi/content/abstract/164/11/5905\">\"Improving Protective Immunity Induced by DNA-Based Immunization: Priming with Antigen and GM-CSF-Encoding Plasmid DNA and Boosting with Antigen-Expressing Recombinant Poxvirus 1 2\"</a>. <i>The Journal of Immunology</i>. <b>164</b> (11): 5905\u20135912. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.4049/jimmunol.164.11.5905\">10.4049/jimmunol.164.11.5905</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10820272\">10820272</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Immunology&amp;rft.atitle=Improving+Protective+Immunity+Induced+by+DNA-Based+Immunization%3A+Priming+with+Antigen+and+GM-CSF-Encoding+Plasmid+DNA+and+Boosting+with+Antigen-Expressing+Recombinant+Poxvirus+1+2&amp;rft.volume=164&amp;rft.issue=11&amp;rft.pages=5905-5912&amp;rft.date=2000-06-01&amp;rft_id=info%3Adoi%2F10.4049%2Fjimmunol.164.11.5905&amp;rft_id=info%3Apmid%2F10820272&amp;rft.au=Sedegah%2C+M.&amp;rft.au=Weiss%2C+W.&amp;rft.au=Sacci%2C+J.B.&amp;rft.au=Charoenvit%2C+Y.&amp;rft.au=Hedstrom%2C+R.&amp;rft.au=Gowda%2C+K.&amp;rft.au=Majam%2C+V.F.&amp;rft.au=Tine%2C+J.&amp;rft.au=Kumar%2C+S.&amp;rft.au=Hobart%2C+P.&amp;rft_id=http%3A%2F%2Fwww.jimmunol.org%2Fcgi%2Fcontent%2Fabstract%2F164%2F11%2F5905&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Barouch1998-62\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Barouch1998_62-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Barouch, D.H.; Santra, S.; Steenbeke, T.D.; Zheng, X.X.; Perry, H.C.; Davies, M.E.; Freed, D.C.; Craiu, A.; Strom, T.B.; Shiver, J.W.;  et al. (August 15, 1998). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jimmunol.org/cgi/content/abstract/161/4/1875\">\"Augmentation and Suppression of Immune Responses to an HIV-1 DNA Vaccine by Plasmid Cytokine/Ig Administration 1\"</a>. <i>The Journal of Immunology</i>. <b>161</b> (4): 1875\u20131882. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9712056\">9712056</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Immunology&amp;rft.atitle=Augmentation+and+Suppression+of+Immune+Responses+to+an+HIV-1+DNA+Vaccine+by+Plasmid+Cytokine%2FIg+Administration+1&amp;rft.volume=161&amp;rft.issue=4&amp;rft.pages=1875-1882&amp;rft.date=1998-08-15&amp;rft_id=info%3Apmid%2F9712056&amp;rft.au=Barouch%2C+D.H.&amp;rft.au=Santra%2C+S.&amp;rft.au=Steenbeke%2C+T.D.&amp;rft.au=Zheng%2C+X.X.&amp;rft.au=Perry%2C+H.C.&amp;rft.au=Davies%2C+M.E.&amp;rft.au=Freed%2C+D.C.&amp;rft.au=Craiu%2C+A.&amp;rft.au=Strom%2C+T.B.&amp;rft.au=Shiver%2C+J.W.&amp;rft_id=http%3A%2F%2Fwww.jimmunol.org%2Fcgi%2Fcontent%2Fabstract%2F161%2F4%2F1875&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Krieg1995-63\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Krieg1995_63-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Krieg1995_63-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Krieg, A.M.; Yi, A.K.; Matson, S.; Waldschmidt, T.J.; Bishop, G.A.; Teasdale, R.; Koretzky, G.A.; Klinman, D.M. (1995). \"CpG motifs in bacterial DNA trigger direct B-cell activation\". <i>Nature</i>. <b>374</b> (6522): 546\u2013549. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/374546a0\">10.1038/374546a0</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7700380\">7700380</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=CpG+motifs+in+bacterial+DNA+trigger+direct+B-cell+activation&amp;rft.volume=374&amp;rft.issue=6522&amp;rft.pages=546-549&amp;rft.date=1995&amp;rft_id=info%3Adoi%2F10.1038%2F374546a0&amp;rft_id=info%3Apmid%2F7700380&amp;rft.au=Krieg%2C+A.M.&amp;rft.au=Yi%2C+A.K.&amp;rft.au=Matson%2C+S.&amp;rft.au=Waldschmidt%2C+T.J.&amp;rft.au=Bishop%2C+G.A.&amp;rft.au=Teasdale%2C+R.&amp;rft.au=Koretzky%2C+G.A.&amp;rft.au=Klinman%2C+D.M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Klinman1997-64\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Klinman1997_64-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Klinman, D.M.; Yamshchikov, G; Ishigatsubo, Y (April 15, 1997). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jimmunol.org/cgi/content/abstract/158/8/3635\">\"Contribution of CpG motifs to the immunogenicity of DNA vaccines\"</a>. <i>The Journal of Immunology</i>. <b>158</b> (8): 3635\u20133639. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9103425\">9103425</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Immunology&amp;rft.atitle=Contribution+of+CpG+motifs+to+the+immunogenicity+of+DNA+vaccines&amp;rft.volume=158&amp;rft.issue=8&amp;rft.pages=3635-3639&amp;rft.date=1997-04-15&amp;rft_id=info%3Apmid%2F9103425&amp;rft.au=Klinman%2C+D.M.&amp;rft.au=Yamshchikov%2C+G&amp;rft.au=Ishigatsubo%2C+Y&amp;rft_id=http%3A%2F%2Fwww.jimmunol.org%2Fcgi%2Fcontent%2Fabstract%2F158%2F8%2F3635&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Krieg1998-65\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Krieg1998_65-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Krieg, A.M.; Wu, T.; Weeratna, R.; Efler, S.M.; Love-homan, L.; Yang, L.; Yi, A.K.; Short, D.; Davis, H.L. (1998). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC22882\">\"Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs\"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>95</b> (21): 12631\u20136. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.95.21.12631\">10.1073/pnas.95.21.12631</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC22882\">22882</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9770537\">9770537</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;rft.atitle=Sequence+motifs+in+adenoviral+DNA+block+immune+activation+by+stimulatory+CpG+motifs&amp;rft.volume=95&amp;rft.issue=21&amp;rft.pages=12631-6&amp;rft.date=1998&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC22882&amp;rft_id=info%3Apmid%2F9770537&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.95.21.12631&amp;rft.au=Krieg%2C+A.M.&amp;rft.au=Wu%2C+T.&amp;rft.au=Weeratna%2C+R.&amp;rft.au=Efler%2C+S.M.&amp;rft.au=Love-homan%2C+L.&amp;rft.au=Yang%2C+L.&amp;rft.au=Yi%2C+A.K.&amp;rft.au=Short%2C+D.&amp;rft.au=Davis%2C+H.L.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC22882&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Klinsman1996-66\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Klinsman1996_66-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Klinsman1996_66-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Klinman, D.M.; Yi, A.K.; Beaucage, S.L.; Conover, J.; Krieg, A.M. (1996). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC39727\">\"CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12 and interferon-y\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>93</b> (7): 2879\u201383. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.93.7.2879\">10.1073/pnas.93.7.2879</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC39727\">39727</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8610135\">8610135</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=CpG+motifs+present+in+bacterial+DNA+rapidly+induce+lymphocytes+to+secrete+interleukin+6%2C+interleukin+12+and+interferon-y&amp;rft.volume=93&amp;rft.issue=7&amp;rft.pages=2879-83&amp;rft.date=1996&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC39727&amp;rft_id=info%3Apmid%2F8610135&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.93.7.2879&amp;rft.au=Klinman%2C+D.M.&amp;rft.au=Yi%2C+A.K.&amp;rft.au=Beaucage%2C+S.L.&amp;rft.au=Conover%2C+J.&amp;rft.au=Krieg%2C+A.M.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC39727&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Yi1996-67\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Yi1996_67-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Yi, A.K.; Chace, JH; Cowdery, JS; Krieg, AM (January 15, 1996). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jimmunol.org/cgi/content/abstract/156/2/558\">\"IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides\"</a>. <i>The Journal of Immunology</i>. <b>156</b> (2): 558\u201364. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8543806\">8543806</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2007-11-21</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Immunology&amp;rft.atitle=IFN-gamma+promotes+IL-6+and+IgM+secretion+in+response+to+CpG+motifs+in+bacterial+DNA+and+oligodeoxynucleotides&amp;rft.volume=156&amp;rft.issue=2&amp;rft.pages=558-64&amp;rft.date=1996-01-15&amp;rft_id=info%3Apmid%2F8543806&amp;rft.au=Yi%2C+A.K.&amp;rft.au=Chace%2C+JH&amp;rft.au=Cowdery%2C+JS&amp;rft.au=Krieg%2C+AM&amp;rft_id=http%3A%2F%2Fwww.jimmunol.org%2Fcgi%2Fcontent%2Fabstract%2F156%2F2%2F558&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Letvin1997-68\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Letvin1997_68-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Letvin, N.L.; Montefiori, D.C.; Yasutomi, Y.; Perry, H.C.; Davies, M.E.; Lekutis, C.; Alroy, M.; Freed, D.C.; Lord, C.I.; Handt, L.K.;  et al. (1997). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC23198\">\"Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination\"</a>. <i>Proceedings of the National Academy of Sciences</i>. <b>94</b> (17): 9378\u201383. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.94.17.9378\">10.1073/pnas.94.17.9378</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC23198\">23198</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9256490\">9256490</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences&amp;rft.atitle=Potent%2C+protective+anti-HIV+immune+responses+generated+by+bimodal+HIV+envelope+DNA+plus+protein+vaccination&amp;rft.volume=94&amp;rft.issue=17&amp;rft.pages=9378-83&amp;rft.date=1997&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC23198&amp;rft_id=info%3Apmid%2F9256490&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.94.17.9378&amp;rft.au=Letvin%2C+N.L.&amp;rft.au=Montefiori%2C+D.C.&amp;rft.au=Yasutomi%2C+Y.&amp;rft.au=Perry%2C+H.C.&amp;rft.au=Davies%2C+M.E.&amp;rft.au=Lekutis%2C+C.&amp;rft.au=Alroy%2C+M.&amp;rft.au=Freed%2C+D.C.&amp;rft.au=Lord%2C+C.I.&amp;rft.au=Handt%2C+L.K.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC23198&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Sedegah1998-69\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Sedegah1998_69-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sedegah, M.; Jones, T.R.; Kaur, M.; Hedstrom, R.; Hobart, P.; Tine, J.A.; Hoffman, S.L. (1998). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC22711\">\"Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine\"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>95</b> (13): 7648\u201353. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.95.13.7648\">10.1073/pnas.95.13.7648</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC22711\">22711</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9636204\">9636204</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;rft.atitle=Boosting+with+recombinant+vaccinia+increases+immunogenicity+and+protective+efficacy+of+malaria+DNA+vaccine&amp;rft.volume=95&amp;rft.issue=13&amp;rft.pages=7648-53&amp;rft.date=1998&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC22711&amp;rft_id=info%3Apmid%2F9636204&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.95.13.7648&amp;rft.au=Sedegah%2C+M.&amp;rft.au=Jones%2C+T.R.&amp;rft.au=Kaur%2C+M.&amp;rft.au=Hedstrom%2C+R.&amp;rft.au=Hobart%2C+P.&amp;rft.au=Tine%2C+J.A.&amp;rft.au=Hoffman%2C+S.L.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC22711&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Rogers2001-70\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Rogers2001_70-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rogers, W.O.; Baird, J.K.; Kumar, A.; Tine, J.A.; Weiss, W.; Aguiar, J.C.; Gowda, K.; Gwadz, R.; Kumar, S.; Gold, M.;  et al. (2001). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC98670\">\"Multistage Multiantigen Heterologous Prime Boost Vaccine for Plasmodium knowlesi Malaria Provides Partial Protection in Rhesus Macaques\"</a>. <i>Infection and Immunity</i>. <b>69</b> (9): 5565\u201372. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1128/IAI.69.9.5565-5572.2001\">10.1128/IAI.69.9.5565-5572.2001</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC98670\">98670</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11500430\">11500430</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Infection+and+Immunity&amp;rft.atitle=Multistage+Multiantigen+Heterologous+Prime+Boost+Vaccine+for+Plasmodium+knowlesi+Malaria+Provides+Partial+Protection+in+Rhesus+Macaques&amp;rft.volume=69&amp;rft.issue=9&amp;rft.pages=5565-72&amp;rft.date=2001&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC98670&amp;rft_id=info%3Apmid%2F11500430&amp;rft_id=info%3Adoi%2F10.1128%2FIAI.69.9.5565-5572.2001&amp;rft.au=Rogers%2C+W.O.&amp;rft.au=Baird%2C+J.K.&amp;rft.au=Kumar%2C+A.&amp;rft.au=Tine%2C+J.A.&amp;rft.au=Weiss%2C+W.&amp;rft.au=Aguiar%2C+J.C.&amp;rft.au=Gowda%2C+K.&amp;rft.au=Gwadz%2C+R.&amp;rft.au=Kumar%2C+S.&amp;rft.au=Gold%2C+M.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC98670&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=DNA_vaccination&amp;action=edit&amp;section=39\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.powdermed.com/pdf/PowderMed.Vaccine_Study%20FINAL%20260506.pdf\">PowderMed pdf report</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://202.54.26.221/\">DyNAVacS, an Integrative Tool for Optimised DNA Vaccine Design</a> from the <a href=\"/wiki/Institute_of_Genomics_and_Integrative_Biology\" title=\"Institute of Genomics and Integrative Biology\">Institute of Genomics and Integrative Biology</a>.</li>\n<li><cite class=\"citation journal\">Hooper JW, Thompson E, Wilhelmsen C,  et al. (May 2004). <a rel=\"nofollow\" class=\"external text\" href=\"http://jvi.asm.org/cgi/pmidlookup?view=long&amp;pmid=15078924\">\"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox\"</a>. <i>J. Virol</i>. <b>78</b> (9): 4433\u201343. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1128/JVI.78.9.4433-4443.2004\">10.1128/JVI.78.9.4433-4443.2004</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC387704\">387704</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15078924\">15078924</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Virol.&amp;rft.atitle=Smallpox+DNA+vaccine+protects+nonhuman+primates+against+lethal+monkeypox&amp;rft.volume=78&amp;rft.issue=9&amp;rft.pages=4433-43&amp;rft.date=2004-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC387704&amp;rft_id=info%3Apmid%2F15078924&amp;rft_id=info%3Adoi%2F10.1128%2FJVI.78.9.4433-4443.2004&amp;rft.aulast=Hooper&amp;rft.aufirst=JW&amp;rft.au=Thompson%2C+E&amp;rft.au=Wilhelmsen%2C+C&amp;rft_id=http%3A%2F%2Fjvi.asm.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D15078924&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADNA+vaccination\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li></ul>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Artificial_induction_of_immunity_/_Immunization:_Vaccines,_Vaccination,_Infection,_Inoculation_(J07)\" style=\"padding:3px\"><table class=\"nowraplinks hlist collapsible collapsed navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Vaccines\" title=\"Template:Vaccines\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Vaccines\" title=\"Template talk:Vaccines\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Vaccines&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Artificial_induction_of_immunity_/_Immunization:_Vaccines,_Vaccination,_Infection,_Inoculation_(J07)\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Artificial_induction_of_immunity\" title=\"Artificial induction of immunity\">Artificial induction of immunity</a> / <a href=\"/wiki/Immunization\" title=\"Immunization\">Immunization</a>: <a href=\"/wiki/Vaccine\" title=\"Vaccine\">Vaccines</a>, <a href=\"/wiki/Vaccination\" title=\"Vaccination\">Vaccination</a>, <a href=\"/wiki/Infection\" title=\"Infection\">Infection</a>, <a href=\"/wiki/Inoculation\" title=\"Inoculation\">Inoculation</a> (<a href=\"/wiki/ATC_code_J07\" title=\"ATC code J07\">J07</a>)</div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Development</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Immunologic_adjuvant\" title=\"Immunologic adjuvant\">Adjuvants</a></li>\n<li><a href=\"/wiki/List_of_vaccine_ingredients\" title=\"List of vaccine ingredients\">List of vaccine ingredients</a></li>\n<li><a href=\"/wiki/Mathematical_modelling_of_infectious_disease\" title=\"Mathematical modelling of infectious disease\">Mathematical modelling</a></li>\n<li><a href=\"/wiki/Timeline_of_vaccines\" title=\"Timeline of vaccines\">Timeline</a></li>\n<li><a href=\"/wiki/Vaccine_trial\" title=\"Vaccine trial\">Trials</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Classes</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Conjugate_vaccine\" title=\"Conjugate vaccine\">Conjugate vaccine</a></li>\n<li><a class=\"mw-selflink selflink\">DNA vaccination</a></li>\n<li><a href=\"/wiki/Inactivated_vaccine\" title=\"Inactivated vaccine\">Inactivated vaccine</a></li>\n<li><a href=\"/wiki/Live_vector_vaccine\" title=\"Live vector vaccine\">Live vector vaccine</a>\n<ul><li><a href=\"/wiki/Attenuated_vaccine\" title=\"Attenuated vaccine\">Attenuated vaccine</a></li>\n<li><a href=\"/wiki/Heterologous_vaccine\" title=\"Heterologous vaccine\">Heterologous vaccine</a></li></ul></li>\n<li><a href=\"/wiki/Protein_subunit\" title=\"Protein subunit\">Subunit/component</a> / <a href=\"/wiki/Peptide_vaccine\" title=\"Peptide vaccine\">Peptide</a> / <a href=\"/wiki/Virus-like_particle\" title=\"Virus-like particle\">Virus-like particle</a></li>\n<li><a href=\"/wiki/Toxoid\" title=\"Toxoid\">Toxoid</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Administration</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li>Global:\n<ul><li><a href=\"/wiki/GAVI_Alliance\" class=\"mw-redirect\" title=\"GAVI Alliance\">GAVI Alliance</a></li>\n<li><a href=\"/wiki/Vaccination_policy\" title=\"Vaccination policy\">Policy</a></li>\n<li><a href=\"/wiki/Vaccination_schedule\" title=\"Vaccination schedule\">Schedule</a></li>\n<li><a href=\"/wiki/Vaccine_injury\" title=\"Vaccine injury\">Vaccine injury</a></li></ul></li>\n<li>USA:\n<ul><li><a href=\"/wiki/Advisory_Committee_on_Immunization_Practices\" title=\"Advisory Committee on Immunization Practices\">ACIP</a></li>\n<li><a href=\"/wiki/Vaccine_court\" title=\"Vaccine court\">Vaccine court</a></li>\n<li><a href=\"/wiki/Vaccines_for_Children_Program\" title=\"Vaccines for Children Program\">Vaccines for Children Program</a></li>\n<li><a href=\"/wiki/Vaccine_Adverse_Event_Reporting_System\" title=\"Vaccine Adverse Event Reporting System\">VAERS</a></li>\n<li><a href=\"/wiki/Vaccine_Safety_Datalink\" title=\"Vaccine Safety Datalink\">VSD</a></li></ul></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Vaccines</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Bacterial</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Anthrax_vaccines\" title=\"Anthrax vaccines\">Anthrax</a></li>\n<li><a href=\"/wiki/Brucellosis_vaccine\" title=\"Brucellosis vaccine\">Brucellosis</a></li>\n<li><a href=\"/wiki/Cholera_vaccine\" title=\"Cholera vaccine\">Cholera</a><sup>#</sup></li>\n<li><a href=\"/wiki/Diphtheria_vaccine\" title=\"Diphtheria vaccine\">Diphtheria</a><sup>#</sup></li>\n<li><a href=\"/wiki/Hib_vaccine\" title=\"Hib vaccine\">Hib</a><sup>#</sup></li>\n<li><a href=\"/wiki/Leptospirosis_vaccine\" class=\"mw-redirect\" title=\"Leptospirosis vaccine\">Leptospirosis</a></li>\n<li><a href=\"/wiki/Lyme_disease_vaccine\" class=\"mw-redirect\" title=\"Lyme disease vaccine\">Lyme disease</a><sup>\u2021</sup></li>\n<li><a href=\"/wiki/Meningococcal_vaccine\" title=\"Meningococcal vaccine\">Meningococcus</a><sup>#</sup>\n<ul><li><a href=\"/wiki/MeNZB\" title=\"MeNZB\">MeNZB</a></li>\n<li><a href=\"/wiki/NmVac4-A/C/Y/W-135\" title=\"NmVac4-A/C/Y/W-135\">NmVac4-A/C/Y/W-135</a></li></ul></li>\n<li><a href=\"/wiki/Pertussis_vaccine\" title=\"Pertussis vaccine\">Pertussis</a><sup>#</sup></li>\n<li><a href=\"/wiki/Plague_vaccine\" title=\"Plague vaccine\">Plague</a></li>\n<li><a href=\"/wiki/Pneumococcal_vaccine\" title=\"Pneumococcal vaccine\">Pneumococcal</a><sup>#</sup>\n<ul><li><a href=\"/wiki/Pneumococcal_conjugate_vaccine\" title=\"Pneumococcal conjugate vaccine\">PCV</a></li>\n<li><a href=\"/wiki/Pneumococcal_polysaccharide_vaccine\" title=\"Pneumococcal polysaccharide vaccine\">PPSV</a></li></ul></li>\n<li><a href=\"/wiki/Q_fever_vaccine\" class=\"mw-redirect\" title=\"Q fever vaccine\">Q fever</a></li>\n<li><a href=\"/wiki/Tetanus_vaccine\" title=\"Tetanus vaccine\">Tetanus</a><sup>#</sup></li>\n<li><a href=\"/wiki/Tuberculosis_vaccines\" title=\"Tuberculosis vaccines\">Tuberculosis</a>\n<ul><li><a href=\"/wiki/BCG_vaccine\" title=\"BCG vaccine\">BCG</a><sup>#</sup></li></ul></li>\n<li><a href=\"/wiki/Typhoid_vaccine\" title=\"Typhoid vaccine\">Typhoid</a><sup>#</sup>\n<ul><li><a href=\"/wiki/Ty21a\" title=\"Ty21a\">Ty21a</a></li>\n<li><a href=\"/wiki/Vi_capsular_polysaccharide_vaccine\" title=\"Vi capsular polysaccharide vaccine\">ViCPS</a></li></ul></li>\n<li><a href=\"/wiki/Typhus_vaccine\" title=\"Typhus vaccine\">Typhus</a></li>\n<li>combination: <a href=\"/wiki/DPT_vaccine\" title=\"DPT vaccine\">DTwP/DTaP</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Viral</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Adenovirus_vaccine\" title=\"Adenovirus vaccine\">Adenovirus</a></li>\n<li><a href=\"/wiki/Influenza_vaccine\" title=\"Influenza vaccine\">Flu</a><sup>#</sup>\n<ul><li><a href=\"/wiki/2009_flu_pandemic_vaccine\" title=\"2009 flu pandemic vaccine\">H1N1</a> (<a href=\"/wiki/Pandemrix\" title=\"Pandemrix\">Pandemrix</a>)</li>\n<li><a href=\"/wiki/Live_attenuated_influenza_vaccine\" title=\"Live attenuated influenza vaccine\">LAIV</a></li></ul></li>\n<li><a href=\"/wiki/Hantavirus_vaccine\" title=\"Hantavirus vaccine\">Hantavirus</a></li>\n<li><a href=\"/wiki/Hepatitis_A_vaccine\" title=\"Hepatitis A vaccine\">Hepatitis A</a><sup>#</sup></li>\n<li><a href=\"/wiki/Hepatitis_B_vaccine\" title=\"Hepatitis B vaccine\">Hepatitis B</a><sup>#</sup></li>\n<li><a href=\"/wiki/Hepatitis_E_vaccine\" class=\"mw-redirect\" title=\"Hepatitis E vaccine\">Hepatitis E</a></li>\n<li><a href=\"/wiki/HPV_vaccines\" class=\"mw-redirect\" title=\"HPV vaccines\">HPV</a>\n<ul><li><a href=\"/wiki/Cervarix\" title=\"Cervarix\">Cervarix</a></li>\n<li><a href=\"/wiki/Gardasil\" title=\"Gardasil\">Gardasil</a></li></ul></li>\n<li><a href=\"/wiki/Japanese_encephalitis_vaccine\" title=\"Japanese encephalitis vaccine\">Japanese encephalitis</a><sup>#</sup></li>\n<li><a href=\"/wiki/Measles_vaccine\" title=\"Measles vaccine\">Measles</a><sup>#</sup></li>\n<li><a href=\"/wiki/Mumps_vaccine\" title=\"Mumps vaccine\">Mumps</a><sup>#</sup>\n<ul><li><a href=\"/wiki/Mumpsvax\" class=\"mw-redirect\" title=\"Mumpsvax\">Mumpsvax</a></li></ul></li>\n<li><a href=\"/wiki/Polio_vaccine\" title=\"Polio vaccine\">Polio</a><sup>#</sup>\n<ul><li><a href=\"/wiki/Sabin_polio_vaccine\" class=\"mw-redirect\" title=\"Sabin polio vaccine\">Sabin</a></li>\n<li><a href=\"/wiki/Salk_polio_vaccine\" class=\"mw-redirect\" title=\"Salk polio vaccine\">Salk</a></li></ul></li>\n<li><a href=\"/wiki/Rabies_vaccine\" title=\"Rabies vaccine\">Rabies</a><sup>#</sup></li>\n<li><a href=\"/wiki/Rotavirus_vaccine\" title=\"Rotavirus vaccine\">Rotavirus</a><sup>#</sup></li>\n<li><a href=\"/wiki/Rubella_vaccine\" title=\"Rubella vaccine\">Rubella</a><sup>#</sup></li>\n<li><a href=\"/wiki/Smallpox_vaccine\" title=\"Smallpox vaccine\">Smallpox</a>\n<ul><li><a href=\"/wiki/Dryvax\" class=\"mw-redirect\" title=\"Dryvax\">Dryvax</a></li></ul></li>\n<li><a href=\"/wiki/Tick-borne_encephalitis_vaccine\" title=\"Tick-borne encephalitis vaccine\">Tick-borne encephalitis</a></li>\n<li>Varicella zoster\n<ul><li><a href=\"/wiki/Varicella_vaccine\" title=\"Varicella vaccine\">chicken pox</a><sup>#</sup></li>\n<li><a href=\"/wiki/Zoster_vaccine\" title=\"Zoster vaccine\">Zoster vaccine</a></li></ul></li>\n<li><a href=\"/wiki/Yellow_fever_vaccine\" title=\"Yellow fever vaccine\">Yellow fever</a><sup>#</sup></li>\n<li>combination:\n<ul><li><a href=\"/wiki/MMR_vaccine\" title=\"MMR vaccine\">MMR</a></li>\n<li><a href=\"/wiki/MMRV_vaccine\" title=\"MMRV vaccine\">MMRV</a></li></ul></li>\n<li>research:\n<ul><li><a href=\"/wiki/Chikungunya_vaccine\" class=\"mw-redirect\" title=\"Chikungunya vaccine\">Chikungunya</a></li>\n<li><a href=\"/wiki/Cytomegalovirus_vaccine\" title=\"Cytomegalovirus vaccine\">Cytomegalovirus</a></li>\n<li><a href=\"/wiki/Dengue_vaccine\" title=\"Dengue vaccine\">Dengue</a></li>\n<li><a href=\"/wiki/Ebola_vaccine\" title=\"Ebola vaccine\">Ebola</a></li>\n<li><a href=\"/wiki/Epstein%E2%80%93Barr_virus_vaccine\" title=\"Epstein\u2013Barr virus vaccine\">Epstein\u2013Barr virus</a></li>\n<li><a href=\"/wiki/Hepatitis_C_vaccine\" title=\"Hepatitis C vaccine\">Hepatitis C</a></li>\n<li><a href=\"/wiki/HIV_vaccine\" title=\"HIV vaccine\">HIV</a></li></ul></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Protozoan</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Malaria_vaccine\" title=\"Malaria vaccine\">Malaria</a>\n<ul><li><a href=\"/wiki/RTS,S\" title=\"RTS,S\">RTS,S</a></li></ul></li>\n<li>research:\n<ul><li><a href=\"/wiki/Trypanosomiasis_vaccine\" title=\"Trypanosomiasis vaccine\">Trypanosomiasis</a></li></ul></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Helminthiasis\" title=\"Helminthiasis\">Helminthiasis</a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li>research:\n<ul><li><a href=\"/wiki/Hookworm_vaccine\" title=\"Hookworm vaccine\">Hookworm</a></li>\n<li><a href=\"/wiki/Schistosomiasis_vaccine\" title=\"Schistosomiasis vaccine\">Schistosomiasis</a></li></ul></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Other</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Androvax\" title=\"Androvax\">Androvax (androstenedione albumin)</a></li>\n<li><a href=\"/wiki/Cancer_vaccine\" title=\"Cancer vaccine\">Cancer vaccines</a>\n<ul><li><a href=\"/wiki/ALVAC-CEA_vaccine\" title=\"ALVAC-CEA vaccine\">ALVAC-CEA</a></li>\n<li><a href=\"/wiki/BCG_vaccine\" title=\"BCG vaccine\">BCG</a><sup>#</sup></li>\n<li><a href=\"/wiki/Hepatitis_B_vaccine\" title=\"Hepatitis B vaccine\">Hepatitis B</a><sup>#</sup></li>\n<li><a href=\"/wiki/HPV_vaccines\" class=\"mw-redirect\" title=\"HPV vaccines\">HPV</a>\n<ul><li><a href=\"/wiki/Cervarix\" title=\"Cervarix\">Cervarix</a></li>\n<li><a href=\"/wiki/Gardasil\" title=\"Gardasil\">Gardasil</a></li></ul></li>\n<li><a href=\"/wiki/PROSTVAC\" class=\"mw-redirect\" title=\"PROSTVAC\">PROSTVAC</a></li></ul></li>\n<li><a href=\"/wiki/NicVAX\" title=\"NicVAX\">NicVAX</a></li>\n<li><a href=\"/wiki/Ovandrotone_albumin\" title=\"Ovandrotone albumin\">Ovandrotone albumin (Fecundin)</a></li>\n<li><a href=\"/wiki/TA-CD\" title=\"TA-CD\">TA-CD</a></li>\n<li><a href=\"/wiki/TA-NIC\" title=\"TA-NIC\">TA-NIC</a></li>\n<li>combination\n<ul><li><a href=\"/wiki/DTaP-IPV/Hib\" class=\"mw-redirect\" title=\"DTaP-IPV/Hib\">DTaP-IPV/Hib</a></li>\n<li><a href=\"/wiki/DTaP-IPV-HepB\" class=\"mw-redirect\" title=\"DTaP-IPV-HepB\">DTaP-IPV-HepB</a></li>\n<li><a href=\"/wiki/Hexavalent_vaccine\" title=\"Hexavalent vaccine\">Hexavalent vaccine</a></li>\n<li><a href=\"/wiki/Pentavalent_vaccine\" title=\"Pentavalent vaccine\">Pentavalent vaccine</a></li></ul></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Controversy</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Vaccine_controversies\" title=\"Vaccine controversies\">General</a></li>\n<li><a href=\"/wiki/MMR_vaccine_controversy\" title=\"MMR vaccine controversy\">MMR</a></li>\n<li><a href=\"/wiki/National_Childhood_Vaccine_Injury_Act\" title=\"National Childhood Vaccine Injury Act\">NCVIA</a></li>\n<li><a href=\"/wiki/Pox_party\" title=\"Pox party\">Pox party</a></li>\n<li><a href=\"/wiki/Thiomersal_controversy\" title=\"Thiomersal controversy\">Thiomersal</a></li>\n<li><a href=\"/wiki/Andrew_Wakefield\" title=\"Andrew Wakefield\">Andrew Wakefield</a></li>\n<li><i><a href=\"/wiki/Cedillo_v._Secretary_of_Health_and_Human_Services\" title=\"Cedillo v. Secretary of Health and Human Services\">Cedillo v. Secretary of Health and Human Services</a></i></li>\n<li><a href=\"/wiki/Alternative_vaccination_schedule\" title=\"Alternative vaccination schedule\">Alternative vaccination schedule</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Related</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Epidemiology\" title=\"Epidemiology\">Epidemiology</a></li>\n<li><a href=\"/wiki/Eradication_of_infectious_diseases\" title=\"Eradication of infectious diseases\">Eradication of infectious diseases</a></li>\n<li><a href=\"/wiki/Every_Child_by_Two\" class=\"mw-redirect\" title=\"Every Child by Two\">Every Child by Two</a></li>\n<li><a href=\"/wiki/List_of_vaccine_topics\" title=\"List of vaccine topics\">List of vaccine topics</a></li></ul>\n</div></td></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\" style=\"background: transparent; padding: 0px;\"><div><div class=\"hlist\">\n<ul><li><sup>#</sup><a href=\"/wiki/WHO_Model_List_of_Essential_Medicines\" title=\"WHO Model List of Essential Medicines\">WHO-EM</a></li>\n<li><sup>\u2021</sup><a href=\"/wiki/List_of_withdrawn_drugs\" title=\"List of withdrawn drugs\">Withdrawn</a> from market</li>\n<li><a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">Clinical trials</a>:\n<ul><li><sup>\u2020</sup><a href=\"/wiki/Phases_of_clinical_research#Phase_III\" title=\"Phases of clinical research\">Phase III</a></li>\n<li><sup>\u00a7</sup>Never to phase III</li></ul></li></ul>\n</div></div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw2254\nCached time: 20180913073800\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.828 seconds\nReal time usage: 0.911 seconds\nPreprocessor visited node count: 4462/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 214648/2097152 bytes\nTemplate argument size: 590/2097152 bytes\nHighest expansion depth: 11/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 140464/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.382/10.000 seconds\nLua memory usage: 4.29 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  697.495      1 -total\n 73.77%  514.546      1 Template:Reflist\n 53.74%  374.855     65 Template:Cite_journal\n  9.32%   65.036      1 Template:Citation_needed\n  6.89%   48.077      1 Template:Fix\n  4.68%   32.617      2 Template:Category_handler\n  3.07%   21.422      1 Template:Vaccines\n  2.85%   19.874      2 Template:Navbox\n  1.74%   12.110      1 Template:Delink\n  1.60%   11.192      2 Template:Cite_news\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:45570-0!canonical and timestamp 20180913073759 and revision id 851112829\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D8%AA%D9%84%D9%82%D9%8A%D8%AD_%D8%A7%D9%84%D8%AD%D9%85%D8%B6_%D8%A7%D9%84%D9%86%D9%88%D9%88%D9%8A","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u062a\u0644\u0642\u064a\u062d \u0627\u0644\u062d\u0645\u0636 \u0627\u0644\u0646\u0648\u0648\u064a"},{"lang":"ca","url":"https://ca.wikipedia.org/wiki/Vacuna_d%27ADN","langname":"Catalan","autonym":"catal\u00e0","*":"Vacuna d'ADN"},{"lang":"de","url":"https://de.wikipedia.org/wiki/DNA-Impfung","langname":"German","autonym":"Deutsch","*":"DNA-Impfung"},{"lang":"es","url":"https://es.wikipedia.org/wiki/Vacuna_de_ADN","langname":"Spanish","autonym":"espa\u00f1ol","*":"Vacuna de ADN"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/Vaccin_%C3%A0_ADN","langname":"French","autonym":"fran\u00e7ais","*":"Vaccin \u00e0 ADN"},{"lang":"he","url":"https://he.wikipedia.org/wiki/%D7%97%D7%99%D7%A1%D7%95%D7%9F_DNA","langname":"Hebrew","autonym":"\u05e2\u05d1\u05e8\u05d9\u05ea","*":"\u05d7\u05d9\u05e1\u05d5\u05df DNA"},{"lang":"kn","url":"https://kn.wikipedia.org/wiki/%E0%B2%A1%E0%B2%BF_%E0%B2%8E%E0%B2%A8%E0%B3%8D_%E0%B2%8E_%E0%B2%9A%E0%B3%81%E0%B2%9A%E0%B3%8D%E0%B2%9A%E0%B3%81%E0%B2%AE%E0%B2%A6%E0%B3%8D%E0%B2%A6%E0%B3%81_%E0%B2%B9%E0%B2%BE%E0%B2%95%E0%B3%81%E0%B2%B5%E0%B2%BF%E0%B2%95%E0%B3%86","langname":"Kannada","autonym":"\u0c95\u0ca8\u0ccd\u0ca8\u0ca1","*":"\u0ca1\u0cbf \u0c8e\u0ca8\u0ccd \u0c8e \u0c9a\u0cc1\u0c9a\u0ccd\u0c9a\u0cc1\u0cae\u0ca6\u0ccd\u0ca6\u0cc1 \u0cb9\u0cbe\u0c95\u0cc1\u0cb5\u0cbf\u0c95\u0cc6"},{"lang":"ja","url":"https://ja.wikipedia.org/wiki/DNA%E3%83%AF%E3%82%AF%E3%83%81%E3%83%B3","langname":"Japanese","autonym":"\u65e5\u672c\u8a9e","*":"DNA\u30ef\u30af\u30c1\u30f3"},{"lang":"pl","url":"https://pl.wikipedia.org/wiki/Szczepionki_DNA","langname":"Polish","autonym":"polski","*":"Szczepionki DNA"},{"lang":"pt","url":"https://pt.wikipedia.org/wiki/Vacina_de_DNA","langname":"Portuguese","autonym":"portugu\u00eas","*":"Vacina de DNA"},{"lang":"ru","url":"https://ru.wikipedia.org/wiki/%D0%94%D0%9D%D0%9A-%D0%B2%D0%B0%D0%BA%D1%86%D0%B8%D0%BD%D0%B0","langname":"Russian","autonym":"\u0440\u0443\u0441\u0441\u043a\u0438\u0439","*":"\u0414\u041d\u041a-\u0432\u0430\u043a\u0446\u0438\u043d\u0430"},{"lang":"ckb","url":"https://ckb.wikipedia.org/wiki/%DA%A9%D9%88%D8%AA%D8%A7%D9%88%DB%8C_%D8%AF%DB%8C_%D8%A6%DB%8E%D9%86_%D8%A6%DB%95%DB%8C","langname":"Central Kurdish","autonym":"\u06a9\u0648\u0631\u062f\u06cc","*":"\u06a9\u0648\u062a\u0627\u0648\u06cc \u062f\u06cc \u0626\u06ce\u0646 \u0626\u06d5\u06cc"},{"lang":"uk","url":"https://uk.wikipedia.org/wiki/%D0%94%D0%9D%D0%9A-%D0%B2%D0%B0%D0%BA%D1%86%D0%B8%D0%BD%D0%B0","langname":"Ukrainian","autonym":"\u0443\u043a\u0440\u0430\u0457\u043d\u0441\u044c\u043a\u0430","*":"\u0414\u041d\u041a-\u0432\u0430\u043a\u0446\u0438\u043d\u0430"}],"categories":[{"sortkey":"","hidden":"","*":"CS1_maint:_Multiple_names:_authors_list"},{"sortkey":"","hidden":"","*":"All_articles_with_unsourced_statements"},{"sortkey":"","hidden":"","*":"Articles_with_unsourced_statements_from_August_2015"},{"sortkey":"","*":"Gene_delivery"},{"sortkey":"","*":"DNA"},{"sortkey":"","*":"Vaccination"}],"links":[{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from August 2015"},{"ns":14,"exists":"","*":"Category:CS1 maint: Multiple names: authors list"},{"ns":10,"exists":"","*":"Template:Vaccines"},{"ns":0,"exists":"","*":"2009 flu pandemic vaccine"},{"ns":0,"exists":"","*":"AIDS"},{"ns":0,"exists":"","*":"ALVAC-CEA vaccine"},{"ns":0,"exists":"","*":"ATC code J07"},{"ns":0,"exists":"","*":"Adenovirus"},{"ns":0,"exists":"","*":"Adenovirus vaccine"},{"ns":0,"exists":"","*":"Adjuvants"},{"ns":0,"exists":"","*":"Advisory Committee on Immunization Practices"},{"ns":0,"exists":"","*":"Aerosol"},{"ns":0,"exists":"","*":"Allergic"},{"ns":0,"exists":"","*":"Alphavirus"},{"ns":0,"exists":"","*":"Alternative vaccination schedule"},{"ns":0,"exists":"","*":"Alum"},{"ns":0,"exists":"","*":"Amino-terminal"},{"ns":0,"exists":"","*":"Amino acids"},{"ns":0,"exists":"","*":"Andrew Wakefield"},{"ns":0,"exists":"","*":"Androvax"},{"ns":0,"exists":"","*":"Anthrax vaccines"},{"ns":0,"exists":"","*":"Antibody"},{"ns":0,"exists":"","*":"Antigen"},{"ns":0,"exists":"","*":"Antigen-presenting cell"},{"ns":0,"exists":"","*":"Antigen presenting cells"},{"ns":0,"exists":"","*":"Apicomplexan life cycle"},{"ns":0,"exists":"","*":"Artificial induction of immunity"},{"ns":0,"exists":"","*":"Attenuated vaccine"},{"ns":0,"exists":"","*":"Attenuated virus"},{"ns":0,"exists":"","*":"Autoimmune diseases"},{"ns":0,"exists":"","*":"B-cells"},{"ns":0,"exists":"","*":"BCG vaccine"},{"ns":0,"exists":"","*":"Bacterial"},{"ns":0,"exists":"","*":"Basal lamina"},{"ns":0,"exists":"","*":"Beta-globulin"},{"ns":0,"exists":"","*":"Biodegradable"},{"ns":0,"exists":"","*":"Bone marrow"},{"ns":0,"exists":"","*":"Brucellosis vaccine"},{"ns":0,"exists":"","*":"Bupivacaine"},{"ns":0,"exists":"","*":"CD154"},{"ns":0,"exists":"","*":"CD80"},{"ns":0,"exists":"","*":"CD86"},{"ns":0,"exists":"","*":"Calcium phosphate"},{"ns":0,"exists":"","*":"Cancer vaccine"},{"ns":0,"exists":"","*":"Capsid"},{"ns":0,"exists":"","*":"Carboxymethyl cellulose"},{"ns":0,"exists":"","*":"Caveolae"},{"ns":0,"exists":"","*":"Cedillo v. Secretary of Health and Human Services"},{"ns":0,"exists":"","*":"Cervarix"},{"ns":0,"exists":"","*":"Cetrimonium bromide"},{"ns":0,"exists":"","*":"Chikungunya vaccine"},{"ns":0,"exists":"","*":"Chimera (genetics)"},{"ns":0,"exists":"","*":"Cholera"},{"ns":0,"exists":"","*":"Cholera vaccine"},{"ns":0,"exists":"","*":"Cistron"},{"ns":0,"exists":"","*":"Clinical trial"},{"ns":0,"exists":"","*":"Codon"},{"ns":0,"exists":"","*":"Complementary DNA"},{"ns":0,"exists":"","*":"Conjugate vaccine"},{"ns":0,"exists":"","*":"Connective tissue"},{"ns":0,"exists":"","*":"Cowpox"},{"ns":0,"exists":"","*":"Cytokine"},{"ns":0,"exists":"","*":"Cytomegalovirus"},{"ns":0,"exists":"","*":"Cytomegalovirus vaccine"},{"ns":0,"exists":"","*":"Cytosolic"},{"ns":0,"exists":"","*":"Cytotoxic T-cell"},{"ns":0,"exists":"","*":"Cytotoxic T cell"},{"ns":0,"exists":"","*":"DNA"},{"ns":0,"exists":"","*":"DPT vaccine"},{"ns":0,"exists":"","*":"DTaP-IPV-HepB"},{"ns":0,"exists":"","*":"DTaP-IPV/Hib"},{"ns":0,"exists":"","*":"Dendritic cells"},{"ns":0,"exists":"","*":"Dengue vaccine"},{"ns":0,"exists":"","*":"Dermis"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Diphtheria"},{"ns":0,"exists":"","*":"Diphtheria vaccine"},{"ns":0,"exists":"","*":"Dryvax"},{"ns":0,"exists":"","*":"E. coli"},{"ns":0,"exists":"","*":"Ebola vaccine"},{"ns":0,"exists":"","*":"Electron microscopy"},{"ns":0,"exists":"","*":"Electroporation"},{"ns":0,"exists":"","*":"Endocytosis"},{"ns":0,"exists":"","*":"Endoplasmic reticulum"},{"ns":0,"exists":"","*":"Enzo Paoletti"},{"ns":0,"exists":"","*":"Epidemiology"},{"ns":0,"exists":"","*":"Epithelial"},{"ns":0,"exists":"","*":"Epitopes"},{"ns":0,"exists":"","*":"Epstein\u2013Barr virus vaccine"},{"ns":0,"exists":"","*":"Eradication of infectious diseases"},{"ns":0,"exists":"","*":"Eukaryotic"},{"ns":0,"exists":"","*":"Every Child by Two"},{"ns":0,"exists":"","*":"Expression library"},{"ns":0,"exists":"","*":"Fibroblasts"},{"ns":0,"exists":"","*":"Follicular dendritic cells"},{"ns":0,"exists":"","*":"Fusion protein"},{"ns":0,"exists":"","*":"GAVI Alliance"},{"ns":0,"exists":"","*":"GC-content"},{"ns":0,"exists":"","*":"GM-CSF"},{"ns":0,"exists":"","*":"Gardasil"},{"ns":0,"exists":"","*":"Gene gun"},{"ns":0,"exists":"","*":"Gene sequence"},{"ns":0,"exists":"","*":"Gene therapy"},{"ns":0,"exists":"","*":"Genetic code"},{"ns":0,"exists":"","*":"Genetically engineered"},{"ns":0,"exists":"","*":"Genome"},{"ns":0,"exists":"","*":"Gold"},{"ns":0,"exists":"","*":"Growth hormone"},{"ns":0,"exists":"","*":"Guanine"},{"ns":0,"exists":"","*":"HIV vaccine"},{"ns":0,"exists":"","*":"HPV vaccines"},{"ns":0,"exists":"","*":"Haemagglutinin"},{"ns":0,"exists":"","*":"Hantavirus vaccine"},{"ns":0,"exists":"","*":"Helium"},{"ns":0,"exists":"","*":"Helminthiasis"},{"ns":0,"exists":"","*":"Helper T cell"},{"ns":0,"exists":"","*":"Hepatitis"},{"ns":0,"exists":"","*":"Hepatitis A vaccine"},{"ns":0,"exists":"","*":"Hepatitis B"},{"ns":0,"exists":"","*":"Hepatitis B vaccine"},{"ns":0,"exists":"","*":"Hepatitis C vaccine"},{"ns":0,"exists":"","*":"Hepatitis E vaccine"},{"ns":0,"exists":"","*":"Herpes simplex virus"},{"ns":0,"exists":"","*":"Heterologous vaccine"},{"ns":0,"exists":"","*":"Hexavalent vaccine"},{"ns":0,"exists":"","*":"Hib vaccine"},{"ns":0,"exists":"","*":"Hookworm vaccine"},{"ns":0,"exists":"","*":"Horse"},{"ns":0,"exists":"","*":"Human lung"},{"ns":0,"exists":"","*":"Human nose"},{"ns":0,"exists":"","*":"IL18BP"},{"ns":0,"exists":"","*":"Immune receptor"},{"ns":0,"exists":"","*":"Immune system"},{"ns":0,"exists":"","*":"Immunization"},{"ns":0,"exists":"","*":"Immunocompromised"},{"ns":0,"exists":"","*":"Immunoglobulins"},{"ns":0,"exists":"","*":"Immunologic adjuvant"},{"ns":0,"exists":"","*":"Immunological response"},{"ns":0,"exists":"","*":"Inactivated vaccine"},{"ns":0,"exists":"","*":"Infection"},{"ns":0,"exists":"","*":"Influenza"},{"ns":0,"exists":"","*":"Influenza vaccine"},{"ns":0,"exists":"","*":"Innate immune response"},{"ns":0,"exists":"","*":"Inoculation"},{"ns":0,"exists":"","*":"Institute of Genomics and Integrative Biology"},{"ns":0,"exists":"","*":"Interferon alfa-2b"},{"ns":0,"exists":"","*":"Interferon gamma"},{"ns":0,"exists":"","*":"Interleukin"},{"ns":0,"exists":"","*":"Interleukin-4 receptor"},{"ns":0,"exists":"","*":"Interleukin 10"},{"ns":0,"exists":"","*":"Interleukins"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"Introns"},{"ns":0,"exists":"","*":"JSTOR"},{"ns":0,"exists":"","*":"Japanese encephalitis vaccine"},{"ns":0,"exists":"","*":"Keratinocytes"},{"ns":0,"exists":"","*":"Langerhans cell"},{"ns":0,"exists":"","*":"Langerhans cells"},{"ns":0,"exists":"","*":"Leptospirosis vaccine"},{"ns":0,"exists":"","*":"Lipid"},{"ns":0,"exists":"","*":"Liposome"},{"ns":0,"exists":"","*":"Liposomes"},{"ns":0,"exists":"","*":"List of vaccine ingredients"},{"ns":0,"exists":"","*":"List of vaccine topics"},{"ns":0,"exists":"","*":"List of withdrawn drugs"},{"ns":0,"exists":"","*":"Listeria"},{"ns":0,"exists":"","*":"Live attenuated influenza vaccine"},{"ns":0,"exists":"","*":"Live vector vaccine"},{"ns":0,"exists":"","*":"Lyme disease vaccine"},{"ns":0,"exists":"","*":"Lymph node"},{"ns":0,"exists":"","*":"Lymphokine"},{"ns":0,"exists":"","*":"MHC class I"},{"ns":0,"exists":"","*":"MHC class II"},{"ns":0,"exists":"","*":"MMRV vaccine"},{"ns":0,"exists":"","*":"MMR vaccine"},{"ns":0,"exists":"","*":"MMR vaccine controversy"},{"ns":0,"exists":"","*":"MRNA"},{"ns":0,"exists":"","*":"Macrophage"},{"ns":0,"exists":"","*":"Major histocompatibility complex"},{"ns":0,"exists":"","*":"Malaria"},{"ns":0,"exists":"","*":"Malaria vaccine"},{"ns":0,"exists":"","*":"Mathematical modelling of infectious disease"},{"ns":0,"exists":"","*":"MeNZB"},{"ns":0,"exists":"","*":"Measles vaccine"},{"ns":0,"exists":"","*":"Meningococcal vaccine"},{"ns":0,"exists":"","*":"Mucosa"},{"ns":0,"exists":"","*":"Mucosal"},{"ns":0,"exists":"","*":"Mumps vaccine"},{"ns":0,"exists":"","*":"Mumpsvax"},{"ns":0,"exists":"","*":"Murine"},{"ns":0,"exists":"","*":"Muscle"},{"ns":0,"exists":"","*":"Mycoplasma"},{"ns":0,"exists":"","*":"N-terminal"},{"ns":0,"exists":"","*":"National Childhood Vaccine Injury Act"},{"ns":0,"exists":"","*":"National Institutes of Health"},{"ns":0,"exists":"","*":"NicVAX"},{"ns":0,"exists":"","*":"NmVac4-A/C/Y/W-135"},{"ns":0,"exists":"","*":"Oligomer"},{"ns":0,"exists":"","*":"Ovandrotone albumin"},{"ns":0,"exists":"","*":"PROSTVAC"},{"ns":0,"exists":"","*":"Pandemrix"},{"ns":0,"exists":"","*":"Parasitic"},{"ns":0,"exists":"","*":"Pathogen"},{"ns":0,"exists":"","*":"Pentavalent vaccine"},{"ns":0,"exists":"","*":"Peptide vaccine"},{"ns":0,"exists":"","*":"Peptides"},{"ns":0,"exists":"","*":"Pertussis vaccine"},{"ns":0,"exists":"","*":"Phagocytosis"},{"ns":0,"exists":"","*":"Phases of clinical research"},{"ns":0,"exists":"","*":"Pinocytosis"},{"ns":0,"exists":"","*":"Plague vaccine"},{"ns":0,"exists":"","*":"Plasma membrane"},{"ns":0,"exists":"","*":"Plasmids"},{"ns":0,"exists":"","*":"Plasmodium chabaudi"},{"ns":0,"exists":"","*":"Plasmodium yoelii"},{"ns":0,"exists":"","*":"Pneumococcal conjugate vaccine"},{"ns":0,"exists":"","*":"Pneumococcal polysaccharide vaccine"},{"ns":0,"exists":"","*":"Pneumococcal vaccine"},{"ns":0,"exists":"","*":"Polio"},{"ns":0,"exists":"","*":"Polio vaccine"},{"ns":0,"exists":"","*":"Polyadenylation"},{"ns":0,"exists":"","*":"Polymers"},{"ns":0,"exists":"","*":"Pox party"},{"ns":0,"exists":"","*":"Poxviridae"},{"ns":0,"exists":"","*":"Primates"},{"ns":0,"exists":"","*":"Promoter (biology)"},{"ns":0,"exists":"","*":"Protein"},{"ns":0,"exists":"","*":"Protein conformation"},{"ns":0,"exists":"","*":"Protein sequence"},{"ns":0,"exists":"","*":"Protein subunit"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Purine"},{"ns":0,"exists":"","*":"Pyrimidine"},{"ns":0,"exists":"","*":"QS21"},{"ns":0,"exists":"","*":"Q fever vaccine"},{"ns":0,"exists":"","*":"RTS,S"},{"ns":0,"exists":"","*":"Rabies vaccine"},{"ns":0,"exists":"","*":"Recombinant DNA"},{"ns":0,"exists":"","*":"Recombinant cytokine"},{"ns":0,"exists":"","*":"Replicon (genetics)"},{"ns":0,"exists":"","*":"Rhesus monkeys"},{"ns":0,"exists":"","*":"Ribonucleotides"},{"ns":0,"exists":"","*":"Rotavirus"},{"ns":0,"exists":"","*":"Rotavirus vaccine"},{"ns":0,"exists":"","*":"Rous Sarcoma Virus"},{"ns":0,"exists":"","*":"Rubella vaccine"},{"ns":0,"exists":"","*":"SV40"},{"ns":0,"exists":"","*":"Sabin polio vaccine"},{"ns":0,"exists":"","*":"Saline (medicine)"},{"ns":0,"exists":"","*":"Salk polio vaccine"},{"ns":0,"exists":"","*":"Salmonella"},{"ns":0,"exists":"","*":"Schistosomiasis vaccine"},{"ns":0,"exists":"","*":"Semliki Forest virus"},{"ns":0,"exists":"","*":"Shigella"},{"ns":0,"exists":"","*":"Simian"},{"ns":0,"exists":"","*":"Simian retrovirus"},{"ns":0,"exists":"","*":"Sindbis virus"},{"ns":0,"exists":"","*":"Skeletal muscle"},{"ns":0,"exists":"","*":"Smallpox"},{"ns":0,"exists":"","*":"Smallpox vaccine"},{"ns":0,"exists":"","*":"Spleen"},{"ns":0,"exists":"","*":"Sucrose"},{"ns":0,"exists":"","*":"TA-CD"},{"ns":0,"exists":"","*":"TA-NIC"},{"ns":0,"exists":"","*":"Tetanus"},{"ns":0,"exists":"","*":"Tetanus vaccine"},{"ns":0,"exists":"","*":"Thiomersal controversy"},{"ns":0,"exists":"","*":"Tick-borne encephalitis vaccine"},{"ns":0,"exists":"","*":"Timeline of vaccines"},{"ns":0,"exists":"","*":"Toxoid"},{"ns":0,"exists":"","*":"Transcription (genetics)"},{"ns":0,"exists":"","*":"Translation (biology)"},{"ns":0,"exists":"","*":"Trypanosomiasis vaccine"},{"ns":0,"exists":"","*":"Tuberculosis vaccines"},{"ns":0,"exists":"","*":"Tumor necrosis factor"},{"ns":0,"exists":"","*":"Tumor necrosis factor alpha"},{"ns":0,"exists":"","*":"Tungsten"},{"ns":0,"exists":"","*":"Ty21a"},{"ns":0,"exists":"","*":"Typhoid vaccine"},{"ns":0,"exists":"","*":"Typhus"},{"ns":0,"exists":"","*":"Typhus vaccine"},{"ns":0,"exists":"","*":"Ubenimex"},{"ns":0,"exists":"","*":"Ubiquitin"},{"ns":0,"exists":"","*":"Vaccination"},{"ns":0,"exists":"","*":"Vaccination policy"},{"ns":0,"exists":"","*":"Vaccination schedule"},{"ns":0,"exists":"","*":"Vaccine"},{"ns":0,"exists":"","*":"Vaccine Adverse Event Reporting System"},{"ns":0,"exists":"","*":"Vaccine Safety Datalink"},{"ns":0,"exists":"","*":"Vaccine controversies"},{"ns":0,"exists":"","*":"Vaccine court"},{"ns":0,"exists":"","*":"Vaccine injury"},{"ns":0,"exists":"","*":"Vaccine trial"},{"ns":0,"exists":"","*":"Vaccines for Children Program"},{"ns":0,"exists":"","*":"Vaccinia"},{"ns":0,"exists":"","*":"Varicella vaccine"},{"ns":0,"exists":"","*":"Vector DNA"},{"ns":0,"exists":"","*":"Veterinary"},{"ns":0,"exists":"","*":"Veterinary medicine"},{"ns":0,"exists":"","*":"Vi capsular polysaccharide vaccine"},{"ns":0,"exists":"","*":"Virus"},{"ns":0,"exists":"","*":"Virus-like particle"},{"ns":0,"exists":"","*":"WHO Model List of Essential Medicines"},{"ns":0,"exists":"","*":"West Nile virus"},{"ns":0,"exists":"","*":"Yellow fever vaccine"},{"ns":0,"exists":"","*":"Zika virus"},{"ns":0,"exists":"","*":"Zoster vaccine"},{"ns":4,"exists":"","*":"Wikipedia:Citation needed"},{"ns":11,"exists":"","*":"Template talk:Vaccines"}],"templates":[{"ns":10,"exists":"","*":"Template:Toclimit"},{"ns":10,"exists":"","*":"Template:TOC limit"},{"ns":10,"exists":"","*":"Template:Citation needed"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Vaccines"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":10,"exists":"","*":"Template:PharmNavFootnote"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:Navbar"}],"images":["Lock-green.svg","Making_of_a_DNA_vaccine.jpg","Gene_therapy.jpg","Antigen_presentation.svg","Antibody.svg","Dendritic_cell.JPG"],"externallinks":["//doi.org/10.1016/S0065-308X(08)60152-9","//www.ncbi.nlm.nih.gov/pubmed/10050276","//doi.org/10.1016/S0065-3527(00)55001-5","//www.ncbi.nlm.nih.gov/pubmed/11050940","//www.ncbi.nlm.nih.gov/pmc/articles/PMC384256","//doi.org/10.1073/pnas.80.17.5364","//www.ncbi.nlm.nih.gov/pmc/articles/PMC344637","//doi.org/10.1073/pnas.81.1.193","https://www.technologyreview.com/s/602073/us-government-starts-test-of-zika-vaccine-in-humans/?set=602081","http://www.highbeam.com/doc/1G1-134116417.html","https://web.archive.org/web/20070820194311/http://www.cdc.gov/od/oc/media/pressrel/r050718.htm","https://www.cdc.gov/od/oc/media/pressrel/r050718.htm","//www.ncbi.nlm.nih.gov/pmc/articles/PMC44918","//doi.org/10.1073/pnas.91.21.9866","//www.jstor.org/stable/2365723","//www.ncbi.nlm.nih.gov/pubmed/7937907","http://www.jimmunol.org/cgi/content/abstract/155/4/2039","//www.ncbi.nlm.nih.gov/pubmed/7636255","http://www.jimmunol.org/cgi/content/abstract/159/12/6112","//www.ncbi.nlm.nih.gov/pubmed/9550412","http://linkinghub.elsevier.com/retrieve/pii/002217599600035X","//doi.org/10.1016/0022-1759(96)00035-X","//www.ncbi.nlm.nih.gov/pubmed/8690928","https://books.google.com/books?id=lrMc3G9nIpkC&pg=PA129&dq=lewis","//doi.org/10.1016/S0065-3527(08)60367-X","//www.ncbi.nlm.nih.gov/pubmed/10547676","http://jvi.asm.org/cgi/content/abstract/72/2/1497","//www.ncbi.nlm.nih.gov/pmc/articles/PMC124631","//www.ncbi.nlm.nih.gov/pubmed/9445053","http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WXR-49KGT6R-6&_user=489256&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000022721&_version=1&_urlVersion=0&_userid=489256&md5=5ac81624c72867e12d2a89d0aa3cfc6b","//doi.org/10.1016/S0042-6822(03)00459-8","//www.ncbi.nlm.nih.gov/pubmed/14517067","http://www.sciencedirect.com/science/article/pii/S0167779909001164","//doi.org/10.1016/j.tibtech.2009.06.004","//doi.org/10.1016/j.tibtech.2013.06.001","//www.ncbi.nlm.nih.gov/pubmed/23830144","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4317294","//doi.org/10.1038/nrg2432","//www.ncbi.nlm.nih.gov/pubmed/18781156","//www.ncbi.nlm.nih.gov/pmc/articles/PMC192313","//www.ncbi.nlm.nih.gov/pubmed/9343207","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2196169","//doi.org/10.1084/jem.185.5.909","//www.ncbi.nlm.nih.gov/pubmed/9120397","//doi.org/10.1158/1535-7163.MCT-08-0109","//www.ncbi.nlm.nih.gov/pmc/articles/PMC101545","//doi.org/10.1128/IAI.68.10.5839-5845.2000","//www.ncbi.nlm.nih.gov/pubmed/10992493","http://www.sciamdigital.com/gsp_qpdf.cfm?ISSUEID_CHAR=8FF32714-CA1C-4025-BE8D-0FE4B5C348B&ARTICLEID_CHAR=14F98F90-1708-4B77-A8D4-44F867A153F","http://www.jimmunol.org/cgi/content/abstract/164/9/4635","//doi.org/10.4049/jimmunol.164.9.4635","//www.ncbi.nlm.nih.gov/pubmed/10779767","//www.ncbi.nlm.nih.gov/pmc/articles/PMC48007","//doi.org/10.1073/pnas.90.24.11478","//www.ncbi.nlm.nih.gov/pubmed/8265577","http://www.jimmunol.org/cgi/content/abstract/159/4/1945","//www.ncbi.nlm.nih.gov/pubmed/9257860","http://www.jimmunol.org/cgi/content/abstract/160/5/2425","//www.ncbi.nlm.nih.gov/pubmed/9498786","//doi.org/10.1196/annals.1322.012","http://www.sciencemag.org/cgi/pmidlookup?view=long&pmid=7569980","//doi.org/10.1126/science.270.5234.299","//www.ncbi.nlm.nih.gov/pubmed/7569980","http://www.buffalo.edu/news/releases/2014/11/035.html","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4151754","//doi.org/10.1073/pnas.1411355111","//www.ncbi.nlm.nih.gov/pubmed/25114239","//doi.org/10.1038/377632a0","//www.ncbi.nlm.nih.gov/pubmed/7566175","http://www.jimmunol.org/cgi/content/abstract/158/5/2278","//www.ncbi.nlm.nih.gov/pubmed/9036975","//www.ncbi.nlm.nih.gov/pmc/articles/PMC191015","//www.ncbi.nlm.nih.gov/pubmed/8971047","//www.ncbi.nlm.nih.gov/pmc/articles/PMC191766","//www.ncbi.nlm.nih.gov/pubmed/9188598","//doi.org/10.1038/32588","//www.ncbi.nlm.nih.gov/pubmed/9521319","http://www.jimmunol.org/cgi/content/abstract/161/6/3042","//www.ncbi.nlm.nih.gov/pubmed/9743369","//www.ncbi.nlm.nih.gov/pmc/articles/PMC39421","//doi.org/10.1073/pnas.93.10.5141","//www.ncbi.nlm.nih.gov/pubmed/8643542","http://jvi.asm.org/cgi/pmidlookup?view=long&pmid=9060624","//www.ncbi.nlm.nih.gov/pmc/articles/PMC191393","//www.ncbi.nlm.nih.gov/pubmed/9060624","http://www.jimmunol.org/cgi/content/abstract/154/9/4414","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1952186","//www.ncbi.nlm.nih.gov/pubmed/7722298","http://www.jimmunol.org/cgi/content/abstract/158/10/4591","//www.ncbi.nlm.nih.gov/pubmed/9144471","http://www.jimmunol.org/cgi/content/abstract/161/5/2325","//www.ncbi.nlm.nih.gov/pubmed/9725227","http://www.jimmunol.org/cgi/content/abstract/158/8/4008","//www.ncbi.nlm.nih.gov/pubmed/9103472","http://linkinghub.elsevier.com/retrieve/pii/S0042682296905012","//doi.org/10.1006/viro.1996.0501","//www.ncbi.nlm.nih.gov/pubmed/8862394","//doi.org/10.1016/j.vaccine.2005.08.013","//www.ncbi.nlm.nih.gov/pubmed/16310901","http://jcs.biologists.org/cgi/pmidlookup?view=long&pmid=1487500","//www.ncbi.nlm.nih.gov/pubmed/1487500","http://www.sciencemag.org/cgi/pmidlookup?view=long&pmid=1310359","//doi.org/10.1126/science.1310359","//www.ncbi.nlm.nih.gov/pubmed/1310359","http://www.jem.org/cgi/pmidlookup?view=long&pmid=9348305","//doi.org/10.1084/jem.186.9.1481","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2199124","//www.ncbi.nlm.nih.gov/pubmed/9348305","//www.ncbi.nlm.nih.gov/pmc/articles/PMC424340","//doi.org/10.1172/JCI112226","//www.ncbi.nlm.nih.gov/pubmed/3001145","http://www.jimmunol.org/cgi/content/abstract/140/9/2937","//www.ncbi.nlm.nih.gov/pubmed/2452195","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2192808","//doi.org/10.1084/jem.184.4.1555","//www.ncbi.nlm.nih.gov/pubmed/8879229","http://www.jimmunol.org/cgi/content/abstract/160/12/5707","//www.ncbi.nlm.nih.gov/pubmed/9637479","http://www.jimmunol.org/cgi/pmidlookup?view=long&pmid=9144463","//www.ncbi.nlm.nih.gov/pubmed/9144463","http://www.jimmunol.org/cgi/content/abstract/159/4/2001","//www.ncbi.nlm.nih.gov/pubmed/9257867","//www.ncbi.nlm.nih.gov/pmc/articles/PMC38020","//doi.org/10.1073/pnas.93.22.12496","//www.ncbi.nlm.nih.gov/pubmed/8901610","http://www.jimmunol.org/cgi/content/abstract/163/2/884","//www.ncbi.nlm.nih.gov/pubmed/10395683","http://linkinghub.elsevier.com/retrieve/pii/S0042682296906030","//doi.org/10.1006/viro.1996.0603","//www.ncbi.nlm.nih.gov/pubmed/8918915","//doi.org/10.1126/science.273.5273.352","//www.ncbi.nlm.nih.gov/pubmed/8662521","//www.ncbi.nlm.nih.gov/pmc/articles/PMC101554","//doi.org/10.1128/IAI.68.10.5914-5919.2000","//www.ncbi.nlm.nih.gov/pubmed/10992502","http://www.jimmunol.org/cgi/content/abstract/164/11/5905","//doi.org/10.4049/jimmunol.164.11.5905","//www.ncbi.nlm.nih.gov/pubmed/10820272","http://www.jimmunol.org/cgi/content/abstract/161/4/1875","//www.ncbi.nlm.nih.gov/pubmed/9712056","//doi.org/10.1038/374546a0","//www.ncbi.nlm.nih.gov/pubmed/7700380","http://www.jimmunol.org/cgi/content/abstract/158/8/3635","//www.ncbi.nlm.nih.gov/pubmed/9103425","//www.ncbi.nlm.nih.gov/pmc/articles/PMC22882","//doi.org/10.1073/pnas.95.21.12631","//www.ncbi.nlm.nih.gov/pubmed/9770537","//www.ncbi.nlm.nih.gov/pmc/articles/PMC39727","//doi.org/10.1073/pnas.93.7.2879","//www.ncbi.nlm.nih.gov/pubmed/8610135","http://www.jimmunol.org/cgi/content/abstract/156/2/558","//www.ncbi.nlm.nih.gov/pubmed/8543806","//www.ncbi.nlm.nih.gov/pmc/articles/PMC23198","//doi.org/10.1073/pnas.94.17.9378","//www.ncbi.nlm.nih.gov/pubmed/9256490","//www.ncbi.nlm.nih.gov/pmc/articles/PMC22711","//doi.org/10.1073/pnas.95.13.7648","//www.ncbi.nlm.nih.gov/pubmed/9636204","//www.ncbi.nlm.nih.gov/pmc/articles/PMC98670","//doi.org/10.1128/IAI.69.9.5565-5572.2001","//www.ncbi.nlm.nih.gov/pubmed/11500430","http://www.powdermed.com/pdf/PowderMed.Vaccine_Study%20FINAL%20260506.pdf","http://202.54.26.221/","http://jvi.asm.org/cgi/pmidlookup?view=long&pmid=15078924","//doi.org/10.1128/JVI.78.9.4433-4443.2004","//www.ncbi.nlm.nih.gov/pmc/articles/PMC387704","//www.ncbi.nlm.nih.gov/pubmed/15078924"],"sections":[{"toclevel":1,"level":"2","line":"History","number":"1","index":"1","fromtitle":"DNA_vaccination","byteoffset":739,"anchor":"History"},{"toclevel":2,"level":"3","line":"Whole organism","number":"1.1","index":"2","fromtitle":"DNA_vaccination","byteoffset":1078,"anchor":"Whole_organism"},{"toclevel":2,"level":"3","line":"Subunit","number":"1.2","index":"3","fromtitle":"DNA_vaccination","byteoffset":2198,"anchor":"Subunit"},{"toclevel":2,"level":"3","line":"DNA","number":"1.3","index":"4","fromtitle":"DNA_vaccination","byteoffset":2610,"anchor":"DNA"},{"toclevel":1,"level":"2","line":"Applications","number":"2","index":"5","fromtitle":"DNA_vaccination","byteoffset":5925,"anchor":"Applications"},{"toclevel":1,"level":"2","line":"Advantages and disadvantages","number":"3","index":"6","fromtitle":"DNA_vaccination","byteoffset":7016,"anchor":"Advantages_and_disadvantages"},{"toclevel":1,"level":"2","line":"Plasmid vectors","number":"4","index":"7","fromtitle":"DNA_vaccination","byteoffset":8863,"anchor":"Plasmid_vectors"},{"toclevel":2,"level":"3","line":"Vector design","number":"4.1","index":"8","fromtitle":"DNA_vaccination","byteoffset":8886,"anchor":"Vector_design"},{"toclevel":2,"level":"3","line":"Mechanism of plasmids","number":"4.2","index":"9","fromtitle":"DNA_vaccination","byteoffset":16300,"anchor":"Mechanism_of_plasmids"},{"toclevel":2,"level":"3","line":"Vaccine insert design","number":"4.3","index":"10","fromtitle":"DNA_vaccination","byteoffset":16986,"anchor":"Vaccine_insert_design"},{"toclevel":1,"level":"2","line":"Delivery","number":"5","index":"11","fromtitle":"DNA_vaccination","byteoffset":19751,"anchor":"Delivery"},{"toclevel":2,"level":"3","line":"Saline injection","number":"5.1","index":"12","fromtitle":"DNA_vaccination","byteoffset":19936,"anchor":"Saline_injection"},{"toclevel":2,"level":"3","line":"Gene gun","number":"5.2","index":"13","fromtitle":"DNA_vaccination","byteoffset":21762,"anchor":"Gene_gun"},{"toclevel":2,"level":"3","line":"Dosage","number":"5.3","index":"14","fromtitle":"DNA_vaccination","byteoffset":22034,"anchor":"Dosage"},{"toclevel":2,"level":"3","line":"Alternatives","number":"5.4","index":"15","fromtitle":"DNA_vaccination","byteoffset":23395,"anchor":"Alternatives"},{"toclevel":1,"level":"2","line":"Immune response","number":"6","index":"16","fromtitle":"DNA_vaccination","byteoffset":30254,"anchor":"Immune_response"},{"toclevel":2,"level":"3","line":"Helper T cell responses","number":"6.1","index":"17","fromtitle":"DNA_vaccination","byteoffset":30277,"anchor":"Helper_T_cell_responses"},{"toclevel":3,"level":"4","line":"Other types of T-cell help","number":"6.1.1","index":"18","fromtitle":"DNA_vaccination","byteoffset":31834,"anchor":"Other_types_of_T-cell_help"},{"toclevel":3,"level":"4","line":"Basis for different types of T-cell help","number":"6.1.2","index":"19","fromtitle":"DNA_vaccination","byteoffset":33846,"anchor":"Basis_for_different_types_of_T-cell_help"},{"toclevel":3,"level":"4","line":"Practical uses of polarised T-cell help","number":"6.1.3","index":"20","fromtitle":"DNA_vaccination","byteoffset":35621,"anchor":"Practical_uses_of_polarised_T-cell_help"},{"toclevel":2,"level":"3","line":"Cytotoxic T-cell responses","number":"6.2","index":"21","fromtitle":"DNA_vaccination","byteoffset":36691,"anchor":"Cytotoxic_T-cell_responses"},{"toclevel":2,"level":"3","line":"Humoral (antibody) response","number":"6.3","index":"22","fromtitle":"DNA_vaccination","byteoffset":41577,"anchor":"Humoral_(antibody)_response"},{"toclevel":3,"level":"4","line":"Kinetics of antibody response","number":"6.3.1","index":"23","fromtitle":"DNA_vaccination","byteoffset":41936,"anchor":"Kinetics_of_antibody_response"},{"toclevel":1,"level":"2","line":"Mechanistic basis for DNA-raised immune responses","number":"7","index":"24","fromtitle":"DNA_vaccination","byteoffset":45772,"anchor":"Mechanistic_basis_for_DNA-raised_immune_responses"},{"toclevel":2,"level":"3","line":"DNA uptake mechanism","number":"7.1","index":"25","fromtitle":"DNA_vaccination","byteoffset":45829,"anchor":"DNA_uptake_mechanism"},{"toclevel":2,"level":"3","line":"Antigen presentation by bone marrow-derived cells","number":"7.2","index":"26","fromtitle":"DNA_vaccination","byteoffset":49580,"anchor":"Antigen_presentation_by_bone_marrow-derived_cells"},{"toclevel":2,"level":"3","line":"Target site role","number":"7.3","index":"27","fromtitle":"DNA_vaccination","byteoffset":51990,"anchor":"Target_site_role"},{"toclevel":2,"level":"3","line":"Maintenance of immune response","number":"7.4","index":"28","fromtitle":"DNA_vaccination","byteoffset":52829,"anchor":"Maintenance_of_immune_response"},{"toclevel":2,"level":"3","line":"Interferons","number":"7.5","index":"29","fromtitle":"DNA_vaccination","byteoffset":53333,"anchor":"Interferons"},{"toclevel":1,"level":"2","line":"Immune response modulation","number":"8","index":"30","fromtitle":"DNA_vaccination","byteoffset":55501,"anchor":"Immune_response_modulation"},{"toclevel":2,"level":"3","line":"Cytokine modulation","number":"8.1","index":"31","fromtitle":"DNA_vaccination","byteoffset":55535,"anchor":"Cytokine_modulation"},{"toclevel":2,"level":"3","line":"Immunostimulatory CpG motifs","number":"8.2","index":"32","fromtitle":"DNA_vaccination","byteoffset":61810,"anchor":"Immunostimulatory_CpG_motifs"},{"toclevel":2,"level":"3","line":"Alternative boosts","number":"8.3","index":"33","fromtitle":"DNA_vaccination","byteoffset":67071,"anchor":"Alternative_boosts"},{"toclevel":2,"level":"3","line":"Enhancing immune responses","number":"8.4","index":"34","fromtitle":"DNA_vaccination","byteoffset":71004,"anchor":"Enhancing_immune_responses"},{"toclevel":3,"level":"4","line":"DNA","number":"8.4.1","index":"35","fromtitle":"DNA_vaccination","byteoffset":71040,"anchor":"DNA_2"},{"toclevel":3,"level":"4","line":"Alphavirus vectors","number":"8.4.2","index":"36","fromtitle":"DNA_vaccination","byteoffset":71700,"anchor":"Alphavirus_vectors"},{"toclevel":1,"level":"2","line":"See also","number":"9","index":"37","fromtitle":"DNA_vaccination","byteoffset":72600,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"10","index":"38","fromtitle":"DNA_vaccination","byteoffset":72671,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"11","index":"39","fromtitle":"DNA_vaccination","byteoffset":72707,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"DNA vaccination","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q578537"}]}}